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Abstract
The concept that complex cellular behavior is driven by an intricate network of
biomolecular interactions, which emerged through billions of years of evolution, is one of the
great wonders of nature. Living cells must constantly assimilate vital information from the
surrounding environment and respond appropriately. Such responses include growth,
proliferation, migration, and even death. Much of this activity is tightly regulated through
elaborately integrated signal transduction pathways - sometimes involving hundreds of cellular
components.
In order to further our understanding of the basic molecular machinery responsible for
coordinating life processes at the cellular level, new tools are required. Fluorescence methods
have formed a cornerstone of modern cell biology and have allowed researchers to interrogate
the dynamics of many biomolecular events in real-time. However, the criteria for a good
fluorescent probe are often numerous and demanding, particularly when considering applications
in complex chemical environments like that of a living cell. Tradeoffs often exist between
variables such as good extinction coefficients, suitable wavelengths of excitation and emission,
thermal and photochemical stability, size, and others.
Here in, we report a new series of fluorescent tools based on the solvatochromic 4-N,N-
dimethylamino-1,8-naphthalimide (4-DMN) fluorophore for the study of biomolecular
interactions. This fluorophore is distinctive in that it yields very few compromises by combining
many of the key elements required of a good fluorescent tool. It can be excited in the visible
spectrum (400-450 nm), thus minimizing the damaging effects of high-energy UV light;
derivatives of the dye can be prepared in few synthetic steps for facile incorporation into
peptides and proteins; it is highly stable to a wide range of chemical conditions; and it possesses
extremely sensitive switch-like fluorescent properties capable of responding to subtle changes in
the local solvent environment. This thesis chronicles the design and validation of a new
fluorescent amino acid of the 4-DMN dye as well as. a series of thiol-modifying agents for
application in protein and peptide studies. The power of these new tools is demonstrated using
the calcium binding protein calmodulin as a model system. Ongoing work to develop a sensitive
sensor of Cdc42 activity is also described.
Thesis Supervisor: Barbara Imperiali
Title: Class of 1922 Professor of Chemistry and Professor of Biology
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Chapter 1: Introduction of solvatochromic fluorophores as tools for studying
biomolecular interactions
1-1. The scope
Fluorescence techniques have become a vital component to the fields of molecular cell
biology and protein biochemistry. Many of these techniques include principles of fundamental
importance such as Firster resonance energy transfer (FRET),' fluorescence polarization (FP), 2
and fluorescence correlation spectroscopy (FCS) 3 as well as a broad assortment of fluorescent
dyes exhibiting unique and varied photophysical properties.4 Innovations in instrumentation
have enabled the application of many of these techniques in a wide array of formats ranging from
high throughput screening assays 5 for drug discovery to the latest in state-of-the-art super
resolution microscopy6 for in cellulo studies. Of particular interest are fluorescent dyes that
possess emission properties that are highly responsive to physical changes in the local
environment. Such environmental factors can include temperature, pH, viscosity, certain
biological analytes, and solvent polarity. By conjugating probes of this type to biologically
relevant molecules, it is possible to obtain valuable information regarding the functions,
activities, and interactions of such species in the context of living systems with great spatial and
temporal resolution.
This introductory chapter focuses on recent advances in the development and application
of a specific class of environment sensitive fluorophores that display a property known as
solvatochromism. Particular attention is devoted to the incorporation of these tools into peptides
and proteins to develop powerful sensors of biomolecular dynamics. In surveying a selection of
these applications, various methods that have been developed for the incorporation of such tools
are presented along with a brief analysis of the associated advantages and limitations.
1-2. Solvatochromism
Solvatochromic fluorophores possess emission properties (e.g. fluorescence lifetimes,
emission wavelengths, and fluorescence quantum yields) that are highly sensitive to the nature of
the immediate solvent environment. These effects are often most dramatic when comparing
these species in solvents of different polarities. The origin of this phenomenon is generalized in
the Jablonski diagram of Figure 1-1, which depicts the energies of the different electronic states
of the system. Beginning in the bottom left comer of the diagram, the fluorophore (large oval)
resides in the electronic ground state (So) surrounded by a sphere of solvent molecules (small
ovals). The electric dipole moment of the fluorophore is indicated by the black arrow with the
"+" sign at the positive terminus of the dipole. Upon absorbing a photon of appropriate energy
(hVA), the system is rapidly promoted to an excited singlet state (S'). During this event, the
system adopts a new electronic configuration with a dipole moment that differs significantly
from that of the ground state. In this case, the dipole has increased in magnitude. As described
by the Frank-Condon principle, the process of electronic excitation occurs on a time scale that is
much faster than that of the motions of atomic nuclei.7 Over a period of picoseconds, the dipoles
of the solvent sphere molecules reorient to accommodate the now larger dipole of the
fluorophore, resulting in a more highly ordered arrangement (upper left corner). This step,
termed solvent relaxation, ultimately lowers the energy of the excited singlet state while
simultaneously destabilizing the ground state thereby narrowing the energetic gap between the
two states. When the system finally returns to the ground state through a fluorescence event, the
emitted photon is of a much longer wavelength (i.e. lower energy, hvF) than that which was
originally absorbed during excitation. The degree of solvent relaxation increases with increasing
solvent polarity.
In some instances, the fluorophore will return spontaneously to the ground electronic
state through a thermal (non-radiative) decay process (kr) that competes with fluorescence. A
common feature among many solvatochromic fluorophores is the tendency to exhibit a marked
increase in non-radiative decay as the energy gap separating the SO and S1 states is reduced. This
effect is particularly apparent in polar protic solvents such as water, resulting in a decrease of the
fluorescence quantum yield. The mechanisms for such processes are varied and can include a
range of events such as internal charge transfer (ICT), tautomerization, isomerization, and
intersystem crossing (ISC) to an excited triplet state (T1).8 When non-radiative decay competes
strongly with fluorescence in polar solvents, the fluorophore can exhibit sensitive "switch-like"
emission properties upon perturbations to the ordering of the solvent sphere.
- internal
~ conversion
S1 (10 12s)
solvent relaxation - S1
hv A  (11s)
10"1s s hvy 
10'9 to 104 kr
solvent sphere O
Figure 1-1. Jablonski diagram depicting the effects of solvent relaxation on the emission properties of a typical
solvatochromic fluorophore (large oval). The molecules that comprise the immediate solvent sphere (small ovals)
are shown surrounding the fluorophore. Both the fluorophore and solvent molecules possess electric dipole
moments indicated by the large black arrow bearing a "+" at the positive end of the dipole for the fluorophore and
the red-blue poles for the solvent molecules.8
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1-3. Solvatochromic fluorophores commonly used in biological studies
The dynamic emission properties of solvatochromic fluorophores make these species
particularly well suited as potential tools for probing a variety of biomolecular interactions. For
instance, if the fluorophore were appended to the surface of a protein at a site that mediates a
transient protein-protein interaction, then the probe could report binding provided that the event
results in partial or complete extrusion of the surrounding solvent sphere. This basic strategy has
been successfully applied in the design of a number of fluorescent biosensors and has led to the
emergence of a host of solvatochromic probes with diverse properties, many of which are
currently available through commercial sources. 9
Selecting the appropriate fluorophore for a particular application involves a variety of
factors that must be considered. These factors can include such properties as extinction
coefficient, wavelengths of excitation and emission, quantum yields of fluorescence, size,
hydrophobicity, chemical stability, and reactivity. Often, it is difficult to identify a species that
possesses all of the desired attributes required for a given application. Fortunately, a number of
well established solvatochromic fluorophores (Chart 1-1) possessing overlapping subsets of these
traits have been developed offering researchers more choice over which compromises to accept.
For example, the merocyanine dyes l' possess exceptionally large extinction coefficients
with very long wavelengths of excitation that are ideal for in cellulo studies due to the
minimization of damaging effects of UV light and the potential for signal interference by
autofluorescence. However, these dyes are also large and exhibit rather subtle changes in both
fluorescence quantum yields and emission wavelengths in response to solvent polarity. A
fluorophore like PRODAN,9 on the other hand, is much smaller by comparison and can exhibit
wavelength shifts as great as 100 nm in the emission spectrum. The smaller chromophore size
reduces the likelihood that the probe will negatively impact the native function or activity of the
attached biomolecule. However, unlike the merocyanine derivatives, PRODAN is excited at
wavelengths below 400 nm and has an appreciably smaller extinction coefficient.
Chart 1-1. Established solvatochromic fluorophores used in peptide and protein studies
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The variation of the emission properties of many solvatochromic fluorophores are
difficult to directly compare as most of the studies have been conducted in different laboratories
under varying conditions and using different metrics (i.e. Lippert-Mataga plots8 versus the
ET(30) scale"l). Typically, comparisons are made by measuring the emission properties of the
fluorophores in a range of solvents or solvent mixtures. However, these studies are sometimes
complicated by the fact that the solubility of many of these species is restricted to a very narrow
range of solvents. Methods to overcome this limitation have been developed whereby the dye is
conjugated to another molecule to enhance solubility; 12 however the need still exists for a
standardized system by which the solvatochromic properties of all fluorophores may be
compared more directly and without bias. With that stated, there are a number of generalities
that can be made regarding each species without resorting to meta-analysis. For example, the
dimethylaminophthalimide dyes exhibit extremely weak fluorescence in aqueous buffers 12
providing the advantage of low background signal until the occurrence of an event that perturbs
the local environment. This creates the effect of "switch-like" fluorescence changes with the
potential to produce 1000-fold increases in emission intensity. The dapoxyl® dyes are noted for
the ability to exhibit shifts in emission wavelength greater than 200 nm in response to changes in
solvent polarity alone. 13 Other important properties for consideration are provided in Table 1-1.
Table 1-1. Physical pr perties of several solvatochromic fluorophore families
excitation
maximum MW
extinction coeff. eXCmax range charge
fluorophore family E (cm-1 M') (nm) (g mol 1) z (+/-) Refs
PRODAN 2.0 x 104  390 200 neutral 9
NBDa 2.5 x 104  480 180 neutral 9
Coumarin
derivatives 2.4 x 104 - 5.0 x 104 376-419 160-215 neutral 9
Dansyl derivatives 4.1 x 103 - 5.7 x 103 336-340 235-265 - / neutral 9
Dimethylamino- 6.5 x 103- 8.8 x 103  378-408 190- 240 neutral 12,14,1
phthalimides 5
Merocyanines 1.1 x 105-2.2 x 105 570-605 440-500 +/-/neutral 10
Dapoxyl®
derivatives 2.7 x 104 366- 370 280- 330 neutral 13
PyMPOb 2.3 x 104 412 250 + 9
(a) 7-nitrobenz-2-oxa-1,3-diazol-4-yl amine.
(b) 1-(2-maleimidylethyl)-4-(5-(4-methoxyphenyl)oxazol-2-yl)-pyridinium methanesulfonate.
1-4. Methods of incorporation into peptides and proteins
The same methods developed to introduce solvatochromic fluorophores into peptides and
proteins have been used in a multitude of applications for incorporating other unique
functionalities. These methods can broadly be divided into three categories: 1) direct covalent
modification of proteins; 2) incorporation of unnatural amino acids via expressed protein
ligation; and 3) incorporation of unnatural amino acids via suppression of the amber (TAG) stop
codon. Here, only a brief description of each approach is provided as these have been
thoroughly reviewed elsewhere. 9'
16
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Figure 1-2. Methods for site-selective and site-specific incorporation of solvatochromic fluorophores into protein.
(a) Direct labeling of a solvent exposed cysteine residue using a thiol-reactive agent.9,16 (b) Incorporation of an
unnatural amino acid possessing a solvatochromic fluorophore as the side chain group via suppression of the amber
stop codon. A tRNA molecule designed to recognize and read-through the amber codon is charged with the
23
unnatural amino acid. 17"18 (c) Expressed protein ligation involves a semisynthetic approach requiring either the N-
or C-terminal end of the protein to be prepared by solid phase peptide synthesis. The peptides are then ligated to the
portion of the protein construct that was expressed from a recombinant gene product. 
19-21
Direct covalent modification of proteins. A large number of methods for chemically
modifying proteins with various extrinsic fluorophores have been developed over the years.9' 16
However, not all of these methods are particularly effective for the design and development of
fluorescent protein sensors that rely on solvatochromic dyes. The reason for this resides in the
necessity for the dye to be located at a site on the protein surface that is within range of detecting
a key biomolecular event through some form of direct physical interaction. Protein labeling
methods that require specific peptide or protein motifs to direct labeling22 '2 3 may not offer
sufficient latitude in dye placement, which is typically required for optimizing the fluorescent
response. Lysine and cysteine reactive agents offer a convenient and direct method for labeling
proteins and have been used extensively to conjugate a myriad of auxiliary groups into proteins.
Most common among these are the thiol-selective electrophiles such as maleimides and a-
halocarbonyl compounds, along with the amine-selective acylating agents such as the 0-
succinimidyl esters (Figure 1-2a).
Cysteine residues are ideal for site-specific labeling of proteins as this amino acid occurs
relatively infrequently in many proteins"7 and possesses excellent nucleophilic properties under
most physiological conditions. This permits one to introduce the codon for a cysteine residue
site-specifically within a gene sequence of interest using standard molecular biology techniques.
In contrast, lysine residues are far more abundant in proteins 17 making selective site-specific
labeling of recombinant proteins less straightforward. Additionally, it is possible for amine-
reactive derivatives to label the a-amino group of the N-terminal residue of the protein.
Incorporation of unnatural amino acids via expressed protein ligation. Expressed
protein ligation (EPL)1 9-21 is a powerful semisynthetic approach for incorporating non-native
elements into proteins site-specifically. The technique, which has been used extensively,
involves expressing a truncated form of the desired protein construct to which a synthetically
prepared peptide is ligated at either the N- or C-terminus. The synthetic peptide that is prepared
then constitutes the omitted portion of the native protein, but includes an unnatural amino acid in
place of another residue. The most commonly employed ligation method requires one of the two
fragments to contain an N-terminal cysteine residue while the complementary fragment bears a
C-terminal thioester. The N-terminal cysteine residue facilitates ligation through an initial,
reversible transthioesterification step, followed immediately by an irreversible intramolecular
S-N acyl transfer resulting in the formation of an amide bond (Figure 1-2c).
Many solvatochromic fluorophores have been developed into unnatural amino acids for
incorporation into both peptide and protein biosensors through synthetic and semisynthetic
aproaches.12,14,15,24-28 The technique of EPL offers the advantage of yielding materials of greater
homogeneity than is typically achieved through direct chemical modification using thiol- or
amine-reactive labeling agents. However, EPL does require more synthetic steps and can be
limited by low yields of the desired product. Additionally, most applications of EPL have been
confined to modification of amino acids within approximately 40 residues of the N- and C-
termini of proteins. While methods have been developed to incorporate peptide inserts between
two recombinant protein fragments, this practice is less common due to the cumbersome nature
of performing sequential ligation steps. 29
Incorporation of unnatural amino acids via suppression of the amber stop codon.
Methods to expand the genetic code to include additional unnatural amino acids have been the
source of intense study by several research groups. 17 One of the more successful approaches
utilizes the amber stop codon (TAG) to code for a new amino acid. 18 The infrequent occurrence
of this codon in the genes of protein-expression systems like E. coli makes it ideally suited for
reassignment. 30 Early embodiments of the method involved the semisynthesis of an artificial
tRNA molecule designed to recognize the amber codon through base pairing of the anticodon
loop. Although different methods have been applied to prepare the suppressor tRNACUA
molecule, one of the more straightforward approaches utilizes a technique termed run-off
transcription. " The tRNACUA is transcribed from a DNA template such that it lacks the last two
nucleotides of the 3'-terminus. These components are then prepared synthetically as a
dinucleotide (pdCpA) charged with the desired unnatural amino acid. Using an enzymatic
reaction that requires T4 RNA ligase, the two fragments are then joined together generating the
final product. Once obtained, the artificial tRNA is introduced to a specially prepared cell
extract derived from E. coli (or in other cases derived from yeast or rabbit reticulocyte lysates)
that is rich in the molecular machinery necessary for protein synthesis. The gene of interest,
which has been mutated to incorporate the amber codon site-specifically, is then translated with
the unnatural amino acid successfully integrated into the peptide backbone at the desired position
(Figure 1-2b).
Drawbacks to the in vitro translation approach include the difficulty of synthesizing the
aminoacylated dinucleotide (AA-pdCpA) and the fact that protein yield is limited
stoichiometrically to the quantity of the suppressor tRNACUA added to the reaction. Furthermore,
suppression efficiency is generally low on average (20-30%)17 and can vary widely depending on
the nature of the amino acid, the gene to be expressed, the site within the gene that the amber
codon is located, and the protein expression system being used.
Currently, a great deal of attention is being focused on expanding the utility of this
approach by evolving novel aminoacyl-tRNA synthetase/suppressor tRNA pairs in E. coli,3 1
yeast 32 and mammalian cell 33 lines that may recognize unnatural amino acids. This in vivo
approach shows greater promise in yielding usable quantities of protein and has been utilized for
the incorporation of a wide range of tyrosine derivatives. However, the unnatural amino acid of
interest must first meet several criteria. It must be passively or actively transported into the host
cell and lack any toxic activity. Furthermore, it should be orthogonal to the native aminoacyl-
tRNA synthetases of the host such that it is not recognized as a substrate and used to misacylate
one of the endogenous tRNAs.
1-5. Design considerations when incorporating solvatochromicfluorophores into proteins
The design of a useful fluorescent protein or peptide biosensor often requires an
empirical approach guided by any available structural information regarding the interaction of
interest. On some occasions, the optimal placement of a solvatochromic fluorophore is readily
identified in that a well-defined hydrophobic pocket is already known, which can readily
accommodate the dye. An excellent example of this was the development of a series of
fluorogenic probes to detect peptide loading onto class II MHC proteins involved in the
activation of the adaptive immune response (Figure 1-3).34 Crystallographic data of the class II
MHC protein, HLA-DR1, in complex with a short peptide fragment (HA) derived from influenza
revealed a pronounced hydrophobic pocket (P1) that can bind large aliphatic or aromatic side
chains such as tyrosine. This position in the HA peptide chain was replaced with the fluorescent
amino acids 4-N,N-dimethylaminophthalimidoalanine (4-DAPA)' 5 and 6-N,N-dimethylamino-
2,3-naphthalimidoalanine (6-DMNA). 14 Upon binding to HLA-DR1, the peptide probes
exhibited 102 to 103-fold increases in fluorescence intensity without disrupting the binding
affinity or biological activity of the native complex.
Figure 1-3. Crystal structures of the class II MHC protein, HLA-DR1, in complex with (a) the native influenza-
derived HA peptide (PDB entry 1JWU) and (b) the HA peptide containing the 4-DAPA amino acid (PDB entry
2IPK). This figure was reproduced from Venkatraman et al.3
However, in most cases, determining the optimal site of fluorophore placement is
challenging even when exceptional structural data is available. Additionally, the pockets and
clefts that form the interface of an interaction can be of differing size, shape and charge thereby
admitting some fluorophores while prohibiting others. This has lead many researchers to resort
to screening-based methods to examine both placement and fluorophore type simultaneously.
When utilizing cysteine modifying agents to introduce a solvatochromic fluorophore, the
key is to identify residues that may be mutated without significantly disrupting the native
structure or function of the protein. Furthermore, it is important that the appended fluorophore is
positioned appropriately such that it is capable of producing an adequate signal without
negatively interfering with the interaction of interest. Recently, Zhu et al. reported the results of
a screening approach that produced an effective fluorescent sensor for the detection of a
signaling molecule used in bacterial quorum sensing. 35 A variety of cysteine mutants were
prepared from two protein receptors known to bind different forms of the bacterial autoinducer II
(AI-2). The receptors, LuxP and LsrB, exhibit structural similarity and consist of two domains
linked together by a hinge region with the ligand-binding site located at the interface. The
cysteine residues introduced at the periphery of this site were labeled with an assortment of
solvatochromic fluorophores, including derivatives of dansyl, PRODAN, NBD, dapoxyl®, and
PyMPO. One construct, a LuxP mutant (T137C) labeled with a dapoxyl derivative, was
identified to possess the desired optical properties. It was then compared with the wild-type
receptor by isothermal titration calorimetry (ITC). Although the cysteine mutation had a
negligible impact on AI-2 binding, after labeling with the dapoxyl fluorophore, the LuxP-T137C
mutant exhibited a seven-fold deterioration in the measured dissociation constant. This was not
a major limitation with regard to the intended application of the biosensor, but it does illustrate
an important caveat that should be anticipated when introducing a solvatochromic fluorophore.
In addition to the fluorophore type and placement, the linker length, between the
fluorophore and the target biomolecule, represents another essential variable to be explored when
optimizing the fluorescent response of a biosensor. This matter is treated in greater detail later in
Chapter 5. Though it suffices to say the nature of the linker connecting the dye to the
biomolecule can exert a dramatic influence on both the measured fluorescence change and the
degree of background emission generated by the construct.
The engineering of fluorescently labeled peptides typically offers more flexibility in the
design due to the modular nature of solid phase peptide synthesis (SPPS). 36 Peptide libraries of
moderate size can be generated quickly and screened for the desired fluorescent properties.
Using this approach the fluorophore may be introduced either as an unnatural amino acid
building block or attached through covalent modification of an unprotected side chain residue.
The development of short fluorogenic peptides containing solvatochromic fluorophores is
more straightforward in some ways in that these molecules typically lack the higher order
structures can that occur in globular proteins. A feature common to most solvatochromic
fluorophores is the tendency to exhibit altered fluorescence properties when appended to proteins
than when freely dissolved in water. This is primarily due to local interactions with the protein
surface that can ultimately result in a high degree of background fluorescent signal, limiting the
utility of the probe. Since small peptides generally lack the ability to form such structural
elements, the fluorophore remains largely exposed to the solvent environment until the probe
interacts with another biomolecule.
1-6. Applications ofsolvatochromic fluorophores
The power and versatility of solvatochromic fluorophores to address problems relating to
various biomolecular interactions has been demonstrated repeatedly in a host of applications.
These include the sensitive detection of changes in protein structure37-42 as cited above in the
case of the AI-2 receptor LuxP.3 5 Often, structural modifications can be quite subtle as described
by De Lorimier et al.43 in their work to construct a family of fluorescent biosensors from
different bacterial periplasmic binding proteins (bPBPs). These proteins undergo highly
localized conformational changes in the presence of specific analytes such as carbohydrates,
amino acids, dipeptides, cations, and anions. 43 Work has also been reported on successful
attempts to detect various forms of posttranslational modifications ranging from cysteine
prenylation 44 of peptide substrates to protein phosphorylation.4 5
Another important class of applications involves the development of sensors for protein-
protein and protein-peptide interactions. Research in this area is intensely active as many
biomolecular events of this type constitute a cornerstone of intracellular signal processing. The
temporal and spatial dynamics of these events are still poorly understood and yet are known to
play a vital role in governing both normal and aberrant cellular behavior. Excellent examples
include sensors of Cdc42 activation,46 actin polymerization, 47 and phosphorylation driven
binding events.14,15,48
1-7. Dimethylaminopthalimides as powerful tools for the study of biomolecular interactions
Over the past few years, our group has developed and investigated the application of
novel amino acids that possess solvatochromic fluorophores as the side-chain group. 14,'15,
34 49
Amino acid derivatives of 4-N,N-dimethylaminophthalimide (4-DMAP) and 6-N,N-
dimethylamino-2,3-naphthalimide (6-DMN) are of particular interest (Chart 1-2) due to the
exceptionally low fluorescence quantum yields that they exhibit in polar protic solvents such as
water compared to that in non-polar solvents. This offers the advantage of a greater signal-to-
noise ratio over that of other commercially available solvatochromic fluorophores. With sizes
comparable to tryptophan, the fluorescent amino acid analogues, 4-N,N-
dimethylaminophthalimidoalanine (4-DAPA) and 6-N,N-dimethylamino-2,3-
naphthalimidoalanine (6-DMNA) (Chart 1-2), can be incorporated into the primary sequence of a
peptide or protein without introducing a significant perturbation to the overall surface topology
of the native structure. The 4-DAPA and 6-DMNA amino acids have been incorporated into
peptide motifs that are recognized by 14-3-3 proteins,15 SH2 domains, 14 PDZ domains,
50 opioid
receptors,5 ' and the class II MHC proteins34 and have proven very effective as probes for
monitoring binding. However, due to the intrinsic strain of the five-membered phthalimide ring
systems of 4-DMAP and 6-DMN, these fluorophores are susceptible to nucleophilic attack
leading to the formation of ring-opened byproducts.
Chart 1-2: Dimethylaminophthalimidoalanine Series of Solvatochromic Amino Acids
6-DMN
4-DMAP Me, NMe 4-DMNN Me
Me N Me Me-N 4
2 2 3
N N N
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Recently, we have developed a new solvatochromic amino acid, 4-N,N-dimethylamino-
1,8-naphthalimidoalanine (4-DMNA), 12 to complement 4-DAPA and 6-DMNA. This amino
acid offers several distinct advantages over the previous congeners while retaining many of the
same excellent solvatochromic properties that are characteristic of the
dimethylaminophthalimide series. The six-membered imide ring of 4-N,N-dimethylamino-1,8-
naphthalimide (4-DMN, Chart 1-2) eliminates angle strain on the sp 2 hybridized nuclei resulting
in much greater chemical stability. This allows the flexibility to expose the fluorophore to a
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wider range of conditions (i.e. pH, temperature, buffers, etc.) that bear physiological relevance
for much longer durations, thus greatly expanding the scope of possible applications. In addition
to the fluorescent amino acid, a series of thiol-reactive agents derived from 4-DMN were
developed and characterized. Through the studies presented in this thesis we demonstrate that
these tools nicely complement - and in some instances surpass - the array of fluorescent
probes currently employed in biological studies and will be of great utility in the design of future
experiments for many researchers.
The earliest reports of the fluorescent properties of 4-DMN can be traced to studies
involving derivatives of the parent 4-amino-1,8-naphthalimide group, which were beginning to
draw interest for their brilliant yellow and orange colors.52 Since that time, the fluorophore has
been utilized in a wide range of technologies 53-55 and its photophysical properties have been
studied extensively. 56-61 However, biological applications of 4-DMN are comparatively
scarce.
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This thesis chronicles the body of work devoted to the development of a new suite of
fluorescent tools derived from the 4-DMN fluorophore. In Chapter 2, we examine the sequence
of events that led to a fundamental discovery regarding the chemical stability of the 4-DMAP
and 6-DMN dyes. This finding was the impetus for considering alternative fluorophores that
ultimately drew our attention to 4-DMN. Chapter 3 details some of the challenges encountered
in designing synthetic routes to the molecules described in subsequent chapters. Chapters 4 and
5 present studies that explore many of the key principles that influence the successful design of
biosensors that incorporate the properties of solvatochromic fluorophores while simultaneously
illustrating the excellent advantages offered by the dimethylaminophthalimide dyes. Chapter 4
focuses exclusively on the use of fluorescent amino acids in peptides with the potential to be
applied in proteins. Chapter 5 delves into the many benefits of using thiol-reactive derivatives of
4-DMN. Here, particular consideration is allocated to the importance of linker-type when
attempting to optimize a fluorescent probe. Finally, Chapter 6 discusses ongoing work to
develop a new probe for detecting the activation of Cdc42 of the Rho-family GTPases.
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Chapter 2: Comparative studies on the chemical stability of the
dimethylamino-phthalimide fluorophores
A significant portion of the work described in this chapter has been published in:
Loving, G.; Imperiali, B. A versatile amino acid analogue of the solvatochromic fluorophore 4-
N,N-dimethylamino-1,8-naphthalimide: A powerful tool for the study of dynamic protein
interactions. J. Am. Chem. Soc. 2008, 130, 13630-13638.
Introduction
A major initiative in the Imperiali laboratory over the last few years has focused on the
development and application of novel biochemical tools for probing the dynamics of
biomolecular events involved in cell biology. Many aspects of cellular behavior are controlled
or regulated through a complex network of transient interactions amongst proteins, nucleic acids,
carbohydrates, and other biomolecules. 1 Although many of these interactions have been
identified and even characterized in great structural detail using NMR and X-ray crystallographic
methods, the highly choreographed regulation of such events within the context of living cells is
less clearly understood. One approach to access this information in real-time is to exploit the
highly sensitive emission properties of certain solvatochromic fluorophores. While this method
has been utilized for many years - particularly in regard to in vitro studies2 - we have
developed a number of novel solvatochromic amino acids3-6 (Chart 2-1) that can be incorporated
directly into the peptide backbone of proteins using the various methods introduced earlier in
Chapter 1 and, which due to the greatly improved photophysical properties, can potentially be
employed in highly complex systems.
Chart 2-1. Unnatural amino acids of solvatochromic fluorophores developed in-house3-5,7
Dimethylaminophthalimides:
MeMe NMe MeN Me
Me MeN-Me
N N NO OOO O
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The concept of using unnatural amino acids to serve as probes for detecting various
protein-mediated interactions has been supported by numerous reports in the literature in which
the natural amino acid tryptophans' was used to measure the occurrence of such events.
Exemplary applications include the detection of changes in protein structure as well as protein-
protein binding. Tryptophan possesses a fluorescent indole heterocycle as the side chain group,
which exhibits sensitive solvatochromic properties.8  If a protein containing this residue
undergoes a transformation of some form that alters the exposure of the indole group to the
aqueous environment, then an associated change in the emission properties would be observed.
Unfortunately, tryptophan lacks the key attributes required to make it an effective probe for the
detection of biomolecular interactions in complex environments such as living cells. This is due
to the fact that the natural abundance of this amino acid within cells would overshadow any
useful fluorescent signal by interference from other proteins. Additionally, the excitation
maximum of tryptophan occurs at 280 nm. This wavelength is particularly damaging to nucleic
acids and select coenzymes and can potentially be lethal to the cell if overexposed. Therefore,
unnatural fluorescent amino acids that possess superior photophysical properties to tryptophan
could greatly benefit the field of live cell imaging.
Early endeavors by our group to develop a solvatochromic amino acid were pioneered by
Dr. Mark Nitz who developed an enantioselective synthesis of the PRODAN derivative 6-(2-
dimethylaminonaphthoyl) alanine (DANA) (Chart 2-1). 3 Similar work by Cohen et al. was also
reported in the same period using the synonym ALADAN in reference to the identical amino
acid.' The PRODAN fluorophore exhibits excellent solvatochromic properties compared to
other amino acid derivatives available at that time, such as that derived from 7-nitrobenz-2-oxa-
1,3-diazol-4-yl amine (NBD)." However, it is limited to some extent by the high degree of
intrinsic fluorescence the fluorophore exhibits in water.12 This issue is discussed in greater detail
later in Chapter 4.
In view of this success, researchers of the Imperiali group began to explore an alternative
class of solvatochromic fluorophores capable of producing more pronounced changes in their
emission properties. Members of the dimethylaminophthalimide family of fluorophores possess
fluorescence quantum yields that are extremely sensitive to solvent polarity. This is primarily
due to an internal charge transfer (ICT) process that occurs with high efficiency when these
species are dissolved in polar protic solvents like water.' 3 Charge transfer processes that occur in
the excited state of fluorophores often lead to intersystem crossing (ISC) and return to the
electronic ground state via non-radiative decay. The amino acid derivative 4-DAPA (Chart 2-1),
which was introduced by Dr. Eugenio Vazquez, 5 contains the solvatochromic fluorophore 4-N,N-
dimethylaminophthalimide (4-DMAP) as the side chain group. This amino acid offers several
distinct advantages over DANA. Foremost, it exemplifies the dramatic changes in fluorescence
quantum yield that are characteristic of the dimethylaminophthalimide family. This property is
demonstrated later in Chapter 4. The size of the chromophore is more comparable to that of the
aromatic side chain of tryptophan making it less likely to interfere with the native activity of a
peptide or protein into which it is introduced (Figure 2-1). Additionally, the synthetic route
developed to prepare 4-DAPA is relatively straightforward in that the anhydride precursor (2-1)
can be directly conjugated to the side chain of a protected (S)-2,3-diaminopropanoic acid
derivative (2-2). This transformation makes use of the "chiral pool" and thus circumvents the
need to generate a new stereocenter as was required for the preparation of DANA.
Figure 2-1. 3-Dimensional overlay of the 4-DAPA
amino acid (grey) with tryptophan (black).
Scheme 2-1. Synthesis of allyl protected Fmoc-4-DAPA building block.
MeNMe
Me, NMe NN
+ NH2  (a,b) O
O FmocHN C0 2-allyl FmocHN C0 2-allyl
4-DMAP anhydride, 2-1 2-2 2-3
Reagents and conditions: (a) DIPEA, DMF, room temperature, 30 min; (b) HBTU/HOBt, overnight, 63%
overall yield for both steps.
Following the development of 4-DAPA, Vizquez attempted to improve upon the
properties of the 4-DMAP by extending the n-system of the chromophore to that of a
naphthalene ring.4 It was anticipated that increasing the conjugation of the system would reduce
the energy gap separating the HOMO and LUMO thereby increasing the wavelengths of
excitation and emission. In his work to characterize the photophysical properties of the new
fluorescent amino acid 6-DMNA (Chart 2-1), Vizquez was able to show that this new probe
exhibits a larger shift in emission wavelength (>100 nm) in response to changes in solvent
polarity. However, the excitation band for 6-DMNA curiously appears at a shorter wavelength
(375 nm) compared to that of 4-DAPA (395 nm).
While exploring new applications of the 6-DMNA amino acid in small peptide probes for
protein motifs such as SH2 domains and PDZ 14 domains, it was observed by Dr. Matthieu
Sainlos that an anomalous emission band around 460-470 nm would increase steadily in intensity
in aqueous solutions of 6-DMNA samples over the time course of a few hours. The emission
band had originally been reported by Vazquez in his initial characterization of 6-DMNA,4 but it
was noted that although the intensity of the band differed from peptide to peptide, it was almost
invariant throughout the course of his titration experiments. Believing the band to be an intrinsic
feature of 6-DMN, he proposed that the second emission band could potentially be a useful
reference for ratiometric measurements (Figure 2-2). However, as the investigation into the
matter continued it was eventually demonstrated by Sainlos that the aberrant band that appeared
in the emission spectrum was actually the result of a degradation product. Due to the intrinsic
strain of the five-membered phthalimide ring system of 6-DMN, the fluorophore is highly
susceptible to nucleophilic attack leading to the formation of ring-opened byproducts.6 In this
instance, the product was the result of hydrolysis (Figure 2-3a) and happened to be highly
fluorescent compared to that of the ring-closed state.
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Figure 2-2. Titration of a fluorogenic peptide probe containing the 6-DMNA amino acid with an SH2 domain of a
Phosphoinositide 3-kinase (PI3K). The series of fluorescence spectra correspond to increasing concentration of the
SH2 domain. The aberrant emission peak is visible at 460 nm. (Figure reproduced from Vdzquez et al.) 4
The difficulty in determining the underlying chemistry responsible for this phenomenon
was the lack of an apparent byproduct. Although the intensity of the anomalous emission band
would increase several fold over the course of a single hour, this actually represented a very
small percentage of conversion of the 6-DMN fluorophore to the corresponding naphthalamic
acid. When a sample of this peptide solution was then examined by analytical HPLC, UV-vis,
and mass spectrometry, the results always appeared to confirm that no chemical transformation
had occurred. Eventually, Sainlos was able to force the reaction to completion by incubating a
peptide containing 6-DMNA in an aqueous buffer overnight at 42 "C (Figure 2-3b). This
treatment of the peptide sample dramatically increased the magnitude of the emission band at
460 nm. It also had an obvious effect on the UV-spectrum of the chromophore with a shift in the
absorption band from 390 nm down to 315 nm. Furthermore, mass spectral analysis plainly
indicated a new mass corresponding to that of the original peptide with the addition of 18 amu.
The combined data strongly suggested that hydrolysis of the imide ring system was involved. To
confirm this hypothesis, Sainlos independently synthesized the putative ring-opened byproduct
and compared the absorption and emission spectra. The results matched that of the byproduct.
a) b) Hydrolysis of 6-DMN
16x10
460 nm - tme 0 hrsMe, Me 4m - tlmhrsMeNMe fluorescent byproduct - tim 19 hr.
MeS Me Hydrolysis product
H2 0 0 x 'Me 80
N HO
pH 7-8 HN 4x10 625 nm
N 'N
0  H O 0
400 450 0 6s5 600 6o0 700
wavelength (nm)
Figure 2-3. (a) Hydrolysis of the five-membered imide ring system of 6-DMNA leading to the highly fluorescent
naphthalamic acid byproduct. (b) Fluorescence spectra of a 6-DMNA containing peptide in a phosphate buffered
saline solution before and after being heated at 42 "C for 19 hrs. The 6-DMN fluorophore exhibits very little
fluorescence in water and possesses an emission maximum at 625 nm. By contrast, the hydrolysis product is highly
fluorescent in water and exhibits an emission maximum at 625 nm. (Data were obtained by Dr. Matthieu Sainlos).
During this period it was also discovered that the fluorophore 4-DMAP exhibited similar
susceptibility toward hydrolysis. This was less of a problem since the corresponding byproduct
of this reaction was non-fluorescent. Still, the lack of chemical stability exhibited by the 4-
DMAP and 6-DMN fluorophores presented a potentially fundamental limitation that had to be
addressed. If these tools were to eventually be incorporated into proteins, it was determined that
further evolution of the fluorophores was essential. It was this context that ultimately led us to
investigate the potential applications of a new fluorescent amino acid also derived from the
dimethylaminophthalimide family of solvatochromic fluorophores. The experiments described
in this chapter demonstrate the robustness of the new 4-DMNA amino acid while qualitatively
defining the limitations presented by 4-DAPA and 6-DMNA. This work also reveals important
parameters that should be considered when designing experiments that utilize the 4-DMAP and
6-DMN fluorophores.
Results and Discussion
2-1. Stability of 4-DMNA to hydrolysis
Very often proteins are limited to a narrow range of conditions in which they are stable or
functional (e.g. pH, temperature, detergents, etc.). Because these conditions are sometimes
extremely restrictive, it is important to have fluorescent tools devoid of additional environmental
constraints. As stated earlier, a principal vulnerability of the 4-DMAP and 6-DMN fluorophores
is the tendency to hydrolyze over time at high pH. While hydrolysis of the imide ring of 4-
DMAP leads to a non-fluorescent byproduct, the hydrolysis of 6-DMN results in a fluorescent
species with an emission maximum observed at 460 nm. This produces a gradual increase in
background fluorescence that strongly interferes with the signal of interest.
A comparison of 4-DMAP to 4-DMN was performed to demonstrate the enhanced
stability of 4-DMN toward hydrolysis. Both fluorophores were incorporated into a pair of model
peptides rich in lysine and arginine residues (termed the KR peptides) to facilitate solubility.
The KR4DMAP peptide was screened at various concentrations in PBS buffer at three different pH
levels (pH 6, 7, and 8). Since 4-DMAP undergoes a loss of fluorescence upon hydrolysis, the
percent conversion of the fluorophore was simply defined as the percent loss of fluorescence
from the initial starting point of the reaction. These same conditions were also applied to the
KR4DMN peptide. The reactions were monitored in a 96-well plate over the course of 24 hrs (see
Experimental section for details).
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Figure 2-4. (a) The graph depicts the loss of fluorescence due to imide-ring hydrolysis of 4-DMAP in the KR4DMAP
peptide (40 pM) over 24 hrs in PBS buffer at 28 "C. The data reveals the rate enhancement observed at higher pH
levels. (b) This side-by-side comparison of 4-DMN versus 4-DMAP shows that no significant change in
fluorescence was observed for 4-DMN under the harshest conditions anticipated for its use. No hydrolysis
byproduct was detected by ESI MS for the treated KR4DMN peptide.
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Figure 2-5. (a) Graph depicts the pseudo first-order dependence of the hydrolysis of 4-DMAP based on the initial
rates measured at four concentrations of the KR4DMAP peptide. The reaction was examined at three different pH
levels (pH 6, 7, and 8). Regression lines were set to intercept the y-axis at zero. (b) Shown are the calculated rate
constants for the hydrolysis of the KR4DMAP peptide with the reaction scheme and rate law (omitting the contribution
of [H20]) depicted above. (C. I. - Confidence Interval)
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Here, a clear trend emerges from the data of the KR4DMAP peptide. The rate of hydrolysis
is relatively modest at low pH, but increases considerably as the pH is raised (Figures 2-4 and 2-
5). By measuring the initial rates at four different concentrations of the peptide, a pseudo first-
order rate constant was calculated for the reaction at each pH level (Figure 2-5). The results of
this experiment were comparable to those measured for the KR6DMN peptide indicating that the
imide ring size was the dominant driving force for the observed reactivity and that the proximity
of the dimethylamino group bears little impact on the rate of reaction (see Experimental section
for details). By comparison, the KR4DMN peptide showed no signs of degradation under any of
the applied conditions. This is especially apparent in Figure 2-4b, where the fluorescence
emission of the KR4DMN peptide was unchanged after 24 hrs while the fluorescent signal from the
KR4DMAp peptide was almost completely abolished.
2-2. Compatibility of the Fmoc-4DMNA amino acid with standard solid phase peptide
synthesis (SPPS)
A significant drawback to the use of 4-DAPA and 6-DMNA amino acids in SPPS is the
reactivity toward nucleophilic bases such as piperidine analogues like 4-methylpiperidine, 15
which are commonly used for Fmoc group deprotection. While the formation of ring-opened
piperidine adducts of these two amino acids can be circumvented by substituting bases like 4-
methylpiperidine with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), 16 caution must be exercised
with sequences containing certain Asp-Xaa motifs due to the potential for aspartimide
formation. 17 By contrast, the Fmoc amino acid of 4-DMNA has been used for the preparation of
a number of fluorescent peptides and shows no susceptibility to attack by 4-methylpiperidine.
The following experiment illustrates the enhanced stability of 4-DMNA by treating a series of
model peptides (KR4DMAP, KR6DMN, and KR4DMN) with 4-methylpiperidine while still bound to
the solid support (Figure 2-6). The conditions used simulate a standard Fmoc-deprotection
cycle. Samples of the treated and untreated peptides were then cleaved from the resin under
acidic conditions and the crude mixtures were analyzed by HPLC and mass spectrometry (see
Experimental section for details).
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Figure 2-6. Panels (a) and (b) illustrate the susceptibility of the amino acids 4-DAPA and 6-DMNA to nucleophilic
attack by bases such as 4-methylpiperidine leading to ring-opened byproducts. The HPLC traces (shown bottom)
depict the model KR peptides cleaved before and after exposure to the base. The addition of 4-methylpiperidine to
the imide rings of 4-DMAP and 6-DMN gives a mixture of two regioisomers (*) as shown in the HPCL traces after
treatment. Panel (c) shows that the amino acid, 4-DMNA, exhibits no sign of degradation under these same
conditions. The identities of the peaks were determined by a combination of MALDI and ESI mass spectrometry.
The HPLC traces of Figure 2-6a and 2-6b clearly exhibit the presence of two new peaks
that elute later than those of the desired products after treatment with 4-methylpiperidine. These
new peaks correspond to the masses of the ring-opened adducts that occur as a mixture of
regioisomers. By contrast, the KR4DMN peptide yielded virtually identical HPLC traces before
and after treatment with 4-methylpiperidine and showed no signs of degradation. The robustness
of 4-DMNA allows for multiple Fmoc-deprotection cycles to be performed subsequent to its
incorporation into a peptide obviating the need for the use of bases like DBU.
Conclusion
Due to the reactivity of the 4-DMAP and 6-DMN fluorophores in aqueous buffers above
pH 7, we have found that it is important to maintain peptide probes that contain these dyes in a
frozen and lyophilized state for long-term storage. However, such conditions are often
incompatible for many proteins. By contrast, 4-DMN has been observed to remain stable for
multiple days in aqueous buffers at room temperature. This robustness to a wide range of
conditions opens the window to many potential future applications as we aim to incorporate this
tool into full-length proteins for in cellulo studies.
Experimental
Kinetic measurements of 4-DMAP and 6-DMN hydrolysis:
The KR4DMAP peptide was screened at four concentrations (10 gM, 20 jtM, 30 jM, and
40 jiM) and three different pH levels (pH 6, 7, and 8) in PBS buffer at 28 'C. Since 4-DMAP
undergoes a loss of fluorescence upon hydrolysis, the percent conversion of the fluorophore can
be defined as the percent loss of fluorescence from time zero. These same conditions were also
applied to the KR6DMN and KR4DMN peptides. The experiments were performed using a
PerkinElmer® HTS 7000 plate reader with NUNCTM 96-well black PolySorb plates for both the
KR4DMAP and KR4DMN peptides and a FalconTM 96-well black/clear bottom OptiluxTM plate for
the KR6DMN peptide. The plates were assembled such that each condition was repeated a total of
four times. A series of blank samples (PBS buffer without peptide added) were also added to
measure the background, which would later be subtracted from the fluorescence/absorbance
measurements. The wells were loaded with 200 jtL of each sample and then topped with 80 jtL
of white, light, mineral oil (Mallinckrodt Chemicals) to prevent evaporation. After assembly, the
plates were placed in the plate reader and monitored at 30 min intervals over the course of 24
hrs. The 4-DMAP and 4-DMN fluorophores were both excited at 405 nm using a 10 nm band-
pass filter. The fluorescence emission of 4-DMAP and 4-DMN was measured using a 595 nm
filter and 535 nm filter, respectively. Since the byproduct of 6-DMN hydrolysis is highly
fluorescent, the reaction rates were determined by measuring the absorbance at 405 nm (see
Figures 2-7 and 2-8 for results). At this wavelength, the ring-closed product absorbs to an
appreciable extent while the ring-opened product does not absorb at all. Four concentrations for
the KR6DMN peptide were screened (31 jM, 63 jiM, 94 jM, and 125 jM).
After the data was recorded, it was plotted as a function of time. Trend lines were fit to
the initial time points using the least-squares method and used to calculate the initial rates. The
initial rates were then plotted as a function of peptide concentration. Again, a trend line was fit
to these plots for each pH level to compute the pseudo first-order rate constants. The trend lines
gave excellent fits (R2 > 0.99) when the Y-intercept was set at zero. While the 4-DMAP and 6-
DMN fluorophores showed significant signs of hydrolysis over 24 hrs, no change was observed
for 4-DMN. (Note - This experiment was conducted using potassium phosphate buffers
containing 0.2 M phosphate).
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Figure 2-7. Hydrolysis data for the 6-DMN fluorophore. Panel (a) depicts the absorbance of 6-DMN at 405 nm
over time at three pH levels. The decrease is due to conversion of the fluorescent species to the ring-opened
byproduct. Panel (b) indicates the rate dependence of the hydrolysis reaction on the initial fluorophore
concentration.
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Figure 2-8. Measured rate constants of 6-DMN hydrolysis. The
results represent the average of four trials. (C. I. - Confidence Interval)
Treatment of KR peptide series with 4-methylpiperidine:
Approximately 20 mg of Pal-PEG resin for each of the three KR peptides was transferred
to a small 2 mL spin column (Bio-Rad) and treated with a 20% solution of 4-methylpiperidine in
DMF (3 x 5 min) to simulate the conditions of a typical Fmoc deprotection step in SPPS.
Following this, the resin was washed thoroughly with fresh DMF and finally with DCM before
cleaving the peptides from the resin using a solution of 96:2:2 TFA/H 20/EDT for 2.5 hrs. The
resin was then filtered off and the TFA removed by evaporation. The crude products were then
dissolved in 200 gL of dH20 and analyzed by MALDI-MS, HPLC, and ESI-MS. Due to the
highly polar nature of KR peptides, a slow gradient (95:5 to 55:45 H20/MeCN with 0.1% TFA
over 35 min) was used to resolve the starting material from the 4-methylpiperidine adducts. The
HPLC method monitored the absorbance at 228 nm and 280 nm. The isolated products were
then further analyzed by ESI-MS to confirm their identity.
Table 2-1. Evidence of 4-methylpiperidine adducts to 4-DMAP and 6-DMN
MALDI MS ESI MS
4-methylpiperidine [M+xH]x+ [M+H]' [M+xH]1+
adducts of KR peptides Calcd. found found
KR4DMAP 1073.1 (1+) 1073.5 (1+)
537.1 (2+) - 536.9 (2+)
358.4 (3+) - 358.3 (3+)
KR6DMN 1123.2 (1+) 1123.6 (1+)
562.1 (2+) - 562.0 (2+)
375.1 (3+) - 375.0 (3+)
KR4DMN No adducts observed
Acknowledgments
This research was supported by NSF CHE-0414243 (BI), the NIH Cell Migration
Consortium (GM064346), and the Biotechnology Training Program (T32-GM08334). I thank
Dr. Eugenio Vazquez and Dr. Matthieu Sainlos (MIT) for their helpful advice and insight. The
Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (NSF-
0070319) is also gratefully acknowledged.
References
(1)
(2)
Pawson, T.; Nash, P. Assembly of cell regulatory systems through protein interaction
domains. Science 2003, 300, 445-452.
Lakowicz, J. R.; 3rd ed.; Springer: New York, 2006, p 205-235.
(3) Nitz, M.; Mezo, A. R.; Ali, M. H.; Imperiali, B. Enantioselective synthesis and
application of the highly fluorescent and environment-sensitive amino acid 6-(2-
dimethylaminonaphthoyl) alanine (DANA). Chem. Commun. (Camb.) 2002, 1912-1913.
(4) Vazquez, M. E.; Blanco, J. B.; Imperiali, B. Photophysics and biological applications of
the environment-sensitive fluorophore 6-N,N-dimethylamino-2,3-naphthalimide. J. Am.
Chem. Soc. 2005, 127, 1300-1306.
(5) Vazquez, M. E.; Rothman, D. M.; Imperiali, B. A new environment-sensitive fluorescent
amino acid for Fmoc-based solid phase peptide synthesis. Org. Biomol. Chem. 2004, 2,
1965-1966.
(6) Loving, G.; Imperiali, B. A versatile amino acid analogue of the solvatochromic
fluorophore 4-N,N-dimethylamino-1,8-naphthalimide: A powerful tool for the study of
dynamic protein interactions. J. Am. Chem. Soc. 2008, 130, 13630-13638.
(7) Cohen, B. E.; McAnaney, T. B.; Park, E. S.; Jan, Y. N.; Boxer, S. G.; Jan, L. Y. Probing
protein electrostatics with a synthetic fluorescent amino acid. Science 2002, 296, 1700-
1703.
(8) Lakowicz, J. R.; 3rd ed.; Springer: New York, 2006, p 529-575.
(9) Vivian, J. T.; Callis, P. R. Mechanisms of tryptophan fluorescence shifts in proteins.
Biophysical Journal 2001, 80, 2093-2109.
(10) Weljie, A. M.; Vogel, H. J. Tryptophan fluorescence of calmodulin binding domain
peptides interacting with calmodulin containing unnatural methionine analogues. Protein
Engineering 2000, 13, 59-66.
(11) Turcatti, G.; Nemeth, K.; Edgerton, M. D.; Meseth, U.; Talabot, F.; Peitsch, M.;
Knowles, J.; Vogel, H.; Chollet, A. Probing the structure and function of the Tachykinin
Neurokinin-2 receptor through biosynthetic incorporation of fluorescent amino acids at
specific sites. J. Biol. Chem. 1996, 271, 19991-19998.
(12) Prendergast, F. G.; Meyer, M.; Carlson, G. L.; lida, S.; Potter, J. D. Synthesis, spectral
properties, and use of 6-acryloyl-2-dimethylaminonaphthalene (Acrylodan). A thiol-
selective, polarity-sensitive fluorescent probe. J. Biol. Chem. 1983, 258, 7541-7544.
(13) Saroja, G.; Soujanya, T.; Ramachandram, B.; Samanta, A. 4-Aminophthalimide
derivatives as environment-sensitive probes. J. Fluoresc. 1998, 8, 405-410.
(14) Sainlos, M.; Iskenderian, W. S.; Imperiali, B. A General screening strategy for peptide-
based fluorogenic ligands: probes for dynamic studies of PDZ domain-mediated
interactions. J. Am. Chem. Soc. 2009, 131, 6680-6682.
(15) Hachmann, J.; Lebl, M. Alternative to piperidine in Fmoc solid-phase synthesis. J. Comb.
Chem. 2006, 8, 149-149.
(16) Sainlos, M.; Imperiali, B. Tools for investigating peptide-protein interactions: peptide
incorporation of environment-sensitive fluorophores through SPPS-based 'building block'
approach. Nat. Protoc. 2007, 2, 3210-3218.
(17) Wade, J. D.; Mathieu, M. N.; Macris, M.; Tregear, G. W. Base-induced side reactions in
Fmoc-solid phase peptide synthesis: Minimization by use of piperazine as N-alpha-
deprotection reagent. Lett. Pept. Sci. 2000, 7, 107-112.
Chapter 3: Design and synthesis of versatile 4-DMN derivatives for
biochemical studies
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publication in:
Loving, G.; Imperiali, B. A versatile amino acid analogue of the solvatochromic fluorophore 4-
N,N-dimethylamino-1,8-naphthalimide: A powerful tool for the study of dynamic protein
interactions. J. Am. Chem. Soc. 2008, 130, 13630-13638.
Loving, G.; Imperiali, B. Thiol-reactive derivatives of the solvatochromic 4-N,N-dimethylamino-
1,8-naphthalimide fluorophore: A highly sensitive toolset for the detection of biomolecular
interactions. Bioconjug. Chem. Submitted on July 17, 2009.
Introduction
As described in the previous chapter, it was deemed necessary to address important
limitations to the 4-DMAP and 6-DMN dyes in the design and development of superior probes
with advantageous properties for diverse applications. Both of the fluorophores exhibit the
tendency to hydrolyze in aqueous buffers over prolonged periods rendering them unsuitable for
certain applications in biochemical studies. While considering various approaches to reduce the
reactivity of the imide ring system, it was discovered that the 4-DMN fluorophore was a much
more stable alternative. This chapter details the research involved in developing a new series of
fluorescent tools based on the 4-DMN fluorophore to greatly expand the scope of potential
applications.
The synthetic route originally developed by Vazquez et al.1 to prepare the anhydride
precursor of the 6-DMN fluorophore required seven steps. This protocol was relatively labor
intensive and involved two low-yielding transformations, one of which utilizing sublimation to
generate and isolate the anhydride ring-system of the final product. This step was difficult to
perform on large scales and commonly required multiple days to obtain sufficient material for
downstream applications. Furthermore, the method resulted in a significant loss of starting
material through degradation. Although an improved procedure was later developed to replace
the sublimation step (see Appendix), the time invested in preparing this precursor made it
extremely precious and limited broad applicability. In seeking to develop new synthetic routes
leading to derivatives of the 4-DMN fluorophore, one goal was to avoid similar limitations.
In research that focused on examining the triplet route of deactivation for 4-substituted
1,8-naphthalic acid anhydrides Kollir et al.2 developed a highly efficient one-step synthesis
(Scheme 3-1) of the fluorescent 4-dimethylamino-1,8-naphthalic acid anhydride (3-1). The
method yields a highly pure crystalline solid with near quantitative conversion. This approach
represented a significant advantage over the methods that we were employing to prepare the
anhydride precursors of 4-DMAP 3 and 6-DMN. With easy access to gram quantities of
material, the possibilities were now open for synthesizing a wide range of fluorescent derivatives
as well as carrying out detailed photophysical studies.
Scheme 3-1. Synthesis of 4-DMN anhydride (3-1)2
Me
NI
SMe N CN Me O
Br 3-dimethylamino-propionitrile N
- O > Me O- 0
isoamyl alcohol, 132 oC
/ quant. yield O
3-1
An unexpected drawback that was encountered however was the remarkable lack of
reactivity exhibited by this electrophile. In retrospect, it is clear that the stability of 3-1 can be
attributed to the same factors responsible for the enhanced stability of the corresponding imide
ring-system of 4-DMN (Chapter 2). All initial attempts to react the anhydride with primary
amines failed under the conditions commonly used for the 4-DMAP and 6-DMN anhydrides.
Although this issue was eventually overcome, early efforts to prepare fluorescent derivatives of
4-DMN began with the more reactive electrophile 4-nitro-l,8-naphthalic anhydride (3-2). In this
case, the electron withdrawing nature of the nitro group in 3-2 activates the anhydride ring
toward nucleophilic attack allowing the reaction to proceed at room temperature.
This chapter highlights the challenges encountered in the synthesis of the fluorescent
tools 3-3 through 3-7 (Chart 3-1), which constitute the primary focus of this thesis and presents
the approaches that were ultimately developed for their syntheses. The discussion begins with
the development of cysteine modifying agents where particular attention is devoted to
compounds 3-4 and 3-5. The information gained in preparing these derivatives ultimately guided
the successful syntheses of compounds 3-3 and 3-6. The chapter concludes with a brief
description of the experiments that led to a refined synthesis of the Fmoc-4DMNA building
block 3-7.
Chart 3-1. Fluorescent tools including the 4-DMN fluorophore
cysteine modifying agents:
OOO Br 0 0o
Me N-NH N
N 0Me 0e - Me' 03-3 3-4
0H 0 0
N N ) Br N ON
Me, O Me, o /N O N O 0
Me Me
3-63-5
Fmoc building block: Me
N-Me
0 0
O )N OH
H
O
Fmoc-4DMNA (3-7)
Results and Discussion
3-1. Synthesis of the 4-DMN cysteine modifying agents
In developing a synthetic route to the cysteine modifying agents 3-4 and 3-5, the
anhydride 3-2 was first coupled with N-Boc-ethylenediamine to give 3-8. With the linker
installed, reductive amination was performed to convert nitro group to the dimethylamino group
of 3-9 (Scheme 3-2). This reaction was typically sluggish and required the presence of acetic
acid and gentle warming (50 "C) to observe any product formation over 24 hrs. It was
determined that the rate limiting step was the introduction of the second methyl group at the 4-
amino position. The basis for this was attributed to a disadvantageous steric effect due to the
unfavorable peri-interaction that results following addition of the first methyl group. Ultimately,
this approach was abandoned due to the low yield and the fact that it produced a number of
additional byproducts that proved difficult to separate.
Scheme 3-2. Synthesis of compound 3-9
peri-interaction
0 0 0
O (a) N NHBoc (b) N NHBoc
I + I
o 3-2 o 3-8 Me 3-9
(c)
Reagents and conditions: (a) 1st N-Boc-ethylenediamine, DIPEA, DMF, room temperature, 1 hr, 2"d
HOBt/HBTU (1:1), room temperature, overnight, 72% yield; (b) H2 (1 atm), Pd/C 10 wt. %, acetic acid/dioxane
(2:1), formalin 37% aq., 50 "C, 24 hrs, 30% yield; (c) 3-dimethylamino-propionitrile, isoamyl alcohol, A, N2 (1 atm),
22 hrs, 74% yield.
An alternative approach, inspired by the reaction of Scheme 3-1, was found to afford the
desired product with a much higher yield. Specifically, by refluxing 3-8 in isoamyl alcohol in
the presence of 3-dimethylamino-propionitrile, the nitro group is eliminated smoothly without
formation of by-products. Once 3-9 was obtained, the Boc protecting group was removed using
a 1:1 solution of TFA/DCM and isolated as the free amine, 3-10, for subsequent reactions.
Initial attempts to synthesize compound 3-4: The maleimide/isomaleimide dichotomy.
Using a standard approach to introduce the maleimide group4,5 of compound 3-4, the amine 3-10
was reacted with maleic anhydride to generate the maleamic acid intermediate 3-11 (Scheme 3-
3). Next, this intermediate was refluxed with acetic anhydride in the presence of sodium acetate
in an attempt to close the ring. However, for reasons that were not resolved, the reaction failed
to yield any conversion of the starting material. Strong dehydrating agents such as HBTU were
also used in combination with catalytic nucleophiles such as HOBt and DMAP, but this led to
rapid degradation of the product. The cause was attributed to the fact that the maleimide group
exhibits high reactivity toward must nucleophilic species. Therefore, the use of HOBt and
DMAP was avoided in subsequent experiments.
Scheme 3-3. Attempted synthesis of 3-4 via the maleamic acid intermediate 3-11
(b)
0 HO 0
NpNH2 H
I I
Me. 
0
Me Me,, Me.N.
N MeN N
Me 3-10 Me 3-11 (d) e 3-4
Reagents and conditions: (a) maleic anhydride, DIPEA, DCM, quant. yield; (b) Ac 20, NaOAc, A, Ar (1
atm), no conversion; (c) HOBt/HBTU (1:1), DMF, rapid degradation of starting material; (d) EDC, DCM, room
temperature, 15% yield.
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Finally, it was discovered that 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)
alone was capable of promoting quantitative conversion of 3-11 to the product according to TLC
and ESI-MS analysis. However, the product was highly unstable showing a strong tendency to
revert back to the ring-opened maleamic acid when attempting to isolate it by flash column
chromatography on silica gel. This resulted in exceptionally low yields of desired product. The
reason for the unexpected lack of stability was revealed by the 'H NMR of the isolated product,
which exhibited a set of anomalous signals for the maleimide protons (Figure 3-1). The two
protons displayed asymmetry with a 0.65 ppm difference in chemical shift. The protons were
also coupled to each other (J = 5.6 Hz). It was ultimately determined that the isolated product
was not the maleimide 3-4, but instead a structural isomer known as an isomaleimide (3-12).
kinetic product - isomaleimide thermodynamic product - maleimide
Me. 0 H H Me. Hb
SHb
3-12 3-4
0.65 ppm, JAb = 5.6 Hz Ha,Hb
Hb
Ha
ppm (1l)
Figure 3-1. 'H NMR (300 MHz, CDC13) of the structural isomers 3-12 and 3-4. The two spectra show the region
corresponding to the chemical shifts of the maleimide and isomaleimide protons (Ha and Hb). The isomaleimide is
the kinetic product that results from activation of maleamic acid by strong dehydrating agents like EDC.
The isomaleimide is the kinetic product formed when activating a maleamic acid using
powerful dehydrating agents such as phosgene, carbodiimides, acid chlorides, and others.6
Although isomaleimides are highly reactive electrophiles that may be used for protein labeling,
they lack specificity and are capable of N-acylation of lysine side chains.7 Therefore, this
approach to preparing 3-4 was abandoned in favor of an alternative route.
Synthesis of the maleimide 3-4 via a modified Mitsunobu reaction. Shortly after the
difficulties encountered when exploring methods to condense maleic anhydride with compound
3-10, it was discovered that compound 3-1 reacts readily with simple primary amines when
refluxed in ethanol (Scheme 3-4). This reaction proved to be extremely useful in that it reliably
furnished the desired products (3-13 through 3-15) with near quantitative yields and relatively
few impurities. The excess unreacted amine can easily be removed through extraction or by
placing the crude product under high vacuum overnight. The chief limitation is that the reaction
is restricted to ethanol-soluble amines. Therefore, it was not applicable to the synthesis of the
Fmoc-4DMNA building block 3-7.
The primary alcohol of compound 3-13 offered a useful handle for inserting the
maleimide group. Work by Walkers had shown that the Mitsunobu reaction could be adapted to
directly alkylate phenethyl alcohol using maleimide as the nucleophile. When the method was
applied to 3-13 the reaction conditions gave a modest yield (Scheme 3-5). However, the quantity
of material obtained was more than sufficient for all of the downstream applications described in
later chapters. The same Mitsunobu conditions were also applied to 3-14 with similar results.
The isolated products, 3-4 and 3-6, both exhibited significantly greater stability than that of the
previously obtained isomaleimide 3-12.
Scheme 3-4. Coupling of amines to 4-DMN anhydride (3-1)
Me /
N
Me' -
3-1
Me 0
Me N-- OH
O H
3-13
Me 0
NOMe N14 0 0OH
3-14
(c)
Me O
Me N -NH 2
3-15
Reagents and conditions: (a) ethanolamine, ethanol, A, N2 (1 atm), quant. yield; (b) 2-(2-aminoethoxy)-
ethanol, ethanol, A, N2 (1 atm), 98% yield; (c) hydrazine monohydrate, ethanol, A, N2 (1 atm), 87% yield.
Scheme 3-5. Synthesis of the maleimide 3-4 and 3-6 via a modified Mitsunobu reaction
Me 0
N / 0
Me N O H
0
(a)
3-13
Me\O
N-
Me N
0 OH
0
3-14
(b) Me
Me/
Me O
N 0
Me - N
3-4 o
0 N
\. 0
3-6
Reagents and conditions: (a) 1st PPh 3, DEAD, -78 "C, N2 (1 atm), THF, 2 nd neopentyl alcohol, maleimide,
-78 "C to room temperature, overnight, 22% yield; (b) 1st PPh 3, DEAD, -78 "C, N2 (1 atm), THF, 2 nd neopentyl
alcohol, maleimide, -78 C to room temperature, overnight, 24% yield.
Synthesis of the bromoacetamide 3-5. In preparing this series of cysteine-modifying
agents, the type of electrophilic group used to append the labeling agents to protein was also
investigated. Returning to compound 3-10, an attempt was made to acetylate the free amino
group using the symmetric anhydride of bromoacetic acid (Scheme 3-6). The anhydride was
synthesized using a standard protocol 9 in the same reaction vessel to which 3-10 would
subsequently be added. Upon addition of the amine, the reaction appeared to proceed directly to
the desired product as determined by TLC.
Scheme 3-6. Acetylation of 3-10 using the symmetric anhydride of bromoacetic acid
0
0 (a) o 0 (b) 0 Br
HO" Br- Br . O. Br \ Me N N
Me 0
3-5
Reagents and conditions: (a) EDC, DCM (anhydrous), Ar (1 atm), 0 "C; (b) 3-10, DIPEA, DCM, 92%
overall yield.
However, upon isolating the product, the 'H NMR exhibited an unexpected feature. The
resonance corresponding to the methylene protons of the acetamide group was split as was that
of the amide proton. After obtaining the high-resolution mass spectrum, it was clear that what
appeared to be a single product isolated by flash column chromatography was actually a mixture
of the chloro- and bromoacetamides, 3-16 and 3-5 (Figure 3-2). The presence of the byproduct
was puzzling at first as the mixture was determined to contain a precise 1:2 ratio of the chloro-
versus bromoacetamide.
Me 3 Ha ratio 0 H.
3-16 3-5
Hb, (3-5)
Ha, (3-5) Hb, (3-16)
Ha, (3-16)
70 7V 740 730 720 710 10 10 33 '7 100
P . . ..1) I . .
Figure 3-2. 'H NMR (300 MHz, CDCl 3) of the product mixture isolated from the reaction of Scheme 3-6. The
indicated protons of 3-16 and 3-4 reveal a 1:2 ratio of the two compounds.
It was later determined that the source of the problem originated with the use of the
carbodiimide, EDC, to generate the anhydride of bromoacetic acid. The EDC used in the
reaction was obtained as a hydrochloride salt. One equivalent of this salt was used with two
equivalents of the bromoacetic acid in the reaction. It was therefore deduced that as the coupling
reaction was allowed to proceed, a concomitant halide exchange reaction (Finkelstein reaction)
was also occurring that ultimately yielded a statistical ratio of the two products of Figure 3-2. In
order to avoid this complication, bromoacetyl bromide was substituted as the acylating agent
giving the final product in excellent yield (Scheme 3-7).
.. ................................................................................  M M M M M 9
Scheme 3-7. Acylation of 3-10 and 3-15 with bromoacetyl bromide
0 (a) o Br
Br Me N---NH
Br NH
Me' 0
3-5
00 Br 00 Br
0 (b)
Br 0) MeN N-NH + Me N-N
BrVB NB N
Me 0 Me O 0 Br
3-3 3-17
(1:1 ratio of mono- vs. di-acetylated products)
Reagents and conditions: (a) 3-10, DIPEA, -15 "C to room temperature, N2 (1 atm), DCM (anhydrous), 1.5
hrs, 91% yield; (b) 3-15, DIPEA, -15 "C to room temperature, N2 (1 atm), DCM (anhydrous), overnight, 48% yield
of the mono-acetylated product 3-3.
The same reaction was also performed on compound 3-15 using 1.5 equivalents of the
acylating agent. This method also proceeded in a high yield, but resulted in a mixture of the
mono- and di-acetylated products. This was not a significant problem, however, since the two
products were easily separated by flash column chromatography and enough of the desired
product, 3-3, was obtained for later applications. Furthermore, the byproduct could easily be
avoided in future reactions by reducing the quantity of bromoacetyl bromide added to the
reaction.
3-2. Synthesis of N-a-Fmoc-(4-N,N-dimethylamino-1,8-naphthalimido)-alanine (3-7)
The development of a synthetic route leading to Fmoc-4DMNA (3-7) proved to be more
challenging than the cysteine modifying agents since the anhydride 3-1 was unreactive toward
(S)-2,3-diaminopropanoic acid (Dap) derivatives, which were protected at the 2-amino position.
Attempts were made to couple the fluorophore to the amino acid using a variety of solvents (e.g.
ethanol, chloroform, dioxane, toluene) under reflux conditions. However, conversion of the
starting material was not observed. Catalytic nucleophiles such as HOBt, DMAP, and 2-
pyridone were also employed in an unsuccessful effort to facilitate the reaction by ring-opening
of the anhydride. Finally, it was discovered that the reaction could proceed using a mixed
solvent system consisting of dioxane and water. The nucleophile, (S)-3-amino-2-(Boc-amino)-
propionic acid, was dissolved in water under basic conditions while a solution of the anhydride
3-1 is prepared in dioxane. The two solutions were then combined and brought to reflux.
Although much of the anhydride was hydrolyzed to the diacid, the desired product (3-18) was
formed in reasonable yield. The subsequent reactions involving the removal of the Boc group
and addition of the Fmoc amino protecting group proceeded efficiently using standard conditions
(Scheme 3-8).1o
Scheme 3-8. Synthesis of Boc-4DMNA (3-18) and Fmoc-4DMNA (3-7)
Me Me
N-Me N-Me
NH2  (a) - (b,c) 
-
BocHN OH 0- O - 0 )N -BocHN N N
o 0O O O
BocHN OH FmocHN
O O
3-18 3-7
Reagents and conditions: (a) NaHCO 3, 3-1, dioxane/water (5:1), A, N2 (1 atm), 30 min, 55% yield; (b)
TFA/DCM (1:1), room temperature, 1.5 hrs; (c) Fmoc-OSu, NaHCO 3, dioxane/water (5:1), room temperature, 2 hrs,
83% overall yield for steps b and c.
After the development of this synthetic route, an additional series of experiments were
conducted on small scales (50 mg of 3-1) to identify improved conditions for the preparation of
3-18. Recently, it was discovered that heating 3-amino-2-(Boc-amino)-propionic acid with 3-1,
DIPEA, and a catalytic amount of DMAP (0.1 eq.) in NMP (70 oC) for 6 hrs will afford the
desired product with a quantitative yield. Further experiments will have to be conducted to
determine if the reaction yield can be conducted on larger scales.
Conclusions
This chapter describes reliable and facile syntheses of the tools presented in this thesis.
The protocols presented within the Experimental section afford ample quantities - ranging from
milligrams to grams - of the desired products required for any future applications.
Furthermore, many of these tools can be prepared in as few as three to four synthetic steps with a
minimal investment of time.
Experimental
Synthesis of 4-N,N-dimethyl-1,8-naphthalimide cysteine modifying reagents:
NMR and FT-MS of the following derivatives: 1H and 13C NMR spectra were
recorded on a Varian Mercury 300 MHz NMR and Varian Inova 500 MHz NMR spectrometer.
Chemical shifts (6) for 'H and 13C NMR spectra are reported in parts per million (ppm) and are
referenced to residual proton in the deuterated solvent. Coupling constants (J) are reported in
Hertz (Hz) and multiplicities are abbreviated as singlet (s), doublet (d), triplet (t), and multiplet
(m). High-resolution mass spectra were obtained using a Bruker Daltonics APEXIV 4.7 Tesla
Fourier Transform Ion Cyclotron Resonance Mass Spectrometer (FT-ICR-MS).
O 1) N-Boc-ethylenediamine, DIPEA, DMF, O
room temp, 1 hr H N N O " MeO N N
O O 2) HOBt/HBTU (1:1), overnight O O
O- 72% yield O
3-2 3-8
4-Nitro-N-(2-tert-butoxycarbonylamino-ethyl)-1,8-naphthalimide (3-8). Dissolved 4-
nitro-1,8-naphthalic anhydride, 3-2 (9.2 g, 37.7 mmol), in 50 mL of DMF, then added DIPEA
(17.9 mL, 102.9 mmol). In a separate flask, N-Boc-ethylenediamine was dissolved in another 50
mL DMF and added over 4 min to the solution containing the anhydride via an addition funnel.
The reaction was allowed to proceed for 1 hr at ambient temperature before adding the coupling
reagents HOBt/HBTU (100 mL, 0.58 M each in DMF) to facilitate closure of the imide ring
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system. The reaction was allowed to proceed overnight. The next day, the reaction mixture was
poured into a large separatory funnel containing 400 mL of diethyl ether and washed with brine
(3 x 200 mL) to remove DMF (note- some precipitation of the product from the organic layer
may be observed if left for extended periods of time). The organic layer was then dried with
MgSO 4, filtered, and concentrated to dryness. The crude product was then purified by flash
column chromatography using 3:1 hexanes/ethyl acetate to give a light cream colored solid (9.56
g, 24.8 mmol, 72.3% yield, Rf= 0.1 in 3:1 hexanes/EtOAc).
1H NMR (300 MHz, CDC13, 6): 1.21 (s, 9H), 3.53 (m, 2H), 4.34 (t, 2H, J= 5.7 Hz), 4.97
(m, 1H), 7.94 (dd, 1H, J1 = 8.7 Hz, J2 = 7.5 Hz), 8.36 (d, 1H, J= 8.1 Hz), 8.65 (d, 1H, J= 8.1
Hz), 8.69 (dd, 1H, J = 7.4 Hz, J2 = 1.1 Hz), 8.77 (dd, 1H, J = 8.7 Hz, J2 = 0.9 Hz).
13C NMR (300 MHz, CDC13, 6): 28.4, 39.3, 40.7, 79.5, 123.0, 123.7, 124.1, 127.0,
129.3, 129.5, 130.1, 130.1, 132.7, 149.7, 156.3, 163.0, 163.8.
HRMS-ESI (m/z): [M+Na]+ calcd for C19H19N30 6, 408.1166; found, 408.1188.
S H Me 3-dimethylamino-propionitrile, H Me
S N/ 1N( O isoamyl alcohol, A, N
0  Me N2 (1 atm), 22 hrs I Me'N O Me
O- 74% yield Me
3-8 3-9
4-NN-Dimethylamino-N-(2-tert-butoxycarbonylamino-ethyl)-1,8-naphthalimide (3-
9). The 4-nitro-N-(2-tert-butoxycarbonylamino-ethyl)-1,8-naphthalimide, 3-8 (2.00 g, 5.19
mmol), was added to a 250 mL two-necked round-bottom flask equipped with a reflux
condenser, rubber septum, and magnetic stir bar. The assembled reaction vessel was then
charged with and inert atmosphere by evacuating the air under reduced pressure and purging
with N2 gas (3x). The flask then received 52 mL of isoamyl alcohol transferred by syringe
through the rubber septum. The suspension was stirred as the temperature was raised to 132 oC.
Once the starting material dissolved, 3-dimethylamino-propionitrile (2.35 mL, 20.8 mmol) was
added by syringe through the septum of the reaction vessel. The reaction was refluxed for 22 hrs
before stopping by concentrating the reaction mixture to dryness by rotary evaporation. The
crude was then purified by flash chromatography using 7:3 hexanes/ethyl acetate to give an
orange solid (1.47 g, 3.83 mmol, 74% yield, Rf= 0.25 in 1:1 hexanes/ethyl acetate).
1H NMR (300 MHz, CDC13, 6): 1.31 (s, 9H), 3.10 (s, 6H), 3.51 (m, 2H), 4.34 (t, 2H, J=
5.6 Hz), 5.09 (br, 1H), 7.09 (d, 1H, J= 8.1 Hz), 7.64 (dd, 1H, Ji = 8.6 Hz, J2 = 7.4 Hz), 8.42 (dd,
1H, J1 = 8.4 Hz, J2 = 1.2 Hz), 8.46 (d, 1H, J= 8.1 Hz), 8.56 (dd, 1H, J = 7.4 Hz, J2 = 1.1 Hz).
13C NMR (500 MHz, CDC13, 6): 28.2, 39.4, 39.8, 44.7, 78.9, 113.1, 114.5, 122.7, 124.7,
125.1, 130.2, 131.1, 131.2, 132.8, 156.0, 157.0, 164.3, 164.9.
HRMS-ESI (m/z): [M+H] + calcd for C21H25N30 4, 384.1923; found, 384.1932.
O 1) TFA/DCM (1:1), OH Me room temp, 1.5 hrs
-/ NpN O fMe Br
Me. O Me Me 2) bromoacetyl bromide, DIPEA, Me
N O DCM (dry), -15 oC to room temp, N O
Me \ N2 (1 atm), 1.5 hrs Me \
3-9 91% overall yield 3-5
4-NN-Dimethylamino-N-[2-(2-bromo-acetylamino)-ethyl]-1,8-naphthalimide (3-5).
Dissolved 3-9 (0.50 g, 1.30 mmol) in dichloromethane (22.0 mL) in a 100 mL round-bottom
flask. Cold trifluoroacetic acid (22.0 mL) was then added slowly over 5 min by addition funnel
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while stirring the reaction. The reaction was allowed to proceed at room temperature for 1.5 hrs
before concentrating to dryness by rotary evaporation. The crude solid was redissolved in
dichloromethane (100 mL) and washed with 2% NaHCO 3 aq. solution (100 mL). The aqueous
layer was back-extracted with fresh dichloromethane (2 x 100 mL) and the organic layers were
combined (total volume of 300 mL). The organic layer was dried with MgSO 4, filtered and
concentrated to give the free amine as an orange solid. The free base was then transferred to a
250 mL Schlenk flask under an atmosphere of nitrogen and dissolved in dry dichloromethane
(100 mL). The Schlenk flask was cooled to -15 oC in a 1:3 sodium chloride/ice bath. The
bromoacetyl bromide (0.40 g, 1.96 mmol) was then added dropwise by syringe followed by N,N-
diisopropylethylamine (0.25 mL, 1.43 mmol). The reaction was allowed to run for 5 min at -15
'C before warming to room temperature. After 1.5 hrs, the reaction mixture was diluted to a total
volume of 100 mL in dichloromethane and washed with 2% NaHCO 3 aq. solution (100 mL)
followed by a second wash with brine (100 mL). The organic layer was dried with MgSO 4,
filtered, and concentrated by rotary evaporation. The product was purified by flash
chromatography using 2:3 hexanes/ethyl acetate to give an orange solid (0.48 g, 1.19 mmol, 91%
yield, R = 0.10 in 2:3 hexanes/ethyl acetate). The product was stored as solid at -20 oC.
'H NMR (300 MHz, CDC13, 6): 3.11 (s, 6H), 3.67 (m, 2H), 3.78 (s, 2H), 4.43 (t, 2H, J=
5.4 Hz), 7.09 (d, 1H, J = 8.1 Hz), 7.27 (br s, 1H), 7.64 (dd, 1H, J = 8.6 Hz, J2 = 7.4 Hz), 8.43
(dd, 1H, Jr = 8.7 Hz, J2 = 1.2 Hz), 8.46 (d, 1H, J= 8.4 Hz), 8.56 (dd, 1H, J, = 7.4 Hz, J2 = 1.1
Hz).
13C NMR (300 MHz, CDC13, 6): 28.9, 38.5, 40.4, 44.6, 113.1, 114.0, 122.4, 124.7,
124.9, 130.2, 131.2, 131.5, 133.0, 157.2, 164.4, 165.0, 166.0.
HRMS-ESI (m/z): [M+H]+ calcd for C 8H18BrN30 3, 404.0610; found 404.0612.
/ \ ethanolamine, ethanol, / \ OH
A, N2 (1 atm), 1.5 hrsMe O aMe N
/ N quant. yield /Me - O Me - O
3-1 3-13
4-N,N-Dimethylamino-N-(2-hydroxy-ethyl)-1,8-naphthalimide (3-13). Added 4-N,N-
dimethylamino-1,8-naphthalic anhydride, 3-1 (1.00 g, 4.15 mmol), to a 200 mL two-necked
round-bottom flask equipped with a reflux condenser, magnetic stir bar, and rubber septum. The
reaction vessel was then evacuated of air by applying vacuum and flushing with N2 gas (3x).
Anhydrous ethanol (42 mL) was then added to the flask by syringe. The suspension was stirred
as the temperature was raised to reflux. The anhydride was still present as a solid as the
suspension reached reflux until the addition of ethanolamine (0.28 mL, 4.56 mmol) by syringe.
The slurry then turned to a clear deep orange solution. The reaction was allowed to proceed at
reflux for 1.5 hrs then stopped by cooling to room temperature. The solvent was then removed
using rotary evaporation and the crude placed under high vacuum overnight to remove excess
ethanolamine. The product obtained was an orange solid requiring no further purification (1.18
g, 4.15 mmol, quantitative yield).
'H NMR (300 MHz, CDC13, 6): 2.70 (br s, 1H), 3.10 (s, 6H), 3.95 (t, 2H, J= 5.3 Hz),
4.42 (t, 2H, J= 5.3 Hz), 7.06 (d, 1H, J= 8.1 Hz), 7.62 (dd, 1H, J = 8.6 Hz, J2 = 7.4 Hz), 8.40
(dd, 1H, J, = 8.4 Hz, J2 = 1.2 Hz), 8.42 (d, 1H, J= 8.4 Hz), 8.52 (dd, 1H, J = 7.5 Hz, J2 = 1.2
Hz).
13C NMR (300 MHz, CDC13, 8): 42.7, 44.7, 62.1, 113.1, 114.2, 122.6, 124.8, 124.9,
130.2, 131.3, 131.5, 132.9, 157.1, 164.9, 165.4.
HRMS-ESI (m/z): [M+Na] + calcd for C16HI6N 20 3, 307.1053; found, 307.1059.
O PPh 3, DEAD, neopentyl alcohol, O
/ \ OH maleimide, THF, -78 OC, to room temp, 0, 
Me N N2 (1 atm), overnight N
\ - Me N
/ - 22% yield N OMe OMe
3-13 3-4
4-N,N-Dimethylamino-N-(2-maleimidyl-ethyl)-1,8-naphthalimide (3-4). Solid
triphenylphosphine (0.42 g, 1.60 mmol) was added to an oven-dried 100 mL Kjeldahl-style
Schlenk flask equipped with a magnetic stir bar and rubber septum. The flask was evacuated of
air under high vacuum and charged with N2 gas (3x). The triphenylphosphine was then
dissolved in freshly distilled anhydrous THF. The reaction vessel was then cooled to -78 'C by
immersing the Schlenk flask in a dry ice/isopropanol bath. Next, diethyl azodicarboxylate (0.696
mL, 40% solution in toluene, 1.60 mmol) was added dropwise via syringe over 1.5 min. The
mixture was allowed to stir for approximately 5 min to allow formation of the betaine. At this
point, the reaction mixture was a pale yellow color. The alcohol, 3-13 (0.50 g, 1.8 mmol), was
then added as a solid followed by neopentyl alcohol (0.07 g, 0.8 mmol) to form the
oxyphosphonium ion intermediate. Once the two alcohols were fully dissolved, maleimide was
added as a solid and the reacting mixture was allowed to warm to room temperature. The
reaction was allowed to proceed at room temperature overnight before stopping by concentrating
to dryness using a rotary evaporator. TLC indicated that the reaction only preceded 30-40%.
The product was isolated by flash column chromatography using toluene with 5% methanol.
The product was a bright yellow solid (0.13 g, 0.36 mmol, 22.4% yield, Rf = 0.24 in 1:1
hexanes/ethyl acetate) and was dissolved in DMSO for storage at -80 oC in 100 mM aliquots.
'H NMR (300 MHz, CDCl3, 6): 3.06 (s, 6H), 3.94 (t, 2H, J= 5.1 Hz), 4.36 (t, 2H, J= 5.1
Hz), 6.58 (s, 2H), 7.04 (d, 1H, J= 8.4 Hz), 7.58 (dd, 1H, J = 8.6 Hz, J 2 = 7.4 Hz), 8.36 (d, 1H, J
= 8.1 Hz), 8.38 (dd, 1 H, J = 8.7 Hz, J2 = 1.2 Hz), 8.46 (dd, 1H, J, = 7.4 Hz, J2 = 1.1 Hz).
13C NMR (300 MHz, CDC13, 6): 36.2, 38.6, 44.6, 113.1, 114.3, 122.4, 124.7, 125.1,
130.2, 131.0, 131.3, 132.6, 133.9, 156.8, 164.0, 164.6, 170.7.
HRMS-ESI (m/z): [M+H]+ calcd for C20H17N30 4, 364.1292; found, 364.1308.
/ \ 2-(2-aminoethoxy)-ethanol, ethanol, / \ O OH
Me 0 A, N2 (1 atm), 1.5 hrs O Me N
'N 98% yield N
Me - O Me - O
3-1 3-14
4-N,N-Dimethylamino-N-[2-(2-hydroxy-ethoxy)-ethyl]-1,8-naphthalimide (3-14).
Added 4-N,N-dimethylamino-1,8-naphthalic anhydride, 3-1 (1.00 g, 4.15 mmol), to a 200 mL
two-necked round-bottom flask equipped with a reflux condenser, magnetic stir bar, and rubber
septum. The reaction vessel was then evacuated of air by applying vacuum and flushing with N2
gas (3x). Anhydrous ethanol (42 mL) was then added to the flask by syringe. The suspension
was stirred as the temperature was raised to reflux. The anhydride was still present as a solid as
the suspension reached reflux until the addition of 2-(2-aminoethoxy)-ethanol (0.454 mL, 4.56
mmol) by syringe. The slurry then turned to a clear deep orange solution. The reaction was
allowed to proceed at reflux for 1.5 hrs then stopped by cooling to room temperature. The
solvent was removed by rotary evaporation and the crude mixture placed under high vacuum
overnight to remove excess 2-(2-aminoethoxy)-ethanol. The product was isolated by flash
column chromatography using a gradient of 1:3 to 1:4 hexanes/ethyl acetate. The product was a
dark orange oil (1.33 g, 4.05 mmol, 97.7% yield, Rf= 0.1 in 1:3 hexanes/ethyl acetate).
1H NMR (300 MHz, CDC13, 6): 2.76 (br s, 1H), 3.07 (s, 6H), 3.66 (m, 4H), 3.82 (t, 2H, J
= 5.6 Hz), 4.39 (t, 2H, J= 5.7 Hz), 7.05 (d, 1H, J= 8.4 Hz), 7.60 (dd, 1H, J1 = 8.3 Hz, J2 = 7.4
Hz), 8.38 (dd, 1H, J = 8.6 Hz, J2 = 1.1 Hz), 8.42 (d, 1H, J= 8.4 Hz), 8.51 (dd, 1H, J1 = 7.4 Hz,
J2 = 1.1 Hz).
13C NMR (300 MHz, CDC13, 6): 39.2, 44.6, 61.7, 68.4, 72.1, 113.1, 114.4, 122.7, 124.7,
125.0, 130.2, 131.1, 131.3, 132.8, 157.0, 164.2, 164.8.
HRMS-ESI (m/z): [M+H]+ calcd for C18H20N 20 4, 329.1496; found, 329.1506.
PPh 3, DEAD, neopentyl alcohol, O0 OHO maleimide, THF, -78 OC, to room temp, O
S N O OH N2 (1 atm), overnight 
N
Me,N - MeN N \__
M - 24% yield N
Me O Me - O
3-14 3-6
4-NN-Dimethylamino-N-[2-(2-maleimidyl-ethoxy)-ethyl]-1,8-naphthalimide (3-6).
Prior to assembling the Mitsunobu reaction, the alcohol, 3-14 (0.50 g, 1.51 mmol), was
transferred to a 50 mL pear-shaped flask equipped with rubber stopper and placed under high
vacuum overnight to remove trace water that may inhibit the reaction. An oven-dried 100 mL
Kjeldahl-style Schlenk flask equipped with a magnetic stir bar and rubber septum was charged
with solid triphenylphosphine (0.36 g, 1.37 mmol). The Schlenk flask was then evacuated of air
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by placing under high vacuum and charged with N2 gas (3 x). Freshly distilled dry THF (4 mL)
was then transferred to the Schlenk flask by syringe and the triphenylphosphine stirred at
ambient temperature until completely dissolved. This solution was then lowered to -78 'C by
immersing in a dry ice/isopropanol bath. Next, diethyl azodicarboxylate (0.597 mL, 40%
solution in toluene, 1.37 mmol) was added dropwise via syringe over 2 min. The mixture was
allowed to stir for approximately 5 min to allow formation of the betaine. At this point, the
reaction mixture was a pale yellow color. Meanwhile, a solution of the alcohol, 3-14, was
prepared by dissolving in 6 mL of freshly distilled dry THF. This solution was then transferred
very slowly to the reaction vessel by syringe to avoid raising the temperature. Once the transfer
was complete, neopentyl alcohol (0.06 g, 0.69 mmol) was added as a solid. The reaction was
allowed to stir approximately 5 min to allow formation of the oxyphosphonium ion intermediate.
Solid maleimide (0.13 g, 1.37 mmol) was then added and the reaction was allowed to warm to
room temperature and stirred overnight. The reaction was stopped by concentrating to dryness
on the rotary evaporator and the product was isolated by flash column chromatography using 1:2
hexanes/ethyl acetate. The product was a bright yellow solid (0.15 g, 0.37 mmol, 24.4 % yield,
Rf= 0.22 in 1:2 hexanes/ethyl acetate) and was dissolved in DMSO for storage at -80 oC in 100
mM aliquots.
'H NMR (300 MHz, CDC13, 6): 3.09 (s, 6H), 3.65 (m, 4H), 3.74 (t, 2H, J= 6.0 Hz), 4.34
(t, 2H, J= 5.9 Hz), 6.50 (s, 2H), 7.09 (d, 1H, J= 8.1 Hz), 7.63 (dd, 1H, J = 8.4 Hz, J2 = 7.2 Hz),
8.42 (apparent d, 2H, J= 8.1 Hz), 8.51 (dd, 1H, J = 7.5 Hz, J2 = 1.2 Hz).
13C NMR (300 MHz, CDCl3, 6): 37.2, 38.8, 44.7, 67.2, 67.6, 113.2, 114.9, 122.9, 124.8,
125.1, 130.2, 131.0, 131.1, 132.6, 133.8, 156.6, 163.9, 164.4, 170.5.
HRMS-ESI (m/z): [M+H]+ calcd for C22H21N 30 5, 408.1554; found, 408.1567.
0 0/ \ O hydrazine monohydrate, ethanol, / \
A, N2 (1 atm), 45 mins N-NHMe N Me N-NH2
Me 87% yield Me/Me O Me - O
3-1 3-15
N-Amino-4-N,N-dimethylamino-1,8-naphthalimide (3-15). Added 4-N,N-
dimethylamino-1,8-naphthalic anhydride, 3-1 (1.00 g, 4.14 mmol), to a 200 mL two-necked
round-bottom flask equipped with a reflux condenser, magnetic stir bar, and rubber septum. The
reaction vessel was then evacuated of air by applying vacuum and flushing with N 2 gas (3x).
Anhydrous ethanol (42 mL) was then added to the flask by syringe. The suspension was stirred
as the temperature was raised to reflux. The anhydride was still present as a solid as the
suspension reached reflux until the addition of hydrazine monohydrate (0.402 mL, 8.29 mmol)
by syringe. The slurry then turned to a clear deep orange solution. The reaction was allowed to
proceed at reflux for 45 min then stopped by cooling to room temperature. The reaction mixture
was diluted to a final volume of 200 mL with cold water to precipitate the product, which was
then filtered and purified by flash chromatography using 1:3 hexanes/ethyl acetate. The product
was a bright yellow solid (0.925 g, 3.624 mmol, 87.4 % yield, Rf = 0.23 in 1:3 hexanes/ethyl
acetate).
1H NMR (300 MHz, CDC13, 6): 3.09 (s, 6H), 5.26 (br s, 2H), 7.02 (d, 1H, J= 8.4 Hz),
7.58 (dd, 1H, J = 8.4 Hz, J = 7.5 Hz), 8.37 (dd, 1H, J] = 8.6 Hz, J2 = 0.8 Hz), 8.38 (d, 1H, J=
8.4 Hz), 8.49 (dd, 1H, J, = 7.4 Hz, J2 = 0.8 Hz).
13C NMR (300 MHz, CDC13, 6): 44.8, 113.0, 113.4, 121.9, 124.6, 124.9, 128.7, 131.0,
131.5, 132.8, 157.3, 160.7, 161.0.
HRMS-ESI (m/z): [M+H]+ calcd for C14H13N30 2, 256.1081; found, 256.1083.
Me 0 bromoacetyl bromide, DIPEA,eN DCM (dry), -15 oC to room temp, Me 0 Br
S \ / N2 (1 atm), overnight ,NMe N-NH2  Me N-NH
\ / 48% yield of \ /
O mono-acetylated product O
3-15 3-3
4-N,N-Dimethylamino-N-[2-bromoacetamido]-1,8-naphthalimide (3-3). The solid N-
amino-4-N,N-dimethylamino-1,8-naphthalimide, 3-15 (0.50 g, 1.96 mmol), was transferred to an
oven-dried 100 mL Schlenk flask along with a magnetic stir bar. The flask was then capped with
a rubber septum and evacuated of air by placing under high vacuum followed by charging with
N2 gas (3 x). The starting material was then partially dissolved in dry dichloromethane (39 mL)
and stirred as N,N-diisopropylethylamine (0.357 mL, 2.15 mmol) was added through the septum
via syringe. The Schlenk flask was then cooled to -15 oC in an ice bath of 3:1 ice/NaCl. Once
cooled, bromoacetyl bromide (0.255 mL, 2.94 mmol) was added to the suspension dropwise via
syringe and stirred for 5 min before bringing the reaction vessel back to room temperature. A
white solid, presumed to be a bromide salt, was observed precipitating from the reaction mixture
over time. After allowing the reaction to run overnight, the mixture was diluted to a total volume
of 100 mL in dichloromethane and washed with NaHCO 3 (3 x 50 mL). The organic layer was
dried with MgSO 4, filtered, and concentrated on the rotary evaporator. The desired product was
isolated by flash chromatography using 1:1 hexanes/ethyl acetate. The reaction yielded two
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products: the desired monoacylated product, 3-3 (0.24 g, 0.93 mmol, 47.6% yield, Rf = 0.10 in
1:1 hexanes/ethyl acetate), and a diacylated byproduct in nearly a 1:1 ratio. The desired product
was stored as a solid at -20 oC.
1H NMR (300 MHz, CDC13 , 6): 3.13 (s, 6H), 4.31 (s, 2H), 7.08 (d, 1H, J= 8.4Hz), 7.64
(dd, 1H, J = 8.6 Hz, J2 = 6.9 Hz), 8.44 (dd, 1H, J = 8.4 Hz, J2 = 1.2 Hz), 8.46 (d, 1H, J= 8.1
Hz), 8.57 (dd, 1H, J = 7.5 Hz, J2 = 1.2 Hz), 8.62 (br s, 1H).
13C NMR (500 MHz, CDC13, 6): 26.5, 44.7, 113.2, 113.5, 122.3, 124.8, 125.1, 130.4,
132.0, 132.3, 133.7, 157.8, 161.6, 162.2, 164.5.
HRMS-ESI (m/z): [M+H]+ calcd for C16H14BrN30 3, 376.0291; found, 376.0304.
Synthesis of 4-N,N-dimethyl-1,8-naphthalimide derivatives and characterization:
All reagents and solvents were procured from Sigma-Aldrich unless otherwise stated.
Me
N-Me
Me O NH2  NaHCO 3, 3-1, dioxane/water (5:1),
Me>k K OH A, N2, (1 atm), 30 min
Me O N
H 55% yield N
O Me O O
Me O NH 0
3-18
N-a-Boc-(4-N,N-dimethylamino-1,8-naphthalimido)-alanine (3-18). Dissolved (S)-3-
amino-2-(Boc-amino)-propionic acid (2.00 g, 9.79 mmol) (Cat. No. A-3220, Bachem) and
NaHCO 3 (4.11 g, 48.97 mmol) together in dH20 (49 mL) and transferred to a 60 mL addition
funnel. Next, added solid 4-N,N-dimethylamino naphthalic anhydride 3-1 (2.60 g, 10.77 mmol)
to a 500 mL three-necked round-bottom flask equipped with a magnetic stir bar and reflux
condenser. The reaction vessel was evacuated of air by placing under high vacuum, then
charging with N2 gas (3x). Dioxane (245 mL) was then transferred to the reaction vessel via
syringe through the rubber septum. The suspension was stirred vigorously as the temperature
was raised to reflux. Once at reflux, the aqueous solution of the amino acid was added slowly
over 5 min. The reaction was allowed to proceed at reflux for 30 min before allowing cooling to
room temperature. The reaction was then concentrated on the rotary evaporator to remove most
of the dioxane before diluting to 200 mL with dH20 and washing with ether to remove unreacted
anhydride. The aqueous layer was then acidified with 6 N HCI and extracted with DCM (3 x
100 mL). The organic layers were combined, dried with MgSO 4, filtered, and concentrated. The
crude was purified by flash column chromatography using ethyl acetate with 0.5% acetic acid as
the solvent system. The fractions containing the desired product were combined and azeotroped
in toluene (3 x 100 mL) to remove residual acetic acid. The product was isolated as a bright
orange solid (2.31 mg, 5.40 mmol, 55% yield, Rf= 0.2 in EtOAc with 0.5% AcOH).
1H-NMR (500 MHz, CDCl3, 6): 1.26 (s, 9H), 3.12 (s, 6H), 4.61 (m, 2H), 4.81 (m, 1H),
5.67 (d, 1H, J= 7.0 Hz), 7.11 (d, 1H, J= 8.5 Hz), 7.65 (apparent triplet, 1H, J= 8.0 Hz), 8.44 (d,
1H, J= 8.0 Hz), 8.48 (d, 1H, J= 8.0 Hz), 8.56 (d, 1H, J= 7.0 Hz).
13C-NMR (300 MHz, CDC13, 8): 173.7, 165.0, 164.5, 157.1, 156.0, 133.2, 131.6, 131.5,
130.4, 125.0, 124.9, 122.5, 114.1, 113.3, 80.2, 52.8, 44.7, 40.7, 28.0.
HRMS-ESI (m/z): [M+H +] calcd for C22H25N30 6 428.1816, found, 428.1814.
/ \ 1) TFA/DCM (1:1), room temp, 1.5 hrs
2) Fmoc-OSu, NaHCO 3, dioxane/H20 (5:1) 0 N
e O  room temp, 2 hrs
N 0O
Me 0 O 83% overall yield 0 N OH
Me 0 N OH
3-18 3-7
N-a-Fmoc-(4-N,N-dimethylamino-1,8-naphthalimido)-alanine (3-7). The solid Boc-
4DMNA 3-18 (2.0 g, 4.68 mmol) was dissolved in dichloromethane (47 mL) and stirred in a 250
mL round-bottom flask as cold TFA (47 mL) was added by addition funnel over 5 min. The
reaction was allowed to proceed at ambient temperature for 1.5 hrs before concentrating to
dryness and azeotroping with chloroform (3 x 50 mL) to remove residual TFA. The crude was
then placed under high vacuum overnight. The crude was redissolved in dH20 (23 mL) with
NaHCO 3 (1.97 g, 23.40 mmol). The pH was tested to ensure the solution was basic. A solution
of N-(9-fluorenylmethoxycarbonyloxy) succinimide (1.74 g, 5.15 mmol) was then prepared in
dioxane (117 mL) and slowly added to the stirring solution of the amino acid. The reaction was
allowed to proceed for 2 hrs before concentrating to remove most of the dioxane and re-diluting
to a total volume of 150 mL in dH20. The aqueous layer was washed with diethyl ether (1 x 50
mL) to remove excess Fmoc-OSu. The aqueous layer was acidified with 6 N HCl and the
product extracted into dichloromethane (3 x 100 mL). The organic layers were combined, dried
with MgSO 4, filtered, and concentrated. The product was purified by flash column
chromatography using 3:1 ethyl acetate/hexanes with 0.5% acetic acid as the solvent system.
_ _~ ~_~_~ __~~I__~ _r_ __I__ ~ _~~~ _II ~_ I
The product is an orange solid (2.14 g, 3.89 mmol, 83% yield, Rf = 0.2 in EtOAc with 5%
AcOH). Note: the final product contained a small amount of toluene as a result of azeotroping to
ensure the complete removal of residual acetic acid following the purification. (Note - Both the
'
3C-NMR and 'H-NMR of this compound exhibit anisochronous resonances for nine of the ten
aromatic carbons and all eight of the aromatic protons of the 9-fluorenyl group. A variable
temperature experiment showed no coalescence of these aromatic protons at 80 'C. The cause of
this apparent asymmetry is presumed to be the result of partial overlap of one side to the 9-
fluorenyl ring system with that of the fluorescent side-chain of the amino acid. These nuclei
would therefore lack chemical equivalence producing the observed spectra).
1H-NMR (500 MHz, CDC13, 6): 3.02 (s, 6H), 3.95 (t, 1H, J= 7.3 Hz), 4.11 (dd, 1H, J =
10.5 Hz, J 2 = 8.0 Hz), 4.21 (dd, 1H, J1 = 10.8 Hz, J2 = 7.3 Hz), 4.72 (d, 2H, J= 6.5 Hz), 4.99
(apparent dd, 1H, J1 = 14.8 Hz, J2 = 7.3 Hz), 6.17 (d, 1H, J= 8.0 Hz), 6.96 (d, 1H, J= 8.5 Hz),
7.16 (apparent t, 1H, J= 7.5 Hz), 7.21 (apparent t, 1H, J= 8.0 Hz), 7.31 (apparent t, 2H, J= 7.3
Hz), 7.45 (d, 1H, J = 7.5 Hz), 7.5 (d, 1H, J = 7.5 Hz), 7.57 (apparent t, 1H, J = 8.0 Hz), 7.66
(apparent t, 2H, J= 6.5 Hz), 8.34 (d, 1H, J= 8.0 Hz), 8.41 (d, 1H, J= 8.5 Hz), 8.54 (d, 1H, J=
7.5 Hz).
13C-NMR (500 MHz, CDC13, 8): 173.6, 165.1, 164.6, 157.2, 156.3, 143.9, 143.6, 141.0,
133.4, 131.7, 131.6, 130.3, 129.0, 128.2, 127.4, 127.0, 126.9, 125.3, 125.1, 124.8, 124.7, 122.2,
119.7, 119.6, 113.7, 113.1, 67.3, 53.2, 46.9, 44.6, 40.6.
HRMS-ESI (m/z): [M+H +] calcd for C32H27N306 550.1973, found, 550.1959.
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Chapter 4: Comparative studies of the dimethylaminophthalimide amino
acids with other commercial solvatochromic fluorophores
A significant portion of the work described in this chapter has been published:
Loving, G.; Imperiali, B. A versatile amino acid analogue of the solvatochromic fluorophore 4-
N,N-dimethylamino-1,8-naphthalimide: A powerful tool for the study of dynamic protein
interactions. J. Am. Chem. Soc. 2008, 130, 13630-13638.
Introduction
Dynamic protein-protein interactions within the cell play a critical and pervasive role in
nature. Many signal transduction pathways are mediated through the binding and dissociation of
key proteins in a tightly regulated fashion.' The dynamics of these interactions are also vital to
the controlled assembly and disassembly of many functional ensembles such as the actin
filament component of the cytoskeleton 2 or the focal adhesions involved in mammalian cell
migration. 3 As such, concentrated efforts to better understand these interactions have led to the
development of a wide range of techniques that are now commonplace in the field of protein
biochemistry. These techniques span a broad spectrum from purely in vitro biophysical methods
such as isothermal titration calorimetry 4 and analytical ultracentrifugation 5 to ones more
amenable to in cellulo studies like yeast two-hybrid assays6 and photoaffinity labeling.7 While
each of the approaches are indispensible for the unique information that they provide, many of
these methods are limited in the ability to yield spatial and temporal information regarding
dynamic interactions and are often necessarily destructive to the cell. Consequently, a vast
number of questions regarding the temporal and spatial significance of various protein-protein
interactions within living cells remain unanswered and require the continual development of new
generations of tools if further advances are to be made.
An ideal tool for addressing these questions should be one that can sensitively detect the
transient nature of various protein-protein interactions in a reversible manner. By this measure,
Firster Resonance Energy Transfer (FRET) has become increasingly more popular in the
literature and stands as one of the preferred methods for in cellulo studies.8 An alternative
approach is the use of solvatochromic fluorophores, which feature emission properties that
exhibit a significant dependence on changes in solvent polarity, solvent relaxation rates,
orientation to electric fields, and rigidity of the local environment. 9 The effects of these
environmental factors on the photophysical properties of the fluorophore typically manifest as
shifts in the wavelength of maximum emission, changes in the magnitude of the observed
fluorescence lifetime or alterations in the quantum yield. In many instances all three properties,
which constitute the dynamic range of the fluorophore, are affected simultaneously.
Chart 4-1. Dimethylaminophthalimidoalanine series of solvatochromic amino acids
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In this chapter, the new solvatochromic amino acid 4-DMNA is introduced as an
alternative to the 4-DAPA'O and 6-DMNA" amino acids previously reported by the Imperiali
laboratory. The experiments described herein demonstrate the potential of 4-DMN to be utilized
as a tool for detecting biomolecular interactions. The improved stability (Chapter 2), the ease of
synthesis (Chapter 3), and the longer wavelength of excitation of 4-DMNA over that of the
amino acids 4-DAPA and 6-DMNA will greatly expand the range of potential applications. A
comparative study is provided that evaluates the photophysical properties of 4-DMN relative to
those of 6-DMN and 4-DMAP as well as other frequently used solvatochromic fluorophores that
are commercially available: BADAN, dansyl, and NBD. 12
Results and Discussion
4-1. Comparison of the solvatochromic properties of the N,N-dimethylaminophthalimide series
with BADAN, dansyl, and NBD
Since their discovery, reactive derivatives of solvatochromic fluorophores including
dansyl chloride (5-(dimethylamino)-naphthalene-l-sulfonyl chloride), 13 ' 14  BADAN (6-
bromoacetyl-2-dimethylaminonaphthalene),15-17 and NBD fluoride (4-fluoro-7-
nitrobenzofurazan) 18-20 have been used extensively in the areas of cell biology and protein
biochemistry. All three fluorophores exhibit hypsochromic shifts (blue-shifts) in the emission
spectra upon changing from a polar to nonpolar environment. Additionally, these display greater
fluorescence quantum yields in hydrophobic solvents than in aqueous buffers. The same trends
also apply to the dimethylaminophthalimide series of fluorophores, although these probes have
the notable advantage of possessing much larger differences in fluorescence quantum yields in
response to the solvent environment.
To evaluate the properties of 4-DMN, we incorporated the 4-DMNA amino acid into a
test peptide via SPPS. The test peptide consists of a six-residue sequence rich in lysine and
arginine residues, dubbed the KR peptide motif in reference to the single-letter notation for
amino acids. This peptide motif was selected specifically to ensure complete solubility of the
fluorophores in both solvent systems for accurate fluorescence measurements. While the highly
charged peptides are naturally soluble in aqueous buffers such as TBS (pH 7.4), the peptides can
easily be dissolved in dioxane in the presence of 18-crown-6, which forms very strong
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complexes with protonated primary amines such as those of the lysine residues and N-terminus.
We also prepared the same peptide with amino acid derivatives of 4-DMAP, 6-DMN, BADAN,
dansyl and NBD. Each member of the KR peptide series contained one of the six fluorophores
located at the fourth position within the six-residue sequence (Chart 4-2). The peptides were
studied in different solvent systems (dioxane and water) to encompass two extremes of the
solvent-polarity spectrum (see Experimental section for details).
Chart 4-2: The KR Peptide Series of Solvatochromic Fluorophores
R
KR peptide:
H2N-Lys-Arg-Arg-N Lys-Lys-CONH2H 0
Residue # 1 2 3 4 5 6
R = BADAN Dansyl NBD 4DMAP 6DMN 4DMN
NMe 2  Dimethylaminophthalimide series:
NMe 2 Q NMe 2NNN2 eN e ,,o Me  NMe2
O O=S=O N O OHN HN 1O N
S 
N
The most striking trend to emerge from this study was the substantial difference in
fluorescence intensities exhibited by the dimethylaminophthalimide series between the two
solvent systems. In each case, the ratio of the fluorescence intensity was greater than 1000-fold
at the wavelength of maximum emission in dioxane (Table 4-1). This was significantly greater
than that observed for dansyl and NBD. The magnitude of this ratio is attributed primarily to the
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extremely low fluorescence quantum yields of the dimethylaminophthalimides in polar protic
solvents creating the appearance of virtually no fluorescence in TBS buffer as plotted in the
graphs of Figure 4-1. BADAN, a derivative of PRODAN 2 1 that has long been considered state-
of-the-art for applications in biological studies, also displayed a significant fluorescent response
between water and dioxane despite its large quantum yield of fluorescence in water (Owater -
0.18). 22 However, even with this excellent performance under these idealized conditions, such
absolute changes are rarely achieved in actual biological applications. This experiment merely
demonstrates the potential dynamic range of each fluorophore under optimal conditions. In
protein studies, where the conditions are typically far from optimal, even the smallest degree of
background fluorescence can strongly limit the magnitude of the observed fluorescence change.
KRmp peptide KR4,o peptide KRmm peptide
121 479 nm s*a. 512 nm 5so 20 nm
4.x103 fold 1.2x 3 d -1.4x103 fold43 me SU 
-. 0 __o - *- - --- old
Ws soo seo coo se aSO SO s s M ISO 450 ON1 0 0 00
wavelength (nm) wavelength (nm) wavelength (nm)
KR.d peptide KR,, peptide KRND peptide
457 n 499 nm 23 nm
fold7.0 fold
4W 4S0 S0 S" ON 4f0 Soo S me Nm eS 7W
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Figure 4-1. Fluorescence spectra of the KR peptides (5 tM) measured in TBS buffer at pH 7.4 (- - -) and 1,4-
dioxane with 5 mM 18-crown-6 (-). Each spectrum is the average of three independent measurements corrected
for background. The fold-increase in fluorescence is reported at the wavelength of maximum emission in the 1,4-
dioxane solution. All measurements were made at 25 C.
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Table 4-1. Photophysical properties of the fluorescent KR peptide series
TBS dioxane Idioxane/ITBS
Peptide labs (nm) E (M"1 cm"1)  hetc(nm) Xem (nm) Xem (nm) at Xem in dioxanea
KR4DMAP 421 6.5 x 10 3  390 580 497 4.5 x 103 1.4 x 103
KR4DMN 440 8.8 x 103 408 554 512 1.2 x 103 + 0.2 x 103
KR6DMN 390 8.0 x 10 3  378 625 520 1.4 x 10
3 ± 0.2 x 10 3
KRBADAN 391 2.0 x 104 365 550 457 7.0 x 102 f 0.2 x 10
2
KRdansyl 337 5.3 x 10 3  345 564 499 66 + 1
KRNBD 465 2.2 x 104 455 543 523 7.0 + 0.3
a This ratio was calculated by integrating the fluorescence intensity in both solvent systems over a 5 nm window
centered on the wavelength of maximum emission in dioxane. The area of the measured region in dioxane was then
divided by that measured in TBS buffer. The listed errors represent the 90% confidence interval from three trials.
4-2. Preparation of M13 peptide mutants and binding studies with calmodulin
To examine the behavior of these fluorophores in a more biologically relevant context,
another peptide series was prepared (Table 4-2). This series of peptides was derived from the
previously reported M13 peptide, 23 which contains the calmodulin binding domain of skeletal
muscle myosin light chain kinase (skMLCK). Calmodulin (CaM) binds the M13 peptide in a
calcium-dependent manner with a reported Kd on the order of 10-9 to 10-10 M. 24 The structural
details of this interaction have been extremely well characterized and shown to include many
hydrophobic contacts as the protein literally wraps around the peptide binding partner (Figure 4-
2).24 Hence, the calcium-dependent CaM-M13 interaction has served as a model system for
evaluating many new methods for detecting protein-protein interactions.25 28
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Table 4-2. The mutant M13 peptide series containing the solvatochromic fluorophores
Residue #-a
M13mutant: N-term 2 3 4c 5 6 7 8b 9 10 11 12 13 14 15 16 17c 18 19 C-term
M1 3 4DMAP H2N- R R W K K N Dap(4DMAP)I A V S A A N R F K K -CONH 2
M1 3 4DMN H2N- R R W K K N Dap(4DMN) IA V S A A N R F K K -CONH 2
M1 3 6DMN H2N- R R W K K N Dap(6DMN) IA V S A A N R F K K -CONH 2
M13Dany H2N- R R W K K N Dap(dansyl) IA V S A A N R F K K -CONH 2
M13NBD H2N- R R W K K N Dap(NBD) IA V S A A N R F K K -CONH 2
M1 3 ADAN H2N- R R W K K N Cys(BADAN) A V S A A N R F K K -CONH 2
a The residue numbering refers to the original M13 fragment reported by Blumenthal et al.23
b The fluorophore, indicated in parentheses, is appended to the 3-amino group of Dap or, in the case of the
M13 BADAN mutant, the side-chain of the cysteine residue. The wild-type M13 peptide contains a phenylalanine
residue at this position.
c Trp 4 and Phe 17 (bold face) are the key residues that bind in the hydrophobic pockets of the C- and N-terminal
domain, respectively, forming important contacts that may establish the orientation of the a-helical peptide in the
complex. 29
a) Calmodulin b)
r 4
EF-hands EF-hands
N-terminal F C-terminal
domain domain
Caz * * w
fuorecnt
MlS peptdi
Phe 17 DMNA
hv,
hV.
Figure 4-2. (a) A graphical depiction of the Ca2+ activation and binding of CaM (grey) to an M13 peptide mutant
(cyan) that contains a residue with an environment sensitive fluorophore as the side-chain (0). Upon complex
formation, the fluorophore exhibits a measurable change in fluorescence. The Trp 4 and Phe 17 residues are
indicated in this panel using the single-letter notation for amino acids. (b) NMR structure of the Ca2+-CaM-M13
peptide complex deposited by Ikura et al. in the Brookhaven Protein Data Bank (2BBM). 24 The structure indicates
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the solvent exposed surface of CaM (grey) surrounding the M 13 peptide (cyan). Superimposed over the side-chain
of residue Phe 8 is 4-DMN (gold) as it might be oriented in the M 134DMN peptide mutant.30
Based on the structural information available for the Ca2+-CaM-M13 complex, the
phenylalanine residue located at position 8 of the wild-type M13 sequence was selected as the
site for introducing the fluorescent probes. This residue is known to make a number of
hydrophobic contacts with Ca2+-CaM. Furthermore, reports of other peptide sequences that bind
CaM through a mode similar to that of the M13 peptide have shown that CaM is tolerant of most
hydrophobic residues at this position. 29 The mutant M13 peptides of Table 2 represent abridged
versions of the original 27-residue M13 peptide reported by Blumenthal et al.23 The peptides of
this study consist only of the span of residues required for binding. The CaM construct used in
this investigation contained a C-terminal hexahistidine tag used for purification and as an epitope
for Western Blot analysis. The fluorescence spectra for the mutant M13 peptides were recorded
in the presence of saturating CaM, CaCl2, and CaM with CaCl 2 (see Experimental section for
details). These results were then compared to the spectra of the peptides alone (Figure 4-3).
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Figure 4-3. Fluorescence spectra of the M13 mutant peptide series measured in TBS buffer at pH 7.4, 25 'C with
EDTA (40 pM). Four separate conditions were examined for each member of the series shown above: 0, M13
peptide (10 [tM); A, M13 peptide (10 pM) + CaM (15 pM); O, M13 peptide (10 pM) + CaM (15 pM) + Ca 2 + (200
ptM); O, M13 peptide (10 pM) + Ca2+ (200 pM). Each spectrum represents the average of three independent
measurements corrected for background. The fold-increase in fluorescence indicated by the arrows represents the
fluorescence ratio between conditions '0' and 'A' at the wavelength of maximum emission (Xem) in condition 'O'.
Table 4-3. Observed Fluorescence Changes
CaM
for M 13 Mutants in the Presence of CaM and Ca 2+-
Free CaZ+-CaM-M13
M13 peptide complex
Peptide Xexc(nm) em (nm)a Xem (nm)b I(O/I(A) at Xemc I(O/I(*) at kemc
M1 3 4DMAP 390 567 508 26.3 ± 7.4 183 ± 3
M1 3 4DMN 408 550 505 106 + 7 963 ± 100
M1 3 6DMN 378 608 544 18.9 + 1.2 119 ± 4
M1 3BADAN 365 542 483 3.87 ± 0.05 17.9 ± 0.7
M1 3 dansyl 345 553 494 10.4+ 0.1 33.3 ± 2.3
M1 3 NBD 455 541 531 2.94 + 0.14 3.41 + 0.20
a Measurements made in TBS buffer (pH 7.4. 25 "C) with the M 13 peptide concentration at 10 1tM.
b Measurements made in TBS buffer (pH 7.4, 25 °C) with M13 peptide (10 tM), CaM (15 jtM) and CaC12 (200
giM).
c The measured fluorescence intensity ratios are indicated by the subscripted symbols: 0, M13 peptide alone; A,
M13 peptide + CaM; and 0, M13 peptide + CaM + Ca2+. The listed errors represent the 90% confidence interval
from an average of three trials.
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In contrast to the previous study that examined the fluorescent properties of the
fluorophores in dioxane versus water, the measured spectra in this experiment reflect a complex
array of variables extending well beyond solvent polarity. Here, the fluorophores are
sequestered within a highly restricted microenvironment upon binding of the M13 peptide
mutants to calcium-activated CaM. Such microenvironments lack the homogeneity of a fluid
medium of uniform dielectric constant. The packing of each fluorophore within the binding
interface is strongly influenced by its size, shape and hydrophobicity. A deeply buried
solvatochromic fluorophore, stripped of a surrounding solvation sphere, will no longer
experience the effects of solvent relaxation, which reduces the energy gap between the ground
and excited electronic states. 9 The rigidity of the microenvironment can also impact the
observed fluorescence quantum yields by restricting certain vibrational modes within the
fluorophore excited state that may lead to the ground state through nonradiative decay
processes.9 Bearing in mind that each fluorophore can respond differently to a particular
microenvironment and that the nature of such microenvironments can vary widely depending on
the protein interaction of interest, the results of this type of comparative study are relative and
some caution should be exercised when making generalizations. Nevertheless, basic trends do
emerge providing guidelines for gauging the efficacy of these tools in future applications.
With the exception of the M134DMN peptide, all members of this series showed a
significantly smaller hypsochromic shift in their emission maxima between the bound and
unbound states (Table 4-3) compared to that observed in water versus dioxane (Table 4-1) with
the corresponding KR peptides. This observation is fairly typical of environment-sensitive
fluorophores since changes in the local solvent environment are often more subtle in studies of
this type. Despite this fact, the dimethylaminophthalimide series still exhibited the greatest
107
overall changes in fluorescence intensity. Furthermore, the M134DMN peptide produced the most
dramatic results, yielding a greater than 900-fold increase in fluorescence intensity in the
presence of saturating CaM and Ca 2+ compared to that of the peptide alone. The magnitude of
this change, which was approximately 5-8 times greater than that of 4-DMAP and 6-DMN, may
be due to the more effective sequestering of the fluorophore within the peptide-protein complex.
All of the M13 peptide mutants exhibited small increases in fluorescence intensities in
the presence of CaM alone, with the largest change being observed for the M1 3 4DMN peptide (-9-
fold). Initially, this was thought to be the result of some contaminating calcium that was
activating a fraction of the total calmodulin toward binding of the fluorescent peptides.
However, control experiments that were performed, using chelating agents like EDTA to
sequester free calcium, showed this was not the cause of the observed increases. Rather, it was
concluded that the increases in fluorescent signal were due to the weak association constant that
exists for the CaM-M13 complex in the absence of calcium. It has previously been reported that
the Kd of the CaM-M13 complex is approximately two-million-fold higher than that of the Ca2+-
CaM-M13 complex.31 Based on our determination of the Kd of the Ca2+-CaM-M134DMN complex
shown later in Figure 4-4, we estimated that the calcium-independent Kd is on the order of 150-
200 tM. This would imply that roughly 7% of the mutant M13 peptide is bound by CaM under
these experimental concentrations. Consequently, two different ratios are reported in Table 3:
the fluorescence increase upon the addition of calcium when CaM was already present (I(o)/I(A));
and the overall fluorescence increase observed when comparing the Ca2+-CaM-M13 complex to
that of the M13 mutant alone (1(0)/I(*)).
The results of Figure 4-3 exemplify the importance of having low-background
fluorescence for the unbound probe. If the measured hypsochromic shift is small, such that the
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emission spectrum of the Ca2+-CaM-M13 complex partially or fully overlaps with that of the
lone peptide, then a large quantum yield of fluorescence in water may drastically limit the
magnitude of the measured fluorescence increase. Since the dimethylaminophthalimide series
exhibits very little fluorescence in aqueous environments, even a modest shift in the emission
wavelength will typically be accompanied by a significant change in fluorescence intensity.
Hence, these probes closely mimic switch-like or "on-off' emission properties making them
excellent tools for cell microscopy by eliminating the need for extensive washing to remove
unbound probe in order to reduce background signal.32 Furthermore, these probes may readily
be adapted for ratiometric measurements by introducing a secondary non-solvatochromic
fluorophore of a different emission wavelength to afford more quantitative information within
the highly compartmentalized environment of living cells.
4-3. Titration of the M13 4DMN Peptide with Calcium Activated CaM
One caveat of incorporating unnatural structural elements into proteins is the potential to
disrupt a native binding interaction. A titration of the M1 34DMN peptide with Ca2+-CaM was
performed to demonstrate that that the presence of the unnatural amino acid, 3, has a negligible
impact on the affinity of the complex (Figure 4-4). The Kd for the wild-type M13 peptide has
previously been reported by several groups using various techniques that place the value within
the low nanomolar to high picomolar range. 23,33,34 In this study, the Kd for the Ca2+-CaM-
M134DMN complex was determined to be 86 ± 25 pM, indicating an extremely tight interaction
(see Experimental section for details). Therefore, it was concluded that the presence of 4-
DMNA at position 8 in the M13 peptide sequence does not significantly impact the protein-
peptide interaction.
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Figure 4-4. (a) Fluorescence spectra collected from 475 nm to 600 nm as the M134Dn peptide (10 nM) was titrated
with CaM in the presence of 200 gM CaC12. The fluorophore was excited at 408 nm. Each spectrum represents the
average of nine measurements after background correction. (b) The titration curve of the M134DMN peptide
measured at 507 nm. The error bars shown for the measured values represent the 95% confidence interval based on
the average of nine trials. The solid line indicates the least-squares fit to the measured data. The interval shown for
the Kd of the complex was also calculated at the 95% confidence level.
Conclusions
While there are a number of known solvatochromic fluorophores that have been
developed into amino acids, 17 3 5-39 it is rare for a single species to meet all of the criteria for
obtaining optimal results in protein studies. Tradeoffs often exist between variables such as
good extinction coefficients, suitable wavelengths of excitation and emission, thermal and
photochemical stability, size, and many others. The 4-DMNA amino acid is unique in that this
species appears to demonstrate very few compromises by combining many of the key elements
required of a good fluorescent tool. It can be excited in the visible spectrum (400-450 nm), thus
minimizing the damaging effects of high-energy UV light; the Fmoc building block, 3-7, can be
prepared in few synthetic steps and offers facile incorporation into peptides; the fluorescent side-
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chain is significantly more stable than those of 4-DAPA and 6-DMNA; and it possesses the same
switch-like fluorescent properties that are characteristic of the dimethylaminophthalimide series.
Like 4-DAPA and 6-DMNA, the comparative size of 4-DMNA to the natural aromatic amino
acid tryptophan allows it to be incorporated into peptides or proteins without significantly
altering the native surface topology. This is critical in developing new fluorescent probes like
the M13 4DMN peptide, which we have shown to have a binding affinity for Ca2+-CaM similar to
that reported for the wild-type system. The combination of these properties into this single
amino acid opens the window to many potential future applications as we aim to incorporate this
tool into full-length proteins for in cellulo studies.
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Experimental
PBS and TBS buffers:
Phosphate-buffered saline. All references to solutions prepared in PBS buffer pertain to
the following recipe.
10 x PBS Buffer:
80.0 g NaCl
2.0 g KCl
14.4 g Na2HPO 4
2.4 g KH 2PO 4
Dissolved the measured salts in 800 mL of distilled H20 (pH should be approximately 6.8).
Adjust to final volume of 1 L. Upon diluting the 10x PBS buffer ten-fold with distilled H20, the
pH should be 7.4. The final lx PBS concentrations should be 137 mM NaCl, 10 mM phosphate,
and 2.7 mM KC1.
Tris-buffered saline. All references to solutions prepared in TBS buffer pertain to the
following recipe.
10x TBS Buffer:
60.6 g Tris-HCI
87.7 g NaCl
Dissolve the measured salts in 800 mL of distilled H20 and adjust the pH to 7.3 with
concentrated HC1. Then increase the volume to 1 L. Upon diluting the 10x TBS buffer ten-fold
with distilled H20, the pH should be 7.4. The final 1 x TBS concentrations are 50 mM Tris-HC1,
150 mM NaCl, and pH 7.4.
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Synthesis of the KR peptide series:
The KR peptide series was prepared using standard Fmoc-based solid-phase peptide
synthesis techniques (SPPS). 40 Each peptide was prepared using 0.21 mmol/g loading Fmoc-
PAL-PEG-PS resin (Cat. No. GEN913383, Applied Biosystems) in a Poly-Prep®
chromatography column (Cat. No. 731-1550, Bio-Rad). Fmoc-protected amino acids with the
standard side-chain protecting groups were used: Fmoc-Arg(Pbf)-OH and Fmoc-Lys(Boc)-OH.
A Boc-Lys(Boc)-OH residue was incorporated at the N-terminus of each member of the series in
order to yield the free a-amino group following cleavage of the peptides from the solid support.
The KR peptides of 4-DMAP, 6-DMN, dansyl, and NBD were all prepared from the parent
KRDap(alloc) peptide while KRBADAN was prepared from the KRcys(Mmt) peptide. The (S)-2-(Fmoc-
amino)-3-(alloc-amino)-propionic acid (Fmoc-Dap(alloc)-OH) and the Fmoc-Cys(Trt)-OH
residues were both incorporated at position 4 within the KRDap(alloc) and KRcys(Mmt) peptides,
respectively. Synthesis of the KRDap(alloc) peptide was performed on a 105 pmole scale and the
KRcys(Mmt) peptide was prepared on a 21 jpmole scale. Amide couplings were executed using 6
equiv of each amino acid with exception to position 4. Here, only 3 equiv of the Fmoc-
Dap(alloc)-OH and Fmoc-Cys(Mmt)-OH residues were used. All of the amino acids were
dissolved to a final concentration of 50 mM in DMF containing a 1:1 mixture of HOBt/HBTU
(50 mM each) with N,N-diisopropylethylamine (100 mM, 12 equiv). Each coupling reaction was
allowed to proceed at room temperature for 30-45 min. The coupling was monitored by a
colormetric assay for detecting free primary amines known as the 2,4,6-trinitrobenzenesulphonic
acid (TNBS) test.4 1 Removal of the Fmoc group prior to each coupling step was performed
using a 20% 4-methylpiperidine solution 42 in DMF (3 x 5 min). Once the syntheses of the
KRDap(alloc) and KRcys(Mmt) peptides were complete, the Dap and Cys residues were selectively
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deprotected in order to append the desired fluorophores. Removal of the Alloc group was
performed according to the previously described protocol.43 The Mmt group was removed using
a 1% trifluoroacetic acid (TFA) solution in dichloromethane with 5% triisopropylsilane added as
a cation scavenger (4 x 15 min). The side chains of the Dap and Cys residues were then
alkylated with the appropriate fluorophores. The KRBADAN peptide was prepared by first
dissolving 6-bromoacetyl-2-dimethylaminonaphthalene (BADAN, AnaSpec) (3.3 equiv) in N-
methylpyrrolidone with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) (1 equiv). The solution was
then added directly to the resin-bound KRcys peptide. The coupling reaction was allowed to
proceed overnight in the dark at room temperature. The KR4DMAP and KR6DMN peptides were
prepared by coupling the anhydride precursors of 4-DMAP and 6-DMN to the side chain of Dap
according to the previously described protocol. 43 The KRdansyl and KRNBD peptides were
prepared by treating the resin-bound KRDap peptide with a 50 mM solution of 5-
(dimethylamino)-naphthalene-l-sulfonyl chloride (dansyl chloride, 2 equiv) and 4-fluoro-7-
nitrobenzofurazan (NBD fluoride, 2 equiv) dissolved in DMF with N,N-diisopropylethylamine (2
equiv). The reactions were allowed to proceed at room temperature overnight in the dark.
Preparation of the KR4DMN peptide was unique among the series in that it was prepared using the
Fmoc-4DMNA building block (3-7) instead of coupling the fluorophore to the fully assembled
peptide. The KR peptides were cleaved from the resin using a solution of 96:2:2 TFA/H 20/EDT
for 3 hrs. The cleavage cocktail was then filtered and evaporated. The crude peptides were
triturated with cold diethyl ether (3 x 10 mL) and purified by high-performance liquid
chromatography (HPLC) using a Waters 600E HPLC with a Waters 600 automated control
module and Waters 2487 dual wavelength absorbance detector set at 228 and 280 nm. The
separations were performed using a preparative YMC-pack, C18, 20 x 250 mm reverse-phase
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column. A YMC-pack, C18, 4.6 x 150 mm reverse-phase column was used for analytical HPLC.
The following analytical HPLC method was used to verify purity of the peptides:
Time
(min)
initial
5
40
% H 2 0
linear
linear
linear
Table 4-4. Characterization of purified KR peptide series
Peptide Sequence
N-term 1 2 3 4 5 6 C-term
HPLC Ret.
Time (min)
[M+xH]x+
Calc.
[M+xH]x+
found
KR4DMAP H2N- K R R Dap(4DMAP) K K -CONH 2  21.2 974.0(1+) 973.7(1+)
KR4DMN H2N- K R R Dap(4DMN) K K -CONH 2  23.4 1024.1(1+) 1023.6(1+)
KR6DMN H2N- K R R Dap(6DMN) K K -CONH 2  24.0 1024.1(1+) 1023.7(1+)
KIRADAN H2N- K R R Cys(BADAN) K K -CONH 2  26.9 1029.1(1+) 1029.7(1+)
KRDanyl H2N- K R R Dap(dansyl) K K -CONH 2 20.2 1034.0(1+) 1034.2(1+)
KRNBD H2N- K R R Dap(NBD) K K -CONH 2  16.1 482.5(2+) 482.4(2+)a
322.0 (3+) 321.9 (3+)a
a Peptide mass determined by ESI-MS on a Mariner electrospray mass spectrometer (PerSeptive Biosystems). All
other KR peptides in this series were confirmed by MALDI mass spectroscopy on a PerSeptive Biosystems Voyager
MALDI-TOF instrument using a 2,5-dihydroxybenzoic acid matrix.
Synthesis of the M13 mutant peptide series:
The M13 mutant peptide series was prepared using standard Fmoc-based solid-phase
peptide synthesis techniques (SPPS). 40 The peptides were prepared using 0.17 mmol/g loading
Fmoc-NovaPEG Rink Amide resin LL (Cat. No. 01-64-0483, Novabiochem®). Fmoc-protected
amino acids with the standard side-chain protecting groups were used: Fmoc-Ala-OH, Fmoc-
Phe-OH, Fmoc-Ile-OH, Fmoc-Lys(Boc)-OH, Fmoc-Asn(Trt)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-
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KR peptides
Ser(tBu)-OH, Fmoc-Val-OH, and Fmoc-Trp(Boc)-OH. The M13 peptide mutants containing 4-
DMAP, 6-DMN, Dansyl, and NBD were all prepared from the parent M13Dap(alloc) peptide while
M1 3 BADAN was prepared from the M13cys(Mmt) peptide. Synthesis of all the peptides of this series
began by coupling the first seven residues (positions 13-19) with an ABI 431A peptide
synthesizer (Applied Biosystems). The synthesis was performed on the 40 Imol scale using 4
equiv of the Fmoc amino acids in each cycle. It had previously been discovered from earlier
attempts at making these peptides that the coupling efficiency was extremely low for residues
incorporated after the alanine at position 10 in the M13 sequence. This problem was overcome
by using a pseudoproline dipeptide, Fmoc-Val-Ser('Me Mepro)-OH (Cat. No. 05-20-1001,
Novabiochem), at positions 11-12 in place of Fmoc-Val-OH and Fmoc-Ser(tBu)-OH. The
remaining residues were all coupled manually using 6 equiv of the Fmoc amino acids. All of the
building blocks were dissolved to a final concentration of 50 mM in DMF containing a 1:1
mixture of HOBt/HBTU (50 mM each) with N,N-diisopropylethylamine (100 mM, 12 equiv).
Each coupling reaction was allowed to proceed at room temperature for 30-45 min. The
coupling efficiency was monitored using the TNBS test.4 1 Removal of the Fmoc group prior to
each coupling step was performed using a 20% 4-methylpiperidine solution42 in DMF (3 x 5
min). After the incorporation of Fmoc-Ile-OH at position 9, the resin was split into three
aliquots. The Fmoc-Dap(alloc)-OH, Fmoc-Cys(Mmt)-OH, and Fmoc-4DMNA building blocks
were then coupled at position 8. A Boc-Arg(Pbf)-OH residue was incorporated at the N-
terminus of the M1 3 Dap(alloc), M13Cys(Mmt), and M1 3 4DMN peptides in order to yield the free ot-
amino group following cleavage from the solid support. Once the syntheses of the M1 3 Dap(alloc)
and M13cys(Mmt) peptides were complete, the Dap and Cys residues were selectively deprotected
in order to append the desired fluorophores. Removal of the Alloc group was performed
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according to the previously described protocol.43 The Mmt group was removed using a 1% TFA
solution in dichloromethane with 5% triisopropylsilane added as a cation scavenger (4 x 15 min).
The side chains of the Dap and Cys residues were then modified with the appropriate
fluorophores. The M13 BADAN peptide was prepared by first dissolving BADAN (3.3 equiv) in N-
methylpyrrolidone with 1,8-DBU (1 equiv). The solution was then added directly to the resin-
bound M13cys peptide. The coupling reaction was allowed to proceed overnight in the dark at
room temperature. The M1 3 4DMAP and M1 36DMN peptides were prepared by coupling the
anhydride precursors of 4-DMAP and 6-DMN to the side chain of Dap according to the
previously described protocol. 43 The M1 3 dansyl and M13NBD peptides were prepared by treating
the M13Dap peptide with a 50 mM solution of dansyl chloride (2 equiv) and NBD fluoride (2
equiv) dissolved in DMF with N,N-diisopropylethylamine (2 equiv). The reactions were allowed
to proceed at room temperature overnight in the dark. Preparation of the M1 3 4DMN peptide was
unique among the series in that it was prepared using the Fmoc-4DMNA building block (3-7)
instead of coupling the fluorophore to the fully constructed peptide. The M13 mutant peptides
were cleaved from the resin using a solution of 96:2:2 TFA/H20/EDT for 3 hrs. The cleavage
cocktail was then filtered and evaporated. The crude peptides were triturated with cold diethyl
ether (3 x 10 mL) and purified by HPLC using a Waters 600E HPLC with a Waters 600
automated control module and Waters 2487 dual wavelength absorbance detector set at 228 and
280 nm. The separations were performed using a preparative YMC-pack, C18, 20 x 250 mm
reverse-phase column. A YMC-pack, C18, 4.6 x150 mm reverse-phase column was used for
analytical HPLC. The following analytical HPLC method was used to characterize the peptides:
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Time Flow Rate % HzO % acetonitrile Gradient
(min) (mL/min) (with 0.1% TFA) (with 0.1% TFA)
initial 1.00 95 5 linear
5 1.00 95 5 linear
40 1.00 55 45 linear
Table 4-5. Characterization of purified M13 mutant peptide series
M13
peptide Peptide Sequence HPLC Ret. [M+xH]+ [M+xH]
x
+
mutants Time (min) Calc. found
N-term 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 C-term
M134DMAP H2N- R R W K K N Dap(4DMAP) IA V S A A N R F K K -CONH 2  34.8 2332.6(1+) 2332.2(1+)
M134DMN H2N- R R W K K N Dap(4DMN) IA V S A A N R F K K -CONH 2  36.0 2382.6(1+) 2383.1(1+)
M1 3 6DMN H2N- R R W K K N Dap(6DMN) I A V S A A N R F K K -CONH 2  37.0 2382.6(1+) 2382.3(1+)
M13 BADAN H2N- R R W K K N Cys(BADAN) IA V S A A N R F K K -CONH 2  33.0 2387.6(1+) 2388.6(1+)
M13Dansyl H2N- R R W K K N Dap(dansyl) IA V S A A N R F K K -CONH 2  38.1 2392.6(1+) 2393.6(1+)
M13NBD H2N- R R W K K N Dap(NBD) IA V S A A N R F K K -CONH 2  34.0 774.9(3+) 774.4(3+)-
581.4(4+) 581.1(4+)'
465.3(5+) 465.1(5+)a
a Peptide mass determined by ESI-MS on a Mariner electrospray mass spectrometer (PerSeptive Biosystems). All
other M13 peptide mutants in this series were confirmed by MALDI mass spectroscopy on a PerSeptive Biosystems
Voyager MALDI-TOF instrument using a 2,5-dihydroxybenzoic acid matrix.
Expression and purification of CaM-His6:
The CaM-His6 construct was transformed in BL21-Gold(DE3) competent cells from
which a 20% glycerol stock was prepared for subsequent protein expression. The stock was
used to inoculate a 5 mL LB-broth starter culture containing carbenicillin (50 gtg/mL). The
starter culture was allowed to grow overnight in a 37 'C shaker at 225 rpm. The next day, the
starter culture was used to inoculate a 1 L LB-broth culture containing carbenicillin (50 ptg/mL)
and grown at 37 'C with agitation at 225 rpm. The culture was allowed to grow to an OD600nm Z
0.5 after which the 1 L shaker flask was transferred to a 25 'C shaker (225 rpm) for induction.
The cells were induced with 0.1 mM IPTG and shaken for 4 hrs before harvesting at 5000 x g (4
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'C). The pellet was then resuspended in 0.9% NaCi aqueous solution (30 mL) and transferred to
a 50 mL conical tube and repelleted for storage at -80 oC.
On the day of the protein preparation, the pellet was thawed at room temperature and
resuspended in the following lysis buffer:
4 mL 10x PBS buffer
400 pL NP-40 Alternative
4 mL glycerol
40 mg lysozyme
6 mg dithiothreitol
40 gL Protease Cocktail III (Calbiochem)
40 mL final vol. after diluting with dH20
Once the pellet was fully resuspended, the cells were sonicated using a Branson Sonifier
450 at 50% power with a 30% duty cycle for 2 min at 4 C. The lysate was then transferred to 45
mL polycarbonate bottle and spun at 100,000 x g in a Type 28 rotor from Beckman Coulter to
pellet DNA and other cellular debris. Meanwhile, a 5 mL bed of Ni-NTA agarose resin obtained
from Qiagen was pre-equilibrated in PBS buffer. After the spin, the clarified supernatant was
transferred to a clean 50 mL conical tube where it received the pre-equilibrated Ni-NTA agarose
resin and was tumbled gently on a rotisserie at 4 oC for 1 hr. The resin was then recovered by
passing the lysate through 20 mL spin column obtained from Bio-Rad. The resin was washed
first with 4 mL of PBS buffer, then 4 mL of 10 mM imidazole in PBS buffer and then with 4 mL
of 20 mM imidazole in PBS buffer at 4 oC. The protein was then eluted in 6 x 1.5 mL fractions
of 250 mM imidazole in PBS buffer at 4 oC. The fractions were assayed for protein and
combined appropriately. The imidazole was removed by dialysis using a 3.5 kDa MWCO Slide-
A-Lyzer dialysis cassette from Pierce. The protein solution was dialyzed against 3 x 2 L
changes of TBS buffer. The protein was quantified using the Bio-Rad protein assay solution.
Protein yield was -150 mg/L for the purified CaM mutant.
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SDS PAGE (15% polyacrylamide) analysis was performed on the protein to confirm
purity by Coomassie staining. Western blotting of the gel also confirmed the presence of the
poly-histidine tag when probed with the mouse anti-his IgG. After transferring to nitrocellulose
for 1 hr at 4 oC at 100 V, the nitrocellulose was blocked with nonfat dry milk (3 g) in TBS buffer
(30 mL) for approximately 4 hrs. The milk solution was then poured off and washed with TBST
buffer (3 x 30 mL for 5 min each wash). Next, a 1:10,000 dilution in TBST (15 mL) of the
mouse anti-his IgG was added to the nitrocellulose and incubated for 1 hr. The antibody solution
was poured off and the nitrocellulose sheet was again washed with TBST buffer (3 x 30 mL) for
5 min each wash). A 1:10,000 dilution of the goat anti-mouse IgG(H+L) alkaline phosphatase
conjugate in TBST (15 mL) was added to the nitrocellulose and incubated for 1 hr. The antibody
solution was poured off and the nitrocellulose sheet was again washed with TBST buffer (3 x 30
mL) for 5 min each wash). Last, 10 mL of 1-StepTM NBT/BCIP from Pierce was added and
incubated with the nitrocellulose until the band was visible. The nitrocellulose was then washed
with dH20 and blotted dry (Figure 4-5).
50 kDa
37kDa 64kDa
37 kDa
25 kDa
26 kDa
20 kDa g
19 kDa
15 kDa 15kDa
CaM-His6 CaM-HIs6
10 kDa 17.6 kDa 17.6 kDa
Coomassie Mouse anti-His6 IgG
Precision Plus Proteln" ladder (Blo-Rad). PBenchMark pre-stain protein ladder (Invitroen).
Figure 4-5. Coomassie and western blot of the CaM-His6 construct.
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Fluorescence experiments:
General procedures. All fluorescence spectra were recorded using a Fluoromax 3
instrument (Horiba Jobin Yvon) at 25 C. The samples were each excited at the wavelength
appropriate for the fluorescent peptide. The slit widths were set to 3 nm for excitation and 6 nm
for emission. The data points were collected at 0.5 nm increments with a 0.1 s integration
period. All spectra were corrected for intensity using the manufacturer-supplied correction
factors and corrected for background fluorescence by subtracting a blank scan of the buffer
system.
KR peptide study in dioxane/water. Concentrated stocks of each of the purified peptides
in the series were prepared in deionized H20 and quantified by UV-visible spectrometry using
the known or measured extinction coefficients of the corresponding fluorophores (Table 4-1).
Samples of each peptide were then prepared to a final concentration of 5 ptM in either TBS
buffer or dioxane containing 18-crown-6 (5 mM) as an additive to enhance solubility. This was
done using a 10 mL volumetric flask. The samples were then transferred to a 100 tL quartz
cuvette for measurement. This process was repeated in triplicate for both solvent systems. The
fold-increase measured for each fluorescent peptide at the wavelength of maximum emission in
dioxane was calculated by integrating the area under the curve spanning a 5 nm window centered
on the wavelength of interest. The area measured in dioxane was then divided by the area
measured in TBS buffer. The results of three trials were then averaged and the error calculated
from the standard deviation and the Student's t-value for a 90% confidence interval.
Ca2-CaM-M13 mutant study. Concentrated stocks of each of the purified peptides in the
series were prepared in deionized H20 and quantified by UV-visible spectrometry using the
known or measured extinction coefficients of the corresponding fluorophores. A concentrated
121
stock solution of the CaM-His 6 construct was also prepared in TBS buffer and quantified by
measuring the absorbance in 6 M guanidinium chloride using the predicted extinction coefficient
(E280 nm = 2980 cm-1 M 1) based on residue composition.44 Additionally, stocks of CaC12 (2 mM)
and ethylene diamine tetraacetic acid (EDTA, 5 mM) were prepared. From these stock solutions,
four experiments were conducted in triplicate as shown in Table 4-6.
Table 4-6. Experimental conditions for Ca2+-CaM-M 13 mutant study
M13 EDTA CaM-His6 CaCI 2
Experiment (10 M) (40 PM) (15 VM) (200 i)
The fold-increase measured for each fluorescent peptide at the wavelength of maximum
emission under condition '0' was calculated by integrating the area under the curve spanning a
5 nm window centered on the wavelength of interest. The area measured for condition '0' was
then divided by the area measured for conditions 'O' and 'A' to calculate the two reported
ratios. The results of three trials were averaged and the reported errors were calculated from the
standard deviations and the Student's t-value for a 90% confidence interval.
Titration ofM134DMNpeptide with Ca2+-CaM. This experiment was conducted at 25 C
in TBS buffer (pH 7.4) containing 200 jM CaCl 2 and 0.1% BSA. The BSA was added to
prevent nonspecific adsorption of the CaM construct or the mutant M13 peptide to the walls of
the quartz cuvette or pipette tips. The M1 34DMN peptide was dissolved in the buffer system to an
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initial concentration of 10.2 nM and was gradually diluted to 9.9 nM as the titrant was added.
Due to the low signal-to-noise ratio obtained using standard fluorescence instrumentation, lower
concentrations of the fluorescent M13 peptide gave less reliable results. The titrant was a stock
solution of the CaM construct (920 jiM). The total CaM concentration was varied from 0 nM to
22.9 nM as fluorescence spectra were collected at each increment. Due to the low concentration
of the fluorescent peptide, the excitation slit width was opened to 10 nm and the integration
period extended to 0.2 s. The data from nine replicate titrations were imported into
SPECFIT/32TM Global Analysis System for Windows (version 3.0.39) to calculate the Kd of the
interaction. The results of the nine trials were then averaged and the error calculated from the
standard deviation and the Student's t-value for a 95% confidence interval. The data processing
of a typical titration under these conditions is illustrated in Figure 4-6.
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Figure 4-6. Titration of the M134DMN peptide with Ca2+-CaM.
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Chapter 5: A comparative study of the 4-DMN thiol-reactive agents with
other commercial solvatochromic fluorophores
A significant portion of the work described in this chapter has been submitted for publication in:
Loving, G.; Imperiali, B. Thiol-reactive derivatives of the solvatochromic 4-N,N-dimethylamino-
1,8-naphthalimide fluorophore: A highly sensitive toolset for the detection of biomolecular
interactions. Bioconjug. Chem. Submitted on July 17, 2009.
128
Introduction
The solvatochromic properties of many environment-sensitive fluorophores have been
exploited in a wide range of biological applications such as detecting protein-peptide binding
events, 1-6 monitoring changes in protein allostery, 7-12 and reporting various forms of post-
translational modification.13',1 4 Since both intra- and intermolecular interactions of many proteins
often involve a dynamic veiling and unveiling of discrete hydrophobic clefts or pockets within
the topology of these macromolecules, an appropriately placed solvatochromic fluorophore can
provide a general and facile method of detecting protein function or activation. Due to the
adaptable nature of these tools for addressing an array of problems in the biological sciences,
many classes of solvatochromic fluorophores are now commercially available in reactive forms
ready for direct conjugation to proteins and other relevant biomolecules.' 5 This diversity offers
greater prospects of identifying fluorescent constructs with signaling characteristics suitable for
study.
A common application of solvatochromic fluorophores is the development of constructs
in which the measured fluorescence change is integrally coupled to a perturbation in a specific
aspect of protein structure. Such an approach is particularly advantageous when structural
changes are too subtle to be detected by other fluorescence-based methods such as Frster
resonance energy transfer (FRET) 16 and fluorescence polarization (FP). 17 However, a practical
limitation often encountered when using many of the commercially available solvatochromic
probes is that the magnitude of the observed fluorescence change rarely approaches the
maximum potential obtained in the context of a typical solvent comparison study (Chapter 4). 6
The reasons for this observation are varied, but can frequently be attributed in part to the high
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degree of intrinsic fluorescence exhibited by these fluorophores in water as well as insufficient
sensitivity to changes in the local environment.
This chapter describes the development of a new series of cysteine modifying agents, 3-3
through 3-6 (Chart 5-1), based on the solvatochromic fluorophore 4-DMN. The principle
advantage of this fluorophore, along with other members of the dimethylaminophthalimide
family, is that it exhibits extremely low fluorescence quantum yields when exposed to polar
protic solvents like water (Chapter 4). 6 This greatly reduces background signal thereby creating
the effect of 'on-off or 'switch-like' changes in the observed emission intensity with the
potential to exceed ratios of 1000-fold. Furthermore, as described in Chapter 2, it has been
determined that this fluorophore possesses significantly greater chemical stability than the other
dimethylaminophthalimide dyes we have investigated 6 making it particularly suitable for
applications that require prolonged exposure to a wide range of aqueous conditions relevant for
most biological applications.
Much of the former work with the dimethylaminophthalimide dyes in the Imperiali group
focused on the development of fluorescent amino acids for incorporation into small peptide-
based probes designed to recognize and report binding to discrete protein motifs such as 14-3-3
domains,' 8 SH2 domains, 3 and PDZ domains. 19  While these efforts have proved highly
successful, the work described in this chapter aims to expand the scope of applications to include
the integration of these tools into native proteins. However, several fundamental differences
must be considered when applying these tools in proteins versus short peptides. With increasing
peptide length, the polymer chain exhibits greater potential for adopting higher order structure20
leading, in some instances, to significant changes in the local environment of the attached
fluorophore. Such changes may include the degree of solvent exposure, the frequency of
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collisional quenching, and the emergence of local electrostatic fields. Additionally, the
arrangement of the polymer chain around the dye could restrict certain vibrational modes
responsible for non-radiative decay processes that compete with fluorescence. The influence of
such structural elements and the effects they impart on the photophysical properties of the
fluorophore are difficult to predict and can often complicate efforts toward developing useful
fluorescent protein probes that utilize the full potential of the fluorescent tool. Hence, empirical
screening approaches are typically required, leading us to focus on the development of a series of
cysteine-labeling agents. This approach offers a direct and facile method for the site-selective
incorporation of these probes into proteins.
This study identifies key variables that influence the fluorescent response of labeled
proteins to changes in protein structure providing a general framework for understanding the
ways in which solvatochromic tools may best be applied. Additionally, it reveals a systematic
approach to developing future fluorescent protein probes for detecting various biomolecular
interactions. The members of this new series of thiol-modifying agents vary according to the
linker type and the nature of the electrophilic group necessary for cysteine labeling (Chart 5-1).
Using the calcium-sensing protein calmodulin as a model system for our study, we demonstrate
the power of this suite of solvatochromic tools to develop highly effective sensors of dynamic
biomolecular interactions.
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Results
The calcium binding protein calmodulin (CaM), which has been extensively
characterized by a number of research groups,2 1 was selected as the model system for a
comparative study to evaluate the performance of the 4-DMN cysteine modifying agents 3-3
through 3-6. CaM is a soluble protein that responds to sudden influxes of cytosolic Ca2+ levels 22
by rapidly chelating as many as four of these cations through specialized Ca2+-binding motifs
called EF-hands. The binding event induces an allosteric change in the N- and C-terminal
domains of the protein resulting in the formation of two hydrophobic pockets, which can then
bind critical hydrophobic residues of certain peptide motifs that are recognized by the protein
(Figure 5-1).21,23 One advantage to using calmodulin is that the wild-type protein is devoid of
native cysteine residues. This characteristic affords considerable freedom in selecting discrete
sites for cysteine mutagenesis and subsequent modification by a thiol-reactive agent. The
exceptional attributes offered by this unique system provides a useful benchmark for our studies
since numerous research groups12,24 -28 over the last 30 years have attempted to develop CaM-
based calcium sensors by labeling the protein at a variety of sites with various solvatochromic
probes. However, despite extensive efforts, the reported changes in fluorescence emission are
modest and typically encumbered by high background fluorescence, which strongly limits the
utility of these constructs in certain applications such as fluorescence microscopy.
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Figure 5-1. Ca2+ activation of a CaM mutant (grey) results in the burying of an attached solvatochromic fluorophore
(yellow) within one of the newly formed hydrophobic pockets. In response, the fluorophore exhibits a dramatic
increase in fluorescence intensity. Subsequent addition of the M13 peptide (cyan) can displace the fluorophore from
the pocket through insertion of an aromatic side-chain from the phenylalanine or tryptophan residue indicated here
using the single-letter notation for amino acids.
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Based on careful examination of available X-ray and NMR structures of calmodulin in
the apo-state,29 as well as the calcium-bound30 and calcium-peptide-bound 3 1 states, seven sites
were selected for cysteine mutagenesis (Figure 5-2). The basis for the selection process was the
identification of residues that are relatively solvent exposed when the protein exists in the apo-
state and do not appear to play an important functional role that might be disrupted through
mutagenesis and labeling. By exploring multiple sites spanning the breadth of the protein
structure, it is possible to resolve trends that are site-dependent from those that are site-
independent and to better ascertain the robustness of those trends. Site-directed mutagenesis was
performed on the wild-type template to introduce cysteine residues at two sites on the N-terminal
domain (El lC and S38C), two sites within the linker region (M76C and E87C), and three sites in
the C-terminal domain (N111C, E114C, and M145C).
S38C
M145C
M76C
E87C E114C
N1
Figure 5-2. Crystal structure of the Ca2+-CaM complex deposited by Rupp et. al. (PDB entry 1UP5). 30 The structure
indicates the seven sites selected for cysteine mutagenesis (red). The bound calcium ions are indicated by spheres
(yellow).
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In addition to the 4-DMN derivatives 3-3 through 3-6, five commercially available
solvatochromic fluorophores were also included in this study for comparison (Chart 5-1). These
fluorophores provide a representative sampling of the major classes of solvatochromic probes
that are currently available and commonly used at this time. The reagents vary fundamentally in
size, shape, and hydrophobicity and each exhibits distinct photophysical properties.' 5 For the
comparison, we focused on common dyes that were available as thiol-reactive labeling agents
possessing dimensions similar to that of the 4DMN derivatives. With a total of nine fluorescent
labeling agents and seven cysteine mutants of calmodulin, sixty-three possible fluorescent
constructs were prepared for evaluation. The wild-type CaM construct was included as a control
in the labeling experiments, although no significant background labeling was observed.
In order to gauge the capacity of each labeling agent to report a change in the structural
state of the calmodulin mutants, fluorescence spectra were collected in the presence and absence
of saturating calcium. Additionally, since the Ca2+-CaM complex is capable of binding certain
peptide motifs with high affinity, a known peptide binding partner commonly referred to as the
M13 peptide32 was also introduced to the fluorescent constructs, in the presence and absence of
calcium, to observe whether further changes in the emission spectra occur. The constructs were
compared by measuring the ratio of fluorescence intensity at the wavelength of maximum
emission of the Ca2+-CaM complex to that of the apo-state for the three the examined conditions
(saturating Ca2+, saturating M13 peptide, and saturating Ca2+ with the M13 peptide).33 For
brevity, the results of three representative mutants are shown in Figure 5-3 (panels a-c). The
remaining data sets are located at the end of the Experimental section of this chapter (Figure 5-
7).
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A common feature observed among most of the cysteine mutants of this study was the
tendency to exhibit higher fluorescence intensity in the Ca2+-bound state compared to that of the
full Ca2+-CaM-M13 peptide complex (Figure 5-3a,b). This propensity for the labeled constructs
to display a diminished fluorescent signal in the presence of a native peptide-binding partner was
general for all of the solvatochromic fluorophores, with exception to the two charged species
IAEDANS and PyMPO included in this study. The effect is attributed to a process of
competitive displacement in which the fluorophore and ligand both compete for occupancy of
the same hydrophobic binding site thereby increasing the average exposure of the fluorophore to
the surrounding solvent environment. However, this behavior was by no means a rule as many
constructs included in this study, particularly those of the M145C mutant (Figure 5-3c),
exhibited the greatest fluorescence intensity for the Ca2+-CaM-M13 peptide complex.
A number of key trends emerged from the fluorescence screen. One among these was a
pronounced dependence of the measured fluorescence change on the linker type for the 4-DMN
series of compounds 3-3 through 3-6. For instance, the El IC mutant exhibited a strong bias for
the shortest linker of the series (4 A) whereas the trend was the reverse for the S38C mutant,
which yielded the best response with linkers of intermediate to longer length (6-9 A). This result
was largely site-dependent and yielded no clear pattern for determining the optimal linker type a
priori. Hence, the process of identifying a construct with the desired fluorescence properties
may best be accomplished through an empirical approach utilizing the set of 4-DMN-labeling
agents as a combined suite.
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Figure 5-3. Histograms indicating the fluorescence results obtained from three of the cysteine mutants examined in
this study. The vertical bars represent the ratio of fluorescence intensity measured at the wavelength of maximum
emission under the condition that yielded the brightest state for each construct with respect to that of the apo-state.
The fluorophores are indicated along the horizontal axis below the associated results. For each condition, saturating
levels of Ca2+ and/or the M13 peptide were used. The indicated errors represent the 90% confidence intervals
determined from three trials.
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The next revealed trend was the marked ability of the calmodulin cysteine mutants
labeled with the 4-DMN derivatives, 3-3 through 3-6, to produce greater signal increases in
response to the presence of saturating calcium (or calcium plus the M13 peptide) over those
modified by the other dyes considered in the study. Although in some cases these differences
were modest, the overall trend demonstrated that this property was robust and relatively site-
independent. This is particularly apparent for the S38C mutant (Figure 5-3b) labeled with
compound 3-4, which showed a greater than one hundred-fold increase in emission intensity
upon binding calcium. Among the commercially available fluorophores, IANBD was the closest
by comparison exhibiting only a fifteen-fold increase in intensity. Although the influence of
linker type, which played a crucial role in obtaining optimal results with the 4-DMN fluorophore,
was not examined when comparing the other commercial fluorophores, the limiting factor for
those dyes was largely due to the high degree of intrinsic fluorescence that each exhibits in
aqueous environments. This high background effectively reduces the maximum attainable
signal-to-noise ratio despite these dyes being good fluorophores.
Results of the study also suggest that certain factors known to enhance hydrophilicity can
negatively influence the capacity of a solvatochromic fluorophore to respond to perturbations
within the local topology of the protein surface. This was particularly apparent between the two
charged dyes included in the series (IAEDANS and PyMPO). Neither dye displayed significant
changes in emission properties when the associated cysteine mutants were exposed to
combinations of Ca2+ and the M 13 peptide. By bearing a formal positive or negative charge, the
energetic cost of desolvating these fluorescent species may negate any benefit gained by burying
the aromatic ring systems deep within a hydrophobic pocket formed as the result of a
conformational change to the protein structure. This would greatly impact the equilibrium of the
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buried versus solvated state making these probes less sensitive to such structural dynamics
despite otherwise exhibiting good solvatochromic properties. Although this trend was relatively
site-independent for the mutants of the calmodulin protein, it is expected that these probes could
be better suited for applications where the possibility of charge complementarity exists or where
other molecular driving forces are responsible for the partitioning of the probes between two
distinct environments. 34
Discussion
In developing this series of 4-DMN cysteine labeling agents, an essential question we
wished to address was whether there was value in utilizing an assortment of linker types or if this
simply introduced an element of redundancy. The results of this study strongly indicate that the
linker type does play a critical role in influencing the magnitude of the fluorescent response. For
a solvatochromic probe to function optimally, it must directly interact with a feature of interest.
If this feature happens to be a hydrophobic pocket located far from the point of attachment on the
protein surface, then a longer linker would clearly be favored over one that is unable to reach
(Figure 5-4a). However, a caveat of using a longer linker is that the greater range may
inadvertently increase the probability that the fluorophore will encounter and bind a shallow
hydrophobic patch that is unaltered by the structural state of the protein. Such a static interaction
would produce and undesirable increase in the fluorescence background. In this instance a
shorter linker could prove better suited (Figure 5-4b). In fact this appears to be the case for
mutant E 11C where compound 3-3 produced a much greater increase in fluorescence intensity
than compound 3-6 upon the addition of saturating Ca 2+ . Both constructs displayed comparable
emission intensities in the Ca 2+ bound state. However, the apo-state of the construct labeled with
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3-6 exhibited a fluorescence background that was roughly five-fold greater than that of the
construct with the shortest linker resulting in the smaller observed increase.
dynamic site
b) signaling
S event
static site static site
dynamic site
Figure 5-4. (a) Attachment point P, is located far from a hydrophobic pocket formed upon a structural change in
the protein. Here, a longer linker is preferred to a shorter one. (b) Attachment point P 2 is located near the
hydrophobic pocket formed in response to a structural change. Such sites may favor shorter linkers as longer linkers
could tend to allow the fluorophore to encounter non-specific hydrophobic patches that remain static with regard to
the dynamics of protein topology. This would result in higher background fluorescence.
Interference by background fluorescence is a phenomenon that affects all solvatochromic
fluorophores and extends beyond the model system used in this study. Solvatochromic
fluorophores often display somewhat different emission properties when appended to globular
proteins such as calmodulin. 35 A bulky hydrophobic fluorophore protruding into the surrounding
solvent environment demands a large enthalpic cost due to disruption of the dense network of
hydrogen-bonded water molecules. Consequently, the probe will exhibit a strong tendency to
associate with any hydrophobic clefts or pockets formed by structural elements within the
immediate vicinity to minimize this exposure. The degree of background fluorescence
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associated with these non-specific interactions is largely site-dependent for a fluorophore of a
given linker-type. This interference is further compounded by any intrinsic fluorescence already
produced by the probe in water. A convenient method we have developed for measuring the
background resulting from such effects involves comparing the emission spectra of the construct
under both natured (TBS buffer pH 7.4) and denatured conditions (TBS buffer pH 7.4 with 6.67
M guanidine hydrochloride). This was performed with all sixty-three fluorescently labeled
calmodulin constructs and the results summarized in Figure 5-6 located in the Experimental
section of this chapter. Although site-dependent background fluorescence appeared to be a
critical limitation to many of the commercial dyes, this issue proved much less consequential for
the 4-DMN derivatives due to the negligible degree of intrinsic fluorescence exhibited by these
probes in water.
An ideal site for labeling would be one that precludes the solvatochromic fluorophore
from forming any surface associations of this sort until a structural change in the protein has
occurred. In practice, however, identifying an optimal labeling site is often challenging even
when exceptional structural data for the protein is available. As a result, screening of a
strategically selected series of cysteine mutants is typically required. When applied in
combination with the series of 4-DMN labeling agents, this approach allowed us to readily
identify a number of fluorescent mutants that respond sensitively and selectively to the formation
of the Ca2+-CaM complex. Additionally, although the 4-DMN labeled M145C mutants showed
only a modest selectivity for the Ca2+-CaM-M13 peptide complex over that of the Ca2+-CaM
complex, it is possible that a more extensive screen could yield a construct with greatly improved
properties permitting access to a set powerful sensors of either state.
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Conclusion
In this study, the 4-DMN derivatives 3-3 through 3-6 were evaluated and compared with
five other well-established solvatochromic fluorophores to address a number of critical factors
pertaining to the successful application of such tools in detecting specific types of bimolecular
interactions. These factors include the importance of linker type, the influence of
hydrophobicity, and the deleterious effects of high intrinsic fluorescence.
Due to the rarity with which solvatochromic fluorophores exhibit the maximum potential
fluorescence changes when used in many biological applications, the large intrinsic fluorescence
exhibited by many of these probes in aqueous environments represents a critical issue that can
ultimately be limiting. This matter is further compounded by the strong tendency for these
probes to show a marked enhancement in fluorescent signal when appended to proteins as a
result of non-specific topological interactions. Because the 4-DMN derivatives possess such low
intrinsic fluorescence in water, these effects are significantly less consequential.
Linker variety is a fundamental component to designing sensors that incorporate
solvatochromic dyes and is a feature that is not typically examined systematically. Often, the
linker is considered a passive component of fluorescent labeling agents, serving merely to
connect the dye to the target molecule without interfering with native properties like function or
solubility. Here, we demonstrate that linkers play a more active role and can be a vital element
in the optimization of the fluorescent response. When applied in combination with cysteine-
scanning mutagenesis, the number of fluorescent constructs is greatly expanded thereby
increasing the potential for obtaining a sensor with the desired properties. We therefore present
this series of labeling agents as a combined suite that offers the excellent properties of the 4-
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DMN dye in a format ready to meet the strict demands required by a wide spectrum of
applications ranging from high-throughput screening assays to fluorescence microscopy.
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Experimental
Tris-buffered saline. All references to solutions prepared in TBS buffer pertain to the
following recipe.
10x TBS Buffer:
60.6 g Tris-HCI
87.7 g NaCl
Dissolve the measured salts in 800 mL of distilled H20 and adjust the pH to 7.3 with
concentrated HCl. Then increase the volume to 1 L. Upon diluting the 10x TBS buffer ten-fold
with distilled H20, the pH should be 7.4. The final 1 x TBS concentrations are 50 mM Tris-HC1,
150 mM NaCl, and pH 7.4.
Synthesis of the M13 peptide. The peptide used in this study represents a truncated form
of the originally described M13 peptide discovered by Blumenthal et al.32 The sequence
encompasses only the minimum residues required to bind the Ca2+-CaM activated complex. The
residue numbering refers to that of the original fragment.
M13 Peptide
Residue# N-term 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 C-term
Sequence H2N- R RW I K K N F I A V S A N R F K K -CONH 2
The M13 peptide was prepared using standard Fmoc-based solid-phase peptide synthesis
techniques (SPPS) 36 with 0.17 mmol/g loading Fmoc-NovaPEG Rink Amide resin LL (Cat. No.
01-64-0483, Novabiochem®). Fmoc-protected amino acids with the standard side-chain
protecting groups were used: Fmoc-Ala-OH, Fmoc-Phe-OH, Fmoc-Ile-OH, Fmoc-Lys(Boc)-OH,
Fmoc-Asn(Trt)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Ser(tBu)-OH, Fmoc-Val-OH, and Fmoc-
Trp(Boc)-OH. Synthesis of the peptide began by coupling the first seven residues (positions 13-
19) with an ABI 431A peptide synthesizer (Applied Biosystems). The synthesis was performed
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on the 40 gmol scale using 4 equiv of the Fmoc amino acids in each cycle. It had been
discovered from earlier attempts at making the M13 peptide that the coupling efficiency was
extremely low for residues incorporated after the alanine at position 10 in the sequence. This
problem was overcome by using a pseudoproline dipeptide, Fmoc-Val-Ser(Me'Mepro)-OH (Cat.
No. 05-20-1001, Novabiochem), for positions 11-12 in place of Fmoc-Val-OH and Fmoc-
Ser(tBu)-OH. The remaining residues were coupled manually using 6 equiv of the Fmoc amino
acids. The building blocks were dissolved to a final concentration of 50 mM in DMF containing
a 1:1 mixture of HOBt/HBTU (50 mM each) with N,N-diisopropylethylamine (100 mM, 12
equiv). Each coupling reaction was allowed to proceed at room temperature for 30-45 min. The
coupling efficiency was monitored using the TNBS test.37 Removal of the Fmoc group prior to
each coupling step was performed using a 20% 4-methylpiperidine solution38 in DMF (3 x 5
min). A Boc-Arg(Pbf)-OH residue was incorporated at the N-terminus of the peptide in order to
yield the free ca-amino group following cleavage from the solid support. The M13 mutant
peptide was cleaved from the resin using a solution of 96:2:2 TFA/H20/EDT for 3 hrs. The
cleavage cocktail was then filtered and evaporated. The crude peptide was triturated with cold
diethyl ether (3 x 10 mL) and purified by HPLC using a Waters 600E HPLC with a Waters 600
automated control module and Waters 2487 dual wavelength absorbance detector set at 228 and
280 nm. The separation was performed using a preparative YMC-pack, C18, 20 x 250 mm
reverse-phase column. A YMC-pack, C18, 4.6 x150 mm reverse-phase column was used for
analytical HPLC. The following analytical HPLC method was used to characterize the peptide:
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H2 0 %
(with 0.1% TFA)
MeCN %
(with 0.1% TFA)
7
7
100
Retention
time (min)
21.6
ESI-MS (m/z)
[M+xH] x+ calcd
740.9 [M+3]
555.9 [M+4]
444.9 [M+5]
ESI-MS (m/z)
M+xH] x+ founi
740.6 [M+3]
555.7 [M+4]
444.8 [M+5]
The peptide mass was determined by ESI-MS on a Mariner
electrospray mass spectrometer (PerSeptive Biosystems).
Subcloning of codon-optimized CaM gene into the pET-14b vector. The synthetic CaM
construct ordered from Bio Basic Inc. was designed for optimal expression in E. coli. The gene
was inserted into a high-copy pUC-57 vector for ease of amplification. The product was
delivered as a lyophilized powder and also as a stab of transformed DH5ca cells in LB agar with
carbenicillin. A sterile loop was dipped in the stab and swabbed over a fresh LB agar plate
containing carbenicillin (50 jtg/mL). The plate was incubated overnight at 37 'C. The next day,
a colony was selected and amplified in order to isolate the vector using a Qiagen Plasmid
Miniprep kit. The DNA was then quantified by Abs at 260 nm (0.11 ptg/tl).
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Time
(min)
initial
5.0
40.0
Flow
Rate
(mL/min)
1.00
1.00
1.00
Gradient
linear
linear
linear
..
Sequence of codon-optimized CaM gene.
ATGGCAGATCAACTGACTGAAGAACAGATTGCGGAATTTAAAGAAGCATTCAGCCTGTTC
GACAAAGATGGCGATGGCACCATTACGACCAAGGAGCTGGGTACGGTGATGCGTTCTCTG
GGTCAGAACCCAACTGAGGCAGAACTGCAGGATATGATCAACGAGGTTGATGCTGACGGT
AATGGCACCATCGACTTCCCGGAATTCCTGACCATGATGGCCCGTAAAATGAAAGACACC
GATTCCGAAGAAGAAATCCGTGAGGCTTTCCGTGTATTCGACAAAGACGGTAACGGCTAC
ATTTCTGCGGCGGAACTGCGCCATGTGATGACCAACCTGGGCGAAAAACTGACCGACGAA
GAAGTTGACGAGATGATCCGCGAAGCTGATATCGACGGTGATGGTCAGGTCAACTATGAA
GAATTTGTTCAGATGATGACTGCGAAGCACCACCACCACCACCAC
Translation of codon-optimized CaM gene.
MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADG
NGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDE
EVDEMIREADIDGDGQVNYEEFVQMMTAKHHHHHH
A double digestion of the amplified pUC-57(CaM) vector was performed simultaneously
with the double digestion of the pET-14b vector. The reaction conditions were as follows:
pET-14b vector: pUC-57 vector:
1.28 tIL pET-14b (2.34 jtg/gL) 27.0 gtL pUC-57 (0.11 jig/gtL)
41.2 tL dH20 (sterile) 15.5 gL dH20 (sterile)
5.0 pL 10 x NEB buffer 2 5.0 gL 10 x NEB buffer 2
0.5 pL 100x BSA 0.5 gL 100x BSA
1.0 gL XhoI 1.0 L XhoI
1.0 gL Ncol 1.0 ptL NcoI
total volume 50.0 tL total volume
The reactions were allowed to proceed for 1 hr at 37 'C before stopping with the addition
of 12.5 jtL of 5x DNA loading buffer. The both reaction mixtures were then loaded onto a 1%
agarose gel and resolved at 110 V. The desired restriction products (the CaM insert of the pUC-
57 vector and the linearized pET-14b expression vector) were cut from the gel and isolated using
a QIAquickTM Gel Extraction kit. The subcloning vector and insert were then quantified on 1%
agarose gel by comparing band intensities to those of the NEB 2-Log DNA ladder.
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50.0 ttL
Two ligation reactions were assembled: one containing both the CaM insert and the pET-
14b vector, and the other with only the pET-14b vector as a negative control. The reaction
conditions were as follows:
vector (control) vector + insert
0.3 tL pET-14b (120 ng/tL) 0.3 pL pET-14b (120 ng/ tL)
3.2 jtL dH20 (sterile) 1.0 pL CaM insert (15 ng/gL)
1.0 jtL T4 DNA ligase 2.2 gL dH20 (sterile)
0.5 pL 10x T4 ligase buffer 1.0 pL T4 DNA ligase
0.5 p1L 10x T4 ligase buffer
5.0 giL total volume 5.0 pL total volume
Note- There were 36 jtg of pET-14b vector in each reaction and 15 jtg of the insert in the ligation. The insert is 480
bp and the vector is 4500 bp. This corresponds to a 4:1 molar ratio of insert to vector.
The reactions were allowed to proceed for 16 hrs at 16 oC. The reactions were then used
to transform two 30 pL batches of DH5a cells plated on LB/agar with 50 [tg/mL carbenicillin.
The next day, no colonies were observed for the negative control. Three colonies from the non-
control plate were selected and amplified for sequencing. All selected colonies were determined
to be the desired construct. The new vector, pET-14b[CaM], was transformed into BL21-
Gold(DE3) competent cells from Stratagene for protein expression.
Cysteine mutagenesis of wild-type CaM gene. These seven cysteine mutants of the CaM
construct were prepared by site-directed mutagenesis using the following set of PAGE-purified
primers along with the corresponding reverse compliments ordered on the 50 nmole scale from
Operon:
El1C-
CTGACTGAAGAACAGATTGCGTGCTTTAAAGAAGCATTCAGCCTG
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S38C-
GGGTACGGTGATGCGTTGTCTGGGTCAGAACCC
M76C-
CCTGACCATGATGGCCCGTAAATGCAAAGACACCGATTCCG
E87C-
CCGATTCCGAAGAAGAAATCCGTTGCGCTTTCCGTGTATTCGAC
NlIC-
CTGCGCCATGTGATGACCTGCCTGGGCGAAAAACTGACC
E114C-
GTGATGACCAACCTGGGCTGCAAACTGACCGACGAAGAAG
M145C-
CTATGAAGAATTTGTTCAGATGTGCACTGCGAAGCACCACCACC
Upon receiving the primers, stock solutions were prepared in sterile water (125 ng/ tl).
The reactions were assembled accordingly:
5.0 tL 10x Pfu Turbo rxn buffer.
0.5 giL pET14b vector [CaM] (20 ng/gL)
1.0 gtL fwd primer (125 ng/pL)
1.0 L rev primer (125 ng/tL)
2.5 pL dNTP's (10 mM each)
40.0 gL dH2O (sterile)
50.0 tL total volume
A control reaction was also performed in which the primers were excluded from the
reaction mixture. Next, 1 jtL of Pfu Turbo (2.5 U/pL, Stratagene) was added to each reaction.
The reaction solutions were mixed thoroughly by gentle pipetting, centrifuged briefly and loaded
into an MJ-mini PCR machine from Bio-Rad. The PCR method employed was as follows:
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PCR method:
18 cycles
95 C 95- C
I min 50 sec
68-C 68'C
,' 6.5 min 7 min',
" 55'C '
50 sec 4 -C
infinite
After the PCR reaction was complete the parent vector was digested by adding 1 tL of
DpnI (20 U/pL) to each reaction mixture. The reactions were then mixed with gentle pipetting
and incubated at 37 'C for 1.5 hrs each. The reaction mixtures were then used to transform XLl-
blue DH5ca cells obtained from Stratagene. Colonies from each transformation were selected
and submitted for sequencing to confirm the desired constructs were obtained. The DNA from
each of the chosen colonies was isolated using a Qiagen Miniprep kit.
Expression and purification of wild-type CaM and cysteine mutants. The calmodulin
constructs were designed with a C-terminal hexahistidine tag for easy purification of the
expressed product. The CaM-His 6 mutants were transformed in BL21-Gold(DE3) competent
cells from which 20% glycerol stocks were prepared for subsequent protein expression. The
stocks were used to inoculate 5 mL LB-broth starter cultures containing carbenicillin (50
jtg/mL). The starter cultures were allowed to grow overnight in a 37 'C shaker at 225 rpm. The
next day, the starter cultures were used to inoculate 1 L LB-broth cultures containing
carbenicillin (50 ptg/mL) and grown at 37 oC with agitation at 225 rpm. The cultures were
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allowed to grow to an OD600nm = 0.5 after which the 1 L shaker flasks were transferred to a 25 oC
shaker (225 rpm) for induction. The cells were induced with 0.1 mM IPTG and shaken for 4 hrs
before harvesting at 5000 x g (4 'C). The pellets were then resuspended in a 0.9% NaCL aqueous
solution (30 mL) and transferred to 50 mL conical tubes to be repelleted for storage at -80 oC.
On the day of the protein preparation, the pellets were thawed at room temperature and
resuspended in the following lysis buffer:
4 mL 10x TBS buffer
400 gL NP-40 Alternative
4 mL glycerol
40 mg lysozyme
6 mg dithiothreitol
40 gL Protease Cocktail III (Calbiochem)
40 mL final vol. after diluting with dH20
Once the pellets were fully resuspended, the cells were sonicated using a Branson
Sonifier 450 at 50% power with a 30% duty cycle for 2 min at 4 oC. The lysates were then
transferred to 45 mL polycarbonate bottles and spun at 100,000 x g in a Type 28 rotor from
Beckman Coulter to pellet DNA and other cellular debris. Meanwhile, a 5 mL bed of Ni-NTA
agarose resin obtained from Qiagen was pre-equilibrated in TBS buffer for each construct. After
the spin, the clarified supernatants were transferred to clean 50 mL conical tubes and mixed with
the pre-equilibrated Ni-NTA agarose resin. The samples were tumbled gently on a rotisserie at 4
oC for 1 hr to allow binding of the His-tagged proteins. The resin was then recovered by passing
the lysates through 20 mL spin columns obtained from Bio-Rad. The resin was washed first
with 4 mL of TBS buffer, then 4 mL of 10 mM imidazole in TBS buffer and then with 4 mL of
20 mM imidazole in TBS buffer at 4 oC. The protein was then eluted in 6 x 1 mL fractions of
250 mM imidazole in TBS buffer at 4 oC. The fractions were assayed for protein and combined
appropriately. The imidazole was removed by dialysis using a 3.5 kDa MWCO Slide-A-Lyzer
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dialysis cassette from Pierce. The protein solutions were dialyzed against 3 x 2 L changes of
TBS buffer. The protein concentrations were then quantified using the Bio-Rad protein assay
solution. Protein yields were -80 mg/L for the purified CaM mutants.
SDS PAGE (15% polyacrylamide) analysis was performed on the proteins to confirm
purity by Coomassie staining (Figure 5-5). Western blotting of the gel also confirmed the
presence of the poly-histidine tag when probed with the mouse anti-his IgG. After transferring to
nitrocellulose for 1 hr at 4 oC under 100 V, the nitrocellulose membrane was blocked with nonfat
dry milk (3 g) in TBS buffer (30 mL) for approximately 4 hrs. The milk solution was then
poured off and the membrane washed with TBST buffer (3 x 30 mL for 5 min each wash). Next,
a 1:10,000 dilution in TBST (15 mL) of the mouse anti-his IgG was added to the nitrocellulose
and incubated for 1 hr. The antibody solution was poured off and the nitrocellulose membrane
was again washed with TBST buffer (3 x 30 mL) for 5 min each wash). A 1:10,000 dilution of
the goat anti-mouse IgG(H+L) alkaline phosphatase conjugate in TBST (15 mL) was added to
the nitrocellulose and incubated for I hr. The antibody solution was poured off and the
nitrocellulose membrane was again washed with TBST buffer (3 x 30 mL) for 5 min each wash).
Last, 10 mL of 1-StepTM NBT/BCIP from Pierce was added and incubated with the nitrocellulose
until the band was visible. The nitrocellulose was then washed with dH20 and dried.
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Figure 5-5. Coomassie and western blot of the cysteine mutants of the CaM-His6 construct.
ESI-MS of expressed CaM constructs. The cysteine mutants of the CaM-His6 protein
were also analyzed by mass spectrometry (Table 5-1) to confirm the identity of the isolated
protein products. All eight of the expressed products matched the calculated molecular weights
determine from the primary structures minus the N-terminal methionine due to methionine
aminopeptidase activity in E. coli.
Table 5-1. Mass spectrometry of expressed CaM-His6 mutants
ESI-MS (m/z)
[M+xH]xe calcd
1948.7 [M+9]
1753.9 [M+10]
1594.6 [M+111
ESI-MS (m/z)
[M+xH]x+ found
1948.1 [M+9]
1755.2 [M+10]
1593.8 [M+11]
CaM-His6
construct
E87C
ESI-MS (m/z)
[M+xH]x+ calcd
1945.8 [M+9]
1751.3 [M+10]
197_ 7 M+1 11
ESI-MS (m/z)
[M+xH]x+ found
1945.3 [M+9]
1750.6 [M+10]
1q934 rM+111
S38C 1950.5 [M+9] 1950.2 [M+9] E114C 1945.8 [M+9] 1944.9 [M+9]
1755.5 [M+10] 1754.7 [M+10] 1751.3 [M+10] 1752.7 [M+10]
itqof;- [M+111 1595.3 [M+111 1592.2 IM+111 1591.2 [M+111
The protein masses were determined by ESI-MS on a Mariner electrospray mass spectrometer (PerSeptive
Biosystems).
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CaM-His6
construct
Wild-type
Fluorescent labeling and isolation of calmodulin cysteine mutants. The following
procedure was performed on each of seven cysteine mutants of calmodulin (E 1 C, S38C, M76C,
E87C, N111C, E114C, and M145C) as well as the wild-type, which served as a control to
determine whether any of the labeling agents exhibited non-specific labeling under the selected
reaction conditions. All eight of the calmodulin constructs were labeled separately with one of
the nine fluorophores examined in this study [4-DMN derivatives 3-3 through 3-6, 7-
diethylamino-3-((((2-maleimidyl)ethyl)amino)carbonyl)coumarin (MDCC), N,N-dimethyl-N-
(iodoacetyl)-N'-(7-nitrobenz-2-oxa- 1,3-diazol-4-yl)ethylenediamine (IANBD), 6-bromoacetyl-2-
dimethylaminonaphthalene (BADAN), 5-((((2-iodoacetyl)amino)ethyl)amino)naphthalene-1-
sulfonic acid (IAEDANS), and 1-(2-maleimidylethyl)-4-(5-(4-methoxyphenyl)oxazol-2-
yl)pyridinium methanesulfonate (PyMPO)] 1 5 to yield the seventy-two possible combinations.
Following the expression and purification of each calmodulin mutant, the protein concentration
was adjusted to 100 tM in TBS (pH 7.4) containing 1 mM of the reducing agent tris(2-
carboxyethyl)phosphine (TCEP) and allowed to incubate at 4 'C overnight. The proteins were
then analyzed by SDS-PAGE gel under non-reducing conditions to confirm that the cysteine
mutants were in the fully reduced state. Aliquots of each protein (0.6 mL) were then transferred
to clear 1.7 mL microcentrifuge tubes to which 6 gL of the respective cysteine labeling agent
was added from a 100 mM stock solution in DMSO. The final concentration of the labeling
agent in each reaction was 1 mM. The reaction mixtures were inverted 4-6 times immediately
following the addition of the labeling agent and allowed to react overnight in the dark at 4 *C.
The following day, the microcentrifuge tubes containing the reaction mixtures were spun at
16,000 g for 5 min at 4 C to pellet any insoluble material before transferring the protein
solutions to a 0.5 mL centrifugal filtering device (Millipore Ultrafree®-MC, Durapore PVDF
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0.22 gim). The samples were spun again at 16,000 g for 5 min at 4 *C. The excess unreacted
labeling agent in each reaction mixture was then removed using a 5 mL HiTrapTM desalting
column obtained from GE Healthcare Life Sciences. The desalting columns were
preequilibrated with TBS buffer (pH 7.4). The eluted fractions containing the labeled proteins
were then quantified using the Bio-Rad protein assay where a stock solution of wild-type
calmodulin of predetermined concentration was used to generate the standard curve. The
labeling efficiency was determined by measuring the absorbance of the fluorophore for each
construct at the corresponding wavelength of maximum absorption (kmax). The calculated
fluorophore concentration was then compared to the quantified protein concentration to compute
the extent of protein labeling (Table 5-2).
Table 5-2. Labeling efficiencies obtained for each of the CaM-His6 constructs
Labeling ratio of CaM Mutants:
AbSmax a Wild-
Fluorophore: nm) a M a  E11C S38C M76C E87C Nll1C E114C M145C
(nm) (cm' M ) type
3-3 440 8800 0.01 0.64 0.16 0.47 0.62 0.62 0.84 0.55
3-5 440 8800 0.04 0.85 0.41 0.61 0.70 0.78 0.84 0.50
3-4 440 8800 0.00 0.81 0.63 0.60 0.62 0.69 0.84 0.53
3-6 440 8800 0.00 0.72 0.67 0.60 0.60 0.65 0.79 0.67
MDCC 419 50000 0.00 0.42 0.35 0.30 0.28 0.25 0.31 0.21
IANBD 478 25000 0.01 0.56 0.18 0.46 0.47 0.43 0.52 0.31
BADAN 387 21000 0.01 0.53 0.31 0.43 0.43 0.42 0.48 0.31
IAEDANS 336 5700 0.00 0.30 0.25 0.27 0.39 0.32 0.52 0.30
PyMPO 412 23000 0.02 0.60 0.52 0.45 0.47 0.43 0.50 0.41
aThe extinction coefficients of the commercial dyes were obtained from the suppliers (AnaSpec, Inc. and Molecular
Probes®). The extinction coefficient for 4-DMN was determined using compound 3-13 as a standard (see Appendix
section A-1).
Fluorescence studies of calmodulin mutants. Upon isolating the fluorescently labeled
calmodulin constructs, stock solutions of each were prepared at 30 gM in TBS buffer (pH 7.4).
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Stock solutions of CaC12 (2 mM), EDTA (5 mM), guanidine hydrochloride (8 M) and the M13
peptide32 (1 mM) were also prepared in TBS buffer (pH 7.4) and filtered through a 0.2 p.m
Nalgene® cellulose acetate syringe filter prior to use. The fluorescence spectra of each construct
was then measured in triplicate under five different conditions: 1) calmodulin construct only (5
[tM); 2) calmodulin construct (5 gM) with CaC12 (200 gM); 3) calmodulin construct (5 jiM) with
CaCl2 (200pM) plus M13 peptide (10 jtM); 4) calmodulin construct (5 gM) with M13 peptide
(10 pM); 5) calmodulin construct (5 M) with guanidine hydrochloride (6.67 M). Additionally,
each of these experimental conditions included 40 pM EDTA to ensure that no extraneous
calcium, which may have been carried through the protein preparation, interfered with any of the
fluorescence measurements. The samples were loaded in a 96 well black Polysorp Fluoronunc
plate from NUNCTM and the fluorescence spectra were measured for each condition using a
SPECTRAmax GEMINI XS plate reader from Molecular Devices. The total sample volume for
each well was 200 L. The excitation and emission settings selected for each construct are listed
in Table 5-3.
Table 5-3. Emission and excitation settings for
SPECTRAmax GEMINI XS plate reader
Fluorophore exc (nm) em (nm)
1-4 405 440-660
MDCC 400 430-650
IANBD 455 490-710
BADAN 365 400-620
IAEDANS 336 440-660
PyMPO 412 440-660
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Denaturing of fluorescent CaM constructs to determine background emission. There
exist two primary sources of background fluorescence directly associated with a solvatochromic
fluorophore when used to develop a fluorescent protein probe. The first involves the intrinsic
fluorescence exhibited by the fluorophore when fully solvated by water. The second is a
ramification of appending the fluorophore to the surface of a globular protein. This frequently
results in a change in the photophysical properties of the fluorophore that would be expected if it
were participating in some type of non-specific interaction with the local topology of the
attached protein. By denaturing the protein in a concentrated solution of guanidine
hydrochloride, the secondary and tertiary structures that may contribute to this effect are
disrupted permitting one to determine the degree of background emission generated (Figure 5-6).
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Figure 5-6. (a) Graphic depicting the tendency of solvatochromic fluorophore to exhibit background fluorescence
when appended to a globular protein until denatured, thus fully exposing the fluorophore to the aqueous
environment. (b) Example of a typical fluorescent response of a labeled CaM mutant under both natured and
denatured conditions (TBS buffer versus guanidine hydrochloride solution at pH 7.4)
A series of experiments was conducted on each of the sixty-three fluorescent CaM
constructs prepared in this study in which the degree of background fluorescence associated with
the appending of the fluorophore to the protein was determine by measuring the emission spectra
of the constructs in TBS buffer (pH 7.4) and guanidine hydrochloride (6.67 M, pH 7.4) and
calculating the ratio of intensity at the wavelength of maximum emission in the natured state.
The results of this work are displayed in Figure 5-7.
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Figure 5-7. The fluorescent constructs were measured at a concentration of 5 jpM in TBS buffer (pH 7.4) and
guanidine hydrochloride (6.67 M, pH 7.4). The vertical bars represent the magnitude of the ratio of fluorescence in
TBS buffer over that of the construct in the guanidine solution. A greater ratio indicates high initial background
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fluorescence due to non-specific interactions of fluorophore with local features of the attached protein. Indicated
errors represent the 90% confidence interval for three trials.
Fluorescence data for CaM mutants M76C, E87C, N111C, and E114C. The results of
Figure 5-8 reflect the ratio of emission intensity of the CaM mutants under the three indicated
conditions with respect to the apo-state. Measurements were made at the wavelength of
maximum emission for the calcium bound state.
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Figure 5-8. The fluorescent CaM constructs were maintained at a concentration of 5 pM for these measurements.
The Ca2+ and M13 peptide were introduced at saturating levels of 200 gM and 10 jtM respectively. Indicated errors
represent the 90% confidence interval calculated from three trials.
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Chapter 6: Development of a fluorogenic sensor of Cdc42 activity
The work described in this chapter was performed in close collaboration with fellow colleague
Brenda Goguen from the Imperiali laboratory.
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Introduction
The emergence of complex cellular behavior through fundamental biomolecular
interactions has come to represent a basic tenet of cell biology. The normal growth and
development of a living cell requires it to continually receive information from the immediate
environment and respond appropriately. This process often occurs through an elaborate network
of molecular events involving specific proteins capable of assuming multiple signaling states.
The state of a protein involved in a particular signal transduction pathway may be defined by
various forms of posttranslational modification such as phosphorylation. However, structural
changes can also play an important role. Due to the essential functions of these proteins,
pathologies often result in instances where normal activity is impaired or defective. Hence,
methods to interrogate the activities of such regulatory elements are highly sought after.
The protein Cdc42 is a small guanosine triphosphatase (GTPase) that is a member of the
Rho-family of GTPases.' This family of proteins plays an important role in regulating the
dynamics that underlie many cellular processes including cytokinesis, vesicle trafficking, cell
migration, and morphogenesis.2'3 Many of these activities involve the integration of various
extracellular signals relayed though specialized membrane receptors and transmitted through
intracellular signal transduction pathways. These pathways then converge to activate Rho-
GTPases like Cdc42, which are then responsible for coordinating the reorganization of the actin
cytoskeleton.'
Like other GTPases, Cdc42 can exist in two different states: a GTP-bound complex and a
GDP-bound complex. The operative state is the Cdc42-GTP complex, which is capable of
binding certain effector proteins. The Cdc42-GDP complex is typically inactive. The exchange
of a GDP molecule for GTP induces an allosteric change in Cdc42 that can lead to a 1000-fold
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increase in affinity for the GTPase-binding domains (GBDs) of some effector proteins.4 It has
been shown that the GBDs of many effector proteins exert an autoinhibitory effect that may be
abated upon binding to Cdc42-GTP.5 Since a number of these effectors are protein kinases, the
binding of Cdc42 activates the catalytic activity of these enzymes.
There are several proteins that are known to regulate the activation and localization of
Cdc42. These include guanine nucleotide exchange factors (GEFs), GTPase activating proteins
(GAPs), and GDP dissociation inhibitors (GDIs). 3 Additionally, Cdc42 is subject to various
forms of post-translational modification such as prenylation and phosphorylation.6 The
activation of Cdc42 is tightly regulated, both spatially and temporally, through the opposing
functions of GEFs and GAPs (Figure 6-1). Rho-GTPases are intrinsically slow at promoting
GTP hydrolysis to GDP. Likewise, the exchange rate of a GDP molecule for a GTP molecule is
also slow.3 These two processes are facilitated by GEF and GAP activity. The GEF "switches"
Cdc42 to the active state by catalyzing the displacement of a bound GDP with GTP, thus
inducing the necessary structural change required for the protein to bind its effectors. GAPs
compete kinetically with GEFs to promote hydrolysis of the Cdc42-bound GTP molecule in
order to reverse this effect.3 Therefore, the existence of Cdc42 in the operative state can be
extremely transient, requiring an effector protein to be in close proximity in order to intercept the
Cdc42-GTP complex and become activated.
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Figure 6-1. Regulation of Cdc42 activity by guanine nucleotide exchange factors (GEFs) and GTPase activating
proteins (GAPs).
An additional level of Cdc42 regulation is imposed by GDIs.3 These proteins can bind
the Cdc42-GDP complex and block GEF activity. GDIs are also capable of solubilizing
prenylated Cdc42 and sequestering it from the plasma membrane. The interaction of GDIs with
Rho-GTPases is further regulated through the actions of GDI displacement factors (GDFs) 3 and
by direct phosphorylation of the GTPases. 6
Studies of the subcellular localization of Cdc42 have shown that much of the protein is
concentrated at the Golgi apparatus.7 The presence of the protein has also been detected at the
plasma membrane as well as various vesicular structures within the cytosol.8 However, the
abundance of Cdc42 within a localized region of a cell does not necessarily imply that this is
where the protein is most active. In order to determine the regions within the cell that GEF-
mediated activation of Cdc42 occurs during fibroblast adhesion and spreading, researchers of the
Hahn laboratory developed a new fluorescent biosensor.9 In 2004, a report by Nalbant et al.9
described the design of small peptide motif derived from the Cdc42-binding domain of the
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protein WASP that was labeled with a fluorescent merocyanine derivative called I-SO1o (Figure
6-2). The probe, named MeroCBD, was demonstrated to respond selectively to the presence of
Cdc42-GTP over that of the Cdc42-GDP complex by exhibiting an overall 2.8-fold increase in
fluorescence intensity.
The GTPase-binding domain of many Cdc42 effectors is a highly conserved sequence of
residues known as the CRIB (Cdc42- and Rac-Interactive Binding) motif." In designing
MeroCBD, researchers in the Hahn laboratory utilized an available NMR structure of the
complex between Cdc42 and the CRIB motif of the protein WASP (PDB entry ICEE)12 to
identify potential residues of the peptide sequence that could be replaced by a cysteine for
covalent modification with I-SO. They selected three residues (1223, D264, and F271 of WASP)
for mutagenesis. The constructs were expressed in E. coli and purified using a C-terminal
hexahistidine tag before labeling with the solvatochromic dye. The emission spectrum of each
construct was then examined in the presence of Cdc42-GDP and Cdc42-GTPyS' 3 in order to
determine whether the two states could be distinguished by a measurable difference in
fluorescence intensity. Based on their evaluation, the I-SO labeled construct of the F271C
mutant yielded the best result.
Further characterization of the probe showed that it was a highly selective sensor capable
of discriminating between the activation of Cdc42 and that of closely related GTPases such as
RhoA and Rac. The probe was then deployed to detect the kinetics of Cdc42 activation in
fMetLeuPhe (fMLP) peptide-stimulated human neutrophil lysates. A variant of the probe design,
which included an enhanced green fluorescent protein (EGFP), was also used as a ratiometric
sensor of endogenous Cdc42 activity in MEF/3T3 fibroblasts. 9
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WASP-CRIB motif:
KKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGIS
Figure 6-2. Cdc42-GTPPCP (grey) complex with WASP CRIB motif (cyan).12 The sequence for the WASP CRIB
motif is indicated below the structure with the single-letter notation for amino acids. The phenylalanine residue
F271 (gold) that was selected by Nalbant et al. as the site for cysteine mutagenesis and labeling with I-SO
iodoacetamide is indicated by the two arrows.
This chapter describes recent work, performed in collaboration with fellow colleague
Brenda Goguen, to develop a second-generation Cdc42 biosensor based on the original design
described by Nalbant et al. Athough MeroCBD was shown to be an effective probe, it was
limited by small changes in fluorescence intensity and by the fact that its affinity for Cdc42 was
determined to be roughly 2-fold weaker than that of the wild-type WASP CRIB motif. In
response, we conjectured that the fluorescent derivatives of 4-DMN described in the previous
chapters might prove valuable for overcoming both of these issues. The superb "switch-like"
fluorescence properties and discrete size of the 4-DMNA amino acid make it an excellent
candidate for incorporation at position 271 of the WASP CRIB peptide. Two approaches to the
design of this sensor are currently under investigation. The first involves the chemical
modification of a WASP CRIB F271C mutant peptide using the 4-DMN thiol-reactive agents (3-
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3 through 3-6), while the second entails the introduction of the 4-DMNA amino acid via
semisynthesis and expressed protein ligation (EPL). At present, much of the work in this project
area has focused on the former of these two approaches with the preliminary results shown here.
Results and Discussion
6-1. Design considerations for a second-generation Cdc42 biosensor
The CRIB motif of Wiskott-Aldrich syndrome protein (WASP) binds with high affinity
(Kd = 77 ± 9 nM) 9 to Cdc42-GTP. This interaction activates WASP allowing it to then activate
the Arp2/3 complex, which is responsible for initiating the polymerization of actin filaments."
Based on the success of the fluorescent MeroCBD probe, we decided to focus on the same site
(F271) of the WASP CRIB domain for the incorporation of the 4-DMN fluorophore. The NMR
structure of this complex (Figure 6-2) shows that a prominent hydrophobic contact is formed
between the side chain of F271 and residues V36, F37, L67, and L70 of Cdc42. A similar
contact involving a tryptophan residue is revealed in the crystal structure of Cdc42-GTPPCP
bound to the CRIB domain of human P21-activated kinase 6 (Pak6) (Figure 6-3a). This
information, in combination with the fact that the MeroCBD probe exhibits weaker affinity for
Cdc42 compared to wild-type WASP, 9 led us to reason that this interaction is potentially
important and may be preserved by substituting the smaller 4-DMNA amino acid at position 271
(Figure 6-3b) instead of the larger I-SO dye.
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Figure 6-3. (a) Crystal structure of Cdc42-GTPPCP (grey) with the CRIB domain of Pak6 (cyan) (PDB entry
20DB). The Trp40 residue of Pak6 is indicated in gold. (b) The NMR structure of Cdc42-GTPPCP (grey) in
complex with the WASP CRIB domain (cyan) (PDB entry ICEE). The phenylalanine residue at position 271 of the
WASP CRIB domain is replaced with 4-DMNA to illustrate how the mutant construct might interact with activated
Cdc42.
In addition to developing a fluorogenic probe that utilizes the advantageous properties of
the 4-DMNA amino acid, we also elected to use the 4-DMN thiol-modifying agents described in
Chapters 3 and 5 to label an F271C mutant of the WASP CRIB motif. Here, the MeroCBD
probe provides an additional benchmark for evaluating the efficacy of these new fluorescent
tools. The two probe designs are illustrated in Figure 6-4.
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Figure 6-4. Fluorescent biosensors of Cdc42 activation derived from a GB1 fusion of the WASP CRIB domain
(cyan). The GB1 domain (purple) is a 55 amino acid sequence that enhances expression, solubility, and stability of
small protein motifs. 14 (a) A 4-DMN modified F271C mutant of the GB 1-WASP CRIB domain. (b) The 4-DMNA
amino acid (gold) is incorporated into a synthetic peptide bearing an N-terminal cysteine residue. The N-terminal
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fragment of the sensor is prepared as a thioester by expressing it as a fusion with a modified intein that bears a
chitin-binding domain on the C-terminus. The N-terminal fragment is then liberated from the intein through thiol-
inducible cleavage using MESNA. The expressed N-terminal thioester is then ligated to the synthetic C-terminal
peptide via a reversible transthioesterification step, followed by an irreversible intramolecular S -N acyl transfer
resulting in the formation of an amide bond.
The probe design displayed in Figure 6-4a can be prepared in a straightforward manner
through direct chemical modification of a cysteine side chain with one of the thiol-reactive 4-
DMN derivatives (3-3 through 3-6). Both constructs in Figure 6-4 were designed to include a
GB1 domain located at the N-terminus of the sensor. The GB1 domain is a 55 amino acid
sequence that has been shown to enhance expression and solubility of small protein motifs. 14
Based on prior experience in the Imperiali laboratory, this domain has been found to be
extremely useful for applications of this type.
The alternative probe design is illustrated in Figure 6-4b. Here the 4-DMNA amino acid
is incorporated directly into the peptide backbone of the WASP CRIB domain at position 271.
This would be achieved using a method known as expressed protein ligation (EPL).15-17 With
this approach, the N-terminal fragment of the construct is expressed as a fusion with a modified
intein that contains a chitin-binding domain at the C-terminus. Following expression of the
protein in E. coli, the product is isolated by binding to chitin resin. The target protein fragment
is then liberated from the intein as a reactive thioester through a thiol-induced cleavage reaction
using sodium 2-mercaptoethane sulfonate (MESNA). The C-terminal fragment of the construct
is prepared synthetically via solid phase peptide synthesis. Once the two fragments are obtained,
the next step is the ligation reaction, which begins with a reversible transthioesterification step
followed by an irreversible intramolecular S-N acyl transfer resulting in the formation of an
amide bond. Here, we designed the final product such that it contains a hexahistidine tag to help
facilitate purification.
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6-2. Development and validation ofa fluorogenic Cdc42 sensor based on the fluorescence
properties of the 4-DMN dye
(The experiments and associated results described herein represent the work of fellow colleague
Brenda Goguen).
In developing a new Cdc42 sensor based on the design shown in Figure 6-4a, each the of
4-DMN thiol-labeling agents (3-3 through 3-6) was screened to determine which could produce
the greatest fluorescence change. For this experiment, four fluorescent constructs of the GB1-
WASP CRIB (F271 C) mutant were prepared. The fluorescent constructs were then examined at
the same concentration (1 tM) under the three conditions shown in Figure 6-5. The results
illustrate that although some of the constructs produce a much brighter signal in the presence of
Cdc42-GTPyS, the ratio of fluorescence intensity between the GTPyS-bound state versus the
GDP-bound state is uncorrelated. Since the construct labeled with compound 3-3 exhibited the
largest overall enhancement in fluorescence (8.5-fold), it was used in the remaining experiments.
Screen of fluorescent WASP CRIB constructs
35x10
No Cdc42 present 5.6
S30x104 Cdc42-GDP! - Cdc42-GTPS
& 25x10
S20xo6 4.2
o 5IuO'C 8.5 3.1
S10x10
4-DMN thiol-modifying agents
Figure 6-5. Screen for second-generation Cdc42 biosensor. The histograms represent the fluorescence intensity
measured for each construct GB 1-WASP CRIB (F271C) mutant labeled with one of the four 4-DMN thiol-labeling
agents (3-3 through 3-6). The emission intensities were measured at the wavelength of maximum emission in the
presence of the Cdc42-GTPyS complex. The concentration of the fluorescent constructs in these experiments was 1
pM and Cdc42 was 5 pM when present.
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Although the fluorescent response of the WASP construct labeled with 3-3 was an
improvement over the 2.8-fold fluorescence increase reported for the MeroCBD probe, it was
still minor compared to the potential of the 4-DMN fluorophore. It was determined that this was
due primarily to the fact that the experiment was conducted at concentrations of the WASP
construct and Cdc42 that far exceed the native Kd value for the WASP-Cdc42-GTP complex (77
± 9 nM). 9 Since WASP is capable of binding the Cdc42-GDP complex with a Kd value of
roughly 35 gM, 12 then it was estimated that as much as 11% of the fluorescent sensor could have
been bound resulting in an artificially high emission intensity. To test this hypothesis, the
concentrations of the biosensor and Cdc42 were reduced to determine whether the ratio of
fluorescence intensity could be increased (Figure 6-6). Here, the biosensor was maintained at
100 nM, while Cdc42, in the GDP- and GTPyS-bound forms, was introduced at 2 gM. At these
concentrations, the percentage of fluorescent biosensor predicted to be bound to Cdc42-GTPyS
versus Cdc42-GDP should be approximately 96% and 5%, respectively. This is confirmed by
the data shown in Figure 6-6, where the measured ratio of fluorescence intensity now exceeds
20-fold. Future experiments will reveal whether the ratio can further be improved by using more
physiologically relevant concentrations that are closer to the Kd of the WASP-Cdc42-GTP
complex.
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Figure 6-6. Fluorescence spectra of the WASP CRIB (F271C) mutant labeled with compound 3-3. The biosensor in
this experiment is maintained at 100 nM and the Cdc42 protein, in both the GDP- and GTPyS-bound forms, is
introduced at 2 pM.
In order to validate the selectivity of the fluorescent biosensor derived from the WASP
CRIB domain, a series of control experiments were performed. A double mutant of the CRIB
domain (H246D, H249D) that abrogates binding to Cdc42 was prepared. Additionally, a Cdc42
mutation (Q61L) that renders the protein constitutively active was also prepared. For ease of
discussion, these two constructs are referred to as the CRIB mutant and Cdc42(Q61C),
respectively. The CRIB wild-type and CRIB mutant domains were examined in combination
with the Cdc42 wild-type and Cdc42(Q61C) mutant. The Cdc42 constructs were preincubated
with saturating concentrations of either GDP or GTPyS. In all, a total of eight experiments were
conduct and the results shown in Figure 6-7.
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Figure 6-7. Control experiments of the WASP CRIB biosensor labeled with compound 3-3. The CRIB WT and
mutant constructs are maintained at 500 nM while the Cdc42 wild-type and Q61L mutant are introduced at 5 gM.
The fluorescence measurements were made at 518 nm.
The results of this series of experiments agree strongly with the predicted outcomes. The
CRIB mutant shows relatively little change in response to the nucleotide-bound state of Cdc42.
Only the wild-type CRIB is capable of responding. Furthermore, the wild-type CRIB shows
little ability to discriminate between Cdc42(Q61L) that was preincubated with GDP versus that
which was preincubated with GTPyS.
Conclusions
Preliminary work with the Cdc42 sensor described in section 6-2 has revealed the great
potential of this design and the power of the 4-DMN derivates to produce large changes in
fluorescence intensity - particularly when used in the study of biomolecular interactions.
Future investigations will examine the affinity of this biosensor for Cdc42-GTP to determine
whether the presence of the fluorophore disrupts binding in any way. Furthermore, efforts will
continue to focus on the incorporation of the 4-DMNA amino acid at position 271 of the WASP
CRIB domain in order to see if further improvements in the fluorescent response can be attained.
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If successful, this work could lay the foundation for the development of a new array of
fluorescent sensors of other known GTPases.
The key focus of this thesis has been to develop new fluorescent tools capable of
operating in complex cellular environments and the method for incorporating them into proteins.
The criteria for meeting such challenges are numerous and demanding. In Chapters 2 and 4, it
was shown that the 4-DMN fluorophore exhibits significantly enhanced chemical stability while
retaining many of the excellent photophysical properties that are characteristic of the
dimethylaminophthalimide family. This opens the door to exploring new applications that were
previously inaccessible using the 4-DMAP and 6-DMN fluorophores. Chapters 4 and 5
demonstrated two distinctly different approaches in which the power the 4-DMN dye may be
utilized to obtain valuable information regarding the dynamics of biomolecular interactions. The
4-DMNA amino acid offers the advantage of smallness with a size comparable to that of the
natural amino acid tryptophan. Alternatively, the 4-DMN thiol-modifying agents provide a
convenient method for the incorporation of the fluorophore into proteins and other important
biomolecules. Work toward the validation of these tools in the previous chapters has facilitated
our understanding of contexts in which they may best be applied and influenced the design of
improved sensors, such as that described in this chapter, which we anticipate will be of great
value in future cellular studies.
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Experimental
Tris-buffered saline. All fluorescence experiments were conducted in the following
buffer system:
1x TBS (pH 7.9)
1 mM dithiothreitol (DTT)
50 mM Tris-HC1
50 mM NaCl
5 mM MgC12
Nucleotide exchange protocol. In order to prepare the purified Cdc42 protein in the
GDP-bound or GTPyS-bound state, the protein was initially incubated at a concentration of 100
iiM in the presence of EDTA (25 mM) and the corresponding GDP or GTPyS nucleotide (1 mM)
for 30 minutes at 30 C. After this period, MgCl2 was added to a final concentration of 35 mM
and incubated an addition 15 minutes at room temperature.
Fluorescence experiments:
Screening of the 4-DMN thiol-reactive agents. After isolating the GB -WASP CRIB
F217C mutant and labeling it with each of the four 4-DMN thiol-modifying agents (3-3 through
3-6), the fluorescent constructs were screened to determine which produced the largest
fluorescent change in response to the presence of Cdc42-GTPyS compared to Cdc42-GDP. The
constructs were adjusted to a final concentration of 1 gM and Cdc42 was 5 pM. The excitation
wavelength selected for these experiments was 408 nm with the slit width of the light source set
at 5 nm. The emission spectrum of each construct was collected from 450-650 nm under both
conditions.
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Comparison of GB1-WASP CRIB F21 7C(3-3) fluorescence at 100 nM in presence of
Cdc42-GDP vs. Cdc42-GTPyS. In order to reduce the amount of background fluorescence
produced by nucleotide-independent binding of the GB-WASP CRIB biosensor to Cdc42, the
concentration of both components were reduced. The fluorescent GB1-WASP CRIB domain
was maintained at 100 nM for the two examined conditions. Cdc42-GDP and Cdc-GTPyS were
then introduced at 2 gM. The excitation wavelength selected for these measurements was 435
nm. The emission spectra were collected from 450-650 nm. The ratio of fluorescence intensity
for the two conditions was calculated at the wavelength of maximum emission for the complex
of GB 1-WASP CRIB with Cdc42-GTPyS.
Control studies with of GB1-WASP CRIB and Cdc42 mutants. For this set of
experiments, two sets of fluorescently labeled GB1-WASP CRIB constructs were used. Both
possessed the F271C mutation for modification with the 4-DMN derivative 3-3; however, one
also contained a second pair of mutations (H246D and H249D) to prevent it from interacting
with Cdc42. These two constructs are referred to as the CRIB wild-type and the CRIB mutant
for simplicity. Two Cdc42 constructs were also used in these experiments. One was the wild-
type and the other contains a Q61L mutation that renders the construct constitutively active. All
four combinations of the two GB1-WASP CRIB constructs and two Cdc42 constructs were
examined in the presence of saturating GDP as well as GTPyS. The final concentrations of GB 1-
WASP CRIB constructs and Cdc42 mutants used in the experiments were 500 nM and 5 tM,
respectively. The samples were excited at 435 nm and the emission spectra collected from 450-
650 nm. The slit width of the light source was set to 10 nm.
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Cloning of WASP CRIB and Cdc42 constructs:
GBI-WASP CRIB gene sequence. The following gene sequence was synthesized by Bio
Basic Inc. and delivered in a pUC-57 vector. The construct was codon-optimized for expression
in E. coli. The coding region begins at the first ATG (bold) that appears in the sequence.
TATACCATGGGTCAGTATAAACTGGCACTGAACGGTAAAACTCTGAAAGGTGAAACCACCACCGA
GGCTGTAGACGCGGCTACCGCCGAAAAAGTGTTTAAACAATACGCCAACGATAACGGCGTGGATG
GTGAATGGACTTACGACGATGCGACGAAAACCTTCACTGTCACCGAAAAGAAAAAGATCTCCAAA
GCTGACATCGGTGCGCCAAGCGGCTTCAAA TTTTCACGTTTCTCAGAACGG
CTTCGACGTTAATAACCTGGATCCGGATCTGCGCTCTCTGTGCTCTCGTGCAGGCATTTCCCACC
ACCACCATCATCACTAACTCGAG
GB- WASP CRIB amino acid sequence. The following is the translated gene product.
The highlighted region indicates the residues of the GB 1 domain and the cysteine at position 271
is shown in bold face.
MGD A?,T KKKISKAD
IGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLCSRAGISHHHHHH
Subcloning of GBJ-WASP CRIB gene into pET-14b vector. A double digestion of the
amplified pUC-57(GBl-WASP CRIB) vector was performed simultaneously with the double
digestion of the pET-14b vector. The reaction conditions were as follows:
pET-14b vector: pUC-57 vector:
42.5 gL pET-14b (20 ng/pL) 15.0 gL pUC-57 (0.11 tg/gL)
0.0 gL dH20 (sterile) 27.5 pL dH20 (sterile)
5.0 piL 10x buffer D 5.0 jL 10x buffer D
0.5 gL 100x BSA 0.5 gL 100x BSA
1.0 pL XhoI 1.0 L XhoI
1.0 [IL NcoI 1.0 iL NcoI
50.0 gL total volume 50.0 jLL total volume
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The reactions were allowed to proceed for 1 hr at 37 oC before stopping with the addition
of 12.5 pL of 5x DNA loading buffer. The both reaction mixtures were then loaded onto a 1%
agarose gel and resolved at 110 V. The desired restriction products (the GB -WASP CRIB
insert of the pUC-57 vector and the linearized pET-14b expression vector) were cut from the gel
and isolated using a QIAquickTM Gel Extraction kit. The subcloning vector and insert were then
quantified on 1% agarose gel by comparing band intensities to those of the NEB 2-Log DNA
ladder.
Two ligation reactions were assembled: one containing both the GB 1-WASP CRIB insert
and the pET-14b vector, and the other with only the pET-14b vector as a negative control. The
reaction conditions were as follows:
vector (control) vector + insert
1.0 tL pET-14b (50 ng/pL) 1.0 gL pET-14b (50 ng/pL)
1.0 tL dH20 (sterile) 1.0 pL GB 1-WASP CRIB insert
1.0 gL T4 DNA ligase 1.0 gpL T4 DNA ligase
3.0 pL 2x Ligafast buffer 3.0 pL 2x Ligafast buffer
6.0 gL total volume 6.0 gL total volume
Note- Used a 4:1 molar ratio of insert to vector.
The reactions were allowed to proceed for 15 minutes at room temperature. The
reactions were then used to transform two 30 gIL batches of DH5a cells plated on LB/agar with
50 pg/mL carbenicillin. The next day, no colonies were observed for the negative control.
Three colonies from the non-control plate were selected and amplified for sequencing. One of
the selected colonies was determined to be the desired construct. The new vector, pET-
183
14b(GBI-WASP CRIB), was transformed into BL21-Gold(DE3) competent cells from
Stratagene for protein expression.
Subcloning of GB1-WASP CRIB N-terminal fragment into pTWIN1 and pTWIN2
vectors. In order to clone the N-terminal fragment of the GB1-WASP CRIB domain into the
pTWIN vectors obtained from New England Biolabs® Inc., the following primer set was
ordered.
Primers for pTWIN 1&2:
Forward:
(NdeI)
GGTGGTCATATGGGTCAGTATAAACTGGC
Reverse:
(SapI)
GGTGGTTGCTCTTCCGCAGCGCAGATCCGGATCCAGGTTATTA
The desired insert was amplified by PCR using the following reaction conditions:
6.0 tL dNTP mix (10 mM each)
1.2 pL Forward primer (100 tg/ pL)
1.2 pL Reverse primer (100 gg/ tL)
1.0 tL DNA template (200 ng/gL)
30 gL 10x Pfu reaction buffer
254.6 tL sterile dH20
6.0 gL Pfu Turbo (Stratagene)
300.0 L Total reaction volume
Once the reaction components were assembled in the PCR tubes and mixed, the tubes
were centrifuged briefly and loaded into an MJ-mini PCR machine from Bio-Rad. The
following PCR method was employed.
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PCR method:
28 cycles
95 'C 95 -C
2 min 30 sec'
72 C 72 ,C
,' 30 sec 10 min',
, 45'C '
30 sec ' 4 'C
infinite
After the PCR was complete, the amplified insert was isolated using the Wizard® SV Gel
and PCR Clean-Up System from Promega and quantified by UV absorbance at 260 nm. The
insert was then digested using the following reaction conditions:
GB 1-WASP CRIB insert:
4.0 pL insert (500 ng/L)
36.0 jIL dH20 (sterile)
5.0 jiL 10x buffer 4
0.5 jiL 100x BSA
2.5 pL NdeI
2.5 pL SapI
50.0 gL total volume
The restriction reaction run for 3 hours at 37 'C before it was stopped by adding 12.5 jL
of 5 x DNA loading buffer and transferring to a 1% agarose gel and run at 110 V. The gel was
then soaked in ethidium bromide and visualized on the transilluminator. The band corresponding
to the insert was excised and purified using the Wizard® SV Gel and PCR Clean-Up System
from Promega. The DNA was then quantified by UV absorbance at 260 nm.
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Two separate reactions were then assembled to ligate the insert into the two pTWIN
vectors. The following reaction conditions were applied:
pTWIN1 pTWIN2
1.36 [L vector (36.7 ng/jL) 0.95 gL vector (52.7 ng/gL)
0.18 pLL dH20 (sterile) 0.59 [pL dH20 (sterile)
0.46 gL insert (30 ng/gL) 0.46 gL insert (30 ng/gL)
1.00 gL T4 DNA ligase 1.00 gL T4 DNA ligase
3.00 gL 2x Ligafast buffer 3.00 pL 2x Ligafast buffer
6.00 gL total volume 6.00 gL total volume
The reactions were allowed to proceed for 15 minutes at room temperature. The
reactions were then used to transform two 30 pL batches of DH5a cells plated on LB/agar with
50 jig/mL carbenicillin. The next day, no colonies were observed for the negative control.
Three colonies from each of the non-control plates were selected and amplified for sequencing.
The constructs were transformed into BL21-Gold(DE3) competent cells from Stratagene for
protein expression.
Solid phase peptide synthesis of C-terminal fragment of GB1-WASP CRIB domain:
Residue #:
N-term 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 C-term
H2N- C L 4-DMNA S R A G I S H H H H -CONH 2
The C-terminal peptide component of the fluorescent biosensor design illustrated in
Figure 6-4a was prepared using standard Fmoc-based solid-phase peptide synthesis techniques
(SPPS). 18 The peptide was prepared using 0.17 mmol/g loading Fmoc-NovaPEG Rink Amide
resin LL (Cat. No. 01-64-0483, Novabiochem®). Fmoc-protected amino acids with the standard
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side-chain protecting groups were used: Fmoc-4DMNA-OH, Fmoc-Ala-OH, Fmoc-Ile-OH,
Fmoc-Leu-OH, Fmoc-Gly-OH, Fmoc-His(Trt)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Ser(tBu)-OH,
and Fmoc-Cys(Trt)-OH. The synthesis was performed on the 40 imol scale using 4 equiv of the
Fmoc amino acids in each cycle. All of the building blocks were dissolved to a final
concentration of 50 mM in DMF containing a 1:1 mixture of HOBt/HBTU (50 mM each) with
N,N-diisopropylethylamine (100 mM, 12 equiv). Each coupling reaction was allowed to proceed
at room temperature for 30-45 min. The coupling efficiency was monitored using the TNBS
test. 19 Removal of the Fmoc group prior to each coupling step was performed using a 20% 4-
methylpiperidine solution20 in DMF (3 x 5 min). The N-terminal cysteine residue was left as a
free amine for ligation to the N-terminal GB 1-WASP CRIB fragment. The peptide was cleaved
from the resin using a solution of 96:2:2 TFA/H 20/EDT for 3 hrs. The cleavage cocktail was
then filtered and evaporated. The crude peptide was triturated with cold diethyl ether (3 x 10
mL) and purified by HPLC using a Waters 600E HPLC with a Waters 600 automated control
module and Waters 2487 dual wavelength absorbance detector set at 228 and 280 nm. The
separation was performed using a preparative YMC-pack, C18, 20 x 250 mm reverse-phase
column. A YMC-pack, C1 8, 4.6 x 150 mm reverse-phase column was used for analytical HPLC.
The following analytical HPLC method was used to characterize the peptide:
Time Flow Rate H20% MeOH %
(min) (ml/min) (with 0.1% TFA) (with 0.1% TFA) Gradient
initial 1.00 95 5 linear
5.0 1.00 95 5 linear
40.01 1.00 0 100 linear
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Table 6-1: Characterization of the purified
C-terminal GB 1-WASP CRIB peptide
HPLC Ret. [M+xH] x+ [M+xH] x+
Time (min) Calc. found
26.9 1937.9(1+) -
969.5 (2+) 970.1 (2+)
646.7(3+) 647.4(3+)
Peptide mass determined by ESI-MS on a
Mariner electrospray mass spectrometer
(PerSeptive Biosystems).
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Appendix: Useful information
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A-1. Determination of the extinction coefficient of 4-DMN (Beer-Lambert plot)
In order to accurately measure the extinction coefficient (.) of 4-DMN, it was necessary
to identify a species that is fully soluble at the required concentrations in TBS buffer (pH 7.4).
Compound 3-13 was determined to remain soluble in TBS buffer for days at concentrations as
high as 90 M. Three separate stock solutions of 3-13 were prepared in a 1 L volumetric flask to
a final concentration of roughly 90 jM. This concentration corresponds to approximately 25
mg/L. The standard, which had been stored as a solid under high vacuum overnight to desiccate,
was weighed on a micro balance into a 7 mL glass vial. The material was then dissolved in 1 mL
of spectroscopic grade DMSO and immediately transferred to a 1 L volumetric flask to be
diluted in freshly filtered TBS buffer (pH 7.4). The final concentrations of the three stock
solutions were 89.7 gM, 88.6 gM, and 89.3 gM. Serial dilutions from these stock solutions were
then prepared by making four successive two-fold dilutions. The absorption spectrum of each
solution was collected from 220 nm to 600 nm. This enabled the determination of & for multiple
wavelengths. The data corresponding to the absorbance of the chromophore at each wavelength
were plotted as a function of the known concentrations of the measured solutions and fitted by
linear regression. The slopes of the lines represent the value of E (M-' cm') for each wavelength.
The results are summarized in Table A-1 with the associated error for each value indicated by a
90% confidence interval (C. I.) for the three trials. By knowing the F value at each wavelength,
it is possible to resolve the contribution of 4-DMN to the absorption spectrum of a molecule that
contains multiple chromophores with overlapping absorption bands.
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Table A-1. Molar extinction coefficients for compound 3-13 in TBS (pH 7.4)
90% C. I.a
(M-1 cm-1)
280 9520 800
285 9126 600
290 8496 419
295 7414 231
300 5969 126
305 4674 93
310 3772 22
315 3032 45
320 2538 22
325 2237 41
330 2310 41
335 2007 39
340 2170 20
345 2552 30
350 2300 23
355 2534 21
360 3032 23
365 3581 32
370 4171 18
375 4784 16
380 5365 13
385 5917 16
390 6415 6
395 6867 2
400 7240 11
405 7578 6
410 7871 9
415 8120 9
420 8335 24
425 8517 24
430 8662 25
435 8765 28
............................................... ............................................... 
................................................
440 8808
wavelength
(nm)
Cave
(M "1 cm-1 )
90% C. I.a
(M"1 cm-1)
wavelength
(nm)
600 14
(a) The confidence intervals (C. I.) were calculated using the standard deviation determined from three trials and the
appropriate value obtained from the student's t-distribution.
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Save
(M- 1 cm - )
445 8773 22
450 8645 22
455 8410 23
460 8068 22
465 7609 23
470 7056 17
475 6431 16
480 5733 7
485 4925 2
490 4093 9
495 3335 8
500 2602 14
505 1950 19
510 1381 28
515 936 27
520 597 27
525 366 31
530 217 30
535 130 35
540 76 33
545 43 35
550 26 37
555 14 33
560 11 32
565 10 33
570 8 44
575 6 39
580 11 35
585 9 40
590 11 35
595 10 38
................................................ |.............................................. ................................................
Molar extinction coeff. of compound 3-13 in TBS (pH 7.4)
E
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Figure A-1. Graph of the averaged results of three Beer-Lambert plots to determine the molar extinction coefficient
of compound 3-13 as a function of wavelength.
A-2. Emission spectra of 4-DMN in solvents of varying polarity
Me, N
I A-I
Me
tetrahydrofuran (THF), ethyl
dimethyl sulfoxide (DMSO).
To better illustrate the solvatochromic properties of the 4-
DMN fluorophore, compound A-1 was synthesized and dissolved
to a final concentration of 20 M in the following organic
solvents: diethyl ether, benzene, toluene, chloroform, dioxane,
acetate, acetone, 3-propanol, ethanol, acetonitrile, methanol, and
The samples were then excited at 375 nm and the emission spectra
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collected from 390 nm to 730 nm. The compound exhibits the greatest emission intensity in
diethyl ether with an emission maximum at 490 nm. The least emission intensity was observed
in DMSO with an emission maximum at 530 nm.
Solvent effects on emission spectrum of 4-N,N-dimethylamino-1,8-
naphthalimide (4DMN)
-diethyl ether
c 7.OE+08 - benzene
-toluene
. 6.OE+08 
-chloroform
-dioxane
. 5.0E+08
U) 
-THF
4.0E+08 -ethyl acetate
C -acetone
3.0E+08 3-propanol
0 
-ethanol
. 2.E+08 
-- acetonitrile
-methanol
1.OE+08
-DMSO
1.0E+00
390 440 490 540 590 640 690
Wavelenght (nm)
Figure A-2. Emission spectra of compound A-i at 20pM in thirteen different organic solvents of varying polarity.
The fluorophore exhibits the greatest emission intensity in diethyl ether with an emission maximum at 490 nm. The
least emission intensity was observed in DMSO with an emission maximum at 530 nm.
A-3. Improved synthesis of the 4-DMAP anhydride (A-2)
Due to the challenges of synthesizing the 4-DMAP anhydride A-2 on a multigram scale
using the sublimation method described by Vazquez et al.1, and the following alternative
approach was developed. This protocol is significantly faster and higher yielding.
194
........ ............. .................... 
NOW--
Scheme A-1. Improved conditions for the preparation of 4-DMAP anhydride (A-2)
O O
Me. I OH A, N2 (1 atm)
MeN - OH acetic anhydride MeN
Me O Me A-2
Conversion of the diacid precursor of A-2 to the anhydride is performed by dissolving the
starting material (1.00 g, 4.78 mmol) in 239 mL of acetic anhydride. The solution is prepared in
a 500 mL round-bottom flask equipped with a reflux condenser and charged with N2 gas. The
temperature is raised to 140 'C and the reaction is allowed to reflux for 2 hrs. The pale yellow
color of the starting material will change to a brilliant fluorescent yellow as the reaction
proceeds. Caution - the aniline nitrogen will oxidize rapidly if air is allowed to contaminate the
reaction while at high temperature. Once the reaction is complete, the temperature is reduced
before removing the acetic anhydride by rotary evaporation. The isolated product is then placed
under high vacuum overnight to remove any residual acetic anhydride. The desired product is
obtained in quantitative yield (0.91 g, 4.78 mmol).
Reference
(1) Vazquez, M. E.; Rothman, D. M.; Imperiali, B. A new environment-sensitive fluorescent
amino acid for Fmoc-based solid phase peptide synthesis. Org. Biomol. Chem. 2004, 2,
1965-1966.
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